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ABSTRACT 
To Consult or Not To Consult? Investigating Barriers 
Treatment-Seeking in Young Women 
by 
Robyn L. Donaldson, M. A. 
Dr. Marta Meana, Examination Committee Chair 
Associate Professor of Psychology 
University of Nevada, Las Vegas 
Little is known about mediators of treatment-seeking in dyspareunia. The general 
health belief literature as well as some existing qualitative data specific to dyspareunia, 
however, suggests a number of potentially significant barriers that may delay or prevent 
women from enlisting the aid of health care professionals. The aim of this study was to 
investigate influences on dyspareunia treatment-seeking behavior in young women, for 
whom the consequences of treatment avoidance are hypothesized to be the greatest. 
Given the lack of standardized health behavior measures relevant to intercourse pain, we 
constructed a measure assessing potential barriers to dyspareunia treatment-seeking. An 
exploratory principal component analysis yielded a 28-item, 3-component measure 
entitled the Sexual Health Treatment Barrier Scale – Dyspareunia Version (SHTBS-
Dysp). The components (sub-scales) were interpreted and entitled as follows: 
Minimization, Shame, and Fear of Severity.  We then investigated the psychometric 
properties of the SHTBS-Dysp, and explored convergent validity insofar as the 
endorsement of barriers correlated with cognitive and emotional styles associated with 
health behavior in the empirical literature and with self-report of treatment-seeking. 
Contrary to what has been found for most other health problems, treatment-seeking 
barriers for dyspareunia correlated positively with health anxiety, somatic amplification, 
iv 
pain catastrophization, and negative affect. Consistent with expectations, the measure 
correlated negatively with self-report of treatment seeking. Clinical and public health 
implications of the results are discussed. 
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CHAPTER 1 
INTRODUCTION 
Dyspareunia is a sexual pain disorder marked by recurrent pain with sexual 
intercourse that causes distress or interpersonal difficulty (APA, 2000). A significant 
number of women suffer from this disorder, which has a prevalence rate of approximately 
14% (Laumann, Paik, & Rosen, 1999). Dyspareunia is associated with a wide range of 
negative consequences. Pain with intercourse can impair all areas of sexual functioning, 
including desire, arousal, orgasm and overall satisfaction. The experience of pain with 
sex can also lead to numerous psychological sequelae ranging from negative affect and 
emotional lability to self-confidence and self-esteem deficits (e.g., Donaldson & Meana, 
2011; Meana & Binik, 1994). Relationships are another area negatively affected, with 
existing data supporting a link between sexual pain and lower rates of marital adjustment 
(e.g., Meana, Binik, Khalife, & Cohen, 1997). One study even found support for the 
existence of depression in partners of women with dyspareunia and theorized it to be 
linked to the sexual difficulties incurred by the experience of pain (Nylanderlundqvist & 
Bergdahl, 2003). The accumulation over time of the deleterious hypothesized effects of 
dyspareunia is of clinical concern as they impact various dimensions of the quality of life 
and well-being of women and their partners. Young women (18-29) are of particular 
concern as they have the highest prevalence rate (22%; Laumann, et al., 1999) and the 
pain has the potential to seriously disrupt their nascent sexual and romantic lives well 
before relationship and self-concept stability has set in.  
Seeking treatment is crucial to the prevention or management of the potential physical 
and psychological damage than can accumulate over time as a direct complication of 
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dyspareunia, especially for young women. However, the little data that exists indicates 
that they are delaying treatment-seeking for their pain. In a qualitative study addressing 
the psychosocial experience of pain with intercourse, participants reported a number of 
barriers interfering with their enlisting the help of health care professionals (Donaldson & 
Meana, 2011). Our understanding of the reasons underlying this reticence to consult with 
medical doctors or psychologists is not very elaborated in the case of dyspareunia. There 
is, however, theoretical reason to hypothesize that treatment seeking in women with 
dyspareunia may be influenced by factors similar to those involved in the practice of 
other health behaviors.  
The Health Belief Model (HBM: Champion, 1993; Rosenstock, 1966) and the 
empirical literature on determinants of health behavior suggest the influence of a number 
of factors. Of particular salience are the specific HBM dimensions of Seriousness, 
Susceptibility, Benefits, and Barriers, as well as a number of cognitive and emotional 
styles associated with treatment seeking in other conditions; health anxiety, negative 
affect, hypervigilance and somatic amplification, and pain catastrophization (Goubert, 
Francken, Crombez, Vansteenwegen, & Lysens, 2002; Jackson, Fiddler, Kapur, Wells, 
Tomenson, & Creed, 2006; Villanueva-Torrecillas, 2004; Walker & Furer, 2006). 
Considering that various samples of women with dyspareunia have been found to be 
characterized by elevated levels of depression and psychological distress, anxiety, 
hypervigilance, and somatic preoccupation, these factors may be of particular importance 
in the investigation of the influences on treatment seeking (Bohm-Starke, Hilligies, 
Brodda-Jansen, Rylander, & Torebjork, 2001; Jantos & White, 1997; Meana, et al., 1997; 
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Meana, Binik, Khalife, & Cohen, 1998; Meana & Lykins, 2009; Pukall, Binik, Khalife, 
Amsel, & Abbott, 2002;  van Lankveld, Weigenborg, & Ter Kuile, 1996).  
On the other hand, dyspareunia is unlike most health problems in its direct link to 
sexual activity. This makes it likely that certain mediators of health utilization will be 
unique and pertain specifically to the sexual nature of the problem, with all of its 
attendant socio-cultural weight. There is a body of research that has documented the 
reticence that both patients and doctors have to address sexual problems within the 
context of a medical consultation (e.g., Sadovsky, Alam, Enecilla, Consequien, Tipu, & 
Etheridge-Otey, 2006; Wiggins, Wood, Granai, & Dizon, 2007). For this reason, it is also 
important to extend our theorizing beyond the regulation of other health behaviors. 
Treatment seeking for dyspareunia may share characteristics of treatment-seeking for 
other potential health problems, but it may also present a specific and unique case 
because of its sexual and relational context. 
We are interested in expanding our knowledge of the influences on treatment in 
dyspareunia in young women in the belief that this question is a clinically important one. 
Treatment can significantly improve the lives of women reporting pain with intercourse 
and it behooves us to understand and target potential barriers. We thus aim to follow-up 
our initial qualitative investigation of treatment barriers (Donaldson & Meana, 2011) with 
a quantitative investigation of unique treatment-seeking influences, as well as those 
shared with other health problems. After a brief review of the problem of dyspareunia, its 
etiology and psychosocial correlates, the particular dilemma it poses for young women, 
and the question of treatment seeking for this problem, we will review the general 
literatures on treatment-seeking in general and on the health beliefs and 
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cognitive/emotional styles associated with dyspareunia. We will then turn to a review of 
data regarding both patient and physician reticence to address sexual problems in regular 
medical consultations. Finally, we will present the aims of the study and the 
methodology.   
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CHAPTER 2 
LITERATURE REVIEW 
The Problem of Dyspareunia 
One of two sexual pain disorders in the Diagnostic and Statistical Manual of Mental 
Disorders-IV-TR (APA, 2000), dyspareunia refers to the experience of recurrent pain 
with sexual intercourse causing distress or interpersonal difficulty and not produced by 
the physiological effects of a substance or a medical condition. Symptoms of dyspareunia 
are classified as being lifelong or acquired, generalized or situational, and due to 
psychological or combined factors. In the last decade, dyspareunia has come to be 
considered a significant women‟s health problem largely because of its high prevalence 
and because of the serious psychosocial detriments associated with it. 
Prevalence figures have ranged from 3% to 23%, with most studies settling 
somewhere around 15% (Danielsson, Sjoberg, Stenlund & Wikman, 2003; Fugl-Meyer & 
Fugl-Meyer, 1999; Najman, Dunne, Boyle, Cook, & Purdie, 2003). In the most 
epidemiologically sound survey of sexual behavior to date, Laumann, et al. (1999) 
interviewed 1410 men and 1749 women aged 18 to 59 and found approximately 14% of 
women suffered from dyspareunia. Younger women, aged 18 to 29, had the highest 
prevalence rate at 22% with prevalence decreasing with age: 30 to 39, 15%; 40 to 49, 
13% and 50 to 59, 8%. In this survey, Caucasians reported the highest rate (16%) 
followed by Hispanics (14%) and then African Americans (13%). What is evident from 
the literature is that dyspareunia is a disorder that affects a considerable number of 
women across age, ethnicity and geographic location.  
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Etiology and Correlates of Sexual Pain 
The etiology of dyspareunia is considered to be heterogeneous with overlapping 
physiological and psychosocial correlates. Without the benefit of longitudinal studies, it 
is difficult to tease apart causal factors from perpetuating ones, as factors that gave rise to 
the pain may no longer be the ones that maintain it. At this point in the research on 
dyspareunia, we are left to infer causal mechanisms from a collection of correlates of 
sexual pain. However, even when we refrain from making causal links, it is clear that 
there are a number of physiological, psychological, sexual and relational correlates of 
dyspareunia. 
Physiological.  
Most research efforts on potential physiological etiologies of dyspareunia have 
focused on the most common type of dyspareunia, provoked vestibulodynia (PVD) 
(formerly known as vulvar vestibulitis) (Moyal-Barraco & Lynch, 2004). Hypothesized 
etiologic factors have included neurological dysfunctions or hypersensitivity, endocrine 
or hormonal imbalance, vascular inflammation, pelvic floor hypertonicity, and a variety 
of infections such as yeast, sexually transmitted, and urinary tract (Bohm-Starke, et al., 
2001; Brotto, Basson, & Gehring, 2003; Danielsson, Sjoberg, & Wikman, 2000; Denbow 
& Byrne, 1998; Lowenstein, et al., 2004; Pukall, Binik, & Khalife, 2004; Pukall, et al., 
2002; Salonia, et al., 2004; Umpierre, Kaufman, Adam, Woods, & Adler-Storthz, 1991; 
White & Jantos, 1998; Witkin, Gerber & Ledger, 2002). Other medical conditions such 
as endometriosis or benign cysts have also been hypothesized to play a role in the 
development of certain cases of dyspareunia (Canavan & Heckman, 2000; Graziottin, 
2003). Iatrogenic causes linked to episiotomies, radiotherapy for cervical cancer, and 
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pelvic surgery scarring have also been implicated (Canavan & Heckman, 2000). It is 
important to note, however, that no one etiology accounts for a significant number of 
dyspareunia cases. Actually, in the majority of cases of dyspareunia, it has been 
impossible to determine a specific physiological etiology, much as in the case of other 
pain disorders of unknown etiology such as migraines, lower back pain, and fibromyalgia 
(Binik, Bergeron, & Khalife, 2007). 
Psychological. 
In addition to the myriad potential physiological etiologies, psychosocial correlates of 
dyspareunia have also received research attention. Lazarus (1980) organized these into 
three main psychosocial dimensions: developmental (e.g., early sexual attitudes, 
upbringing, and sexual schema), trauma-related (e.g., sexual abuse, genital medical 
procedures) and individual psychological factors (depression, somatization, attribution 
styles, state and trait anxiety, pain hypervigilance, psychological distress, and phobia).  
Women with PVD and other sub-types of dyspareunia have been found to have 
elevated levels of depression, psychological distress (anxiety, psychoticism, paranoid 
ideation, OCD, hostility, interpersonal sensitivity, phobic anxiety), and sexual depression 
(feelings of depression regarding one‟s sex life) than controls (Gates & Galasky, 2001; 
Meana, et al., 1997; Meana, et al., 1998). Nylanderlundqvist and Bergdahl (2003) found 
similar results in regards to depression and anxiety using the Beck Depression Inventory 
(BDI) and the State-Trait Anxiety Inventory (STAI-S) when comparing women with 
dyspareunia and controls. Over half (58.6%) of the women with dyspareunia scored a 10 
or above on the BDI, indicating a potential diagnosis of mild to severe depression. In 
addition, Jantos and White (1997) found that a large percentage of women with 
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dyspareunia scored high on suicidal ideation (57%) and depression (60%). Depressive 
symptomatology has also been associated with more severe pain reports (Meana, et al., 
1998).  
 Some women with dyspareunia have also been found to experience anxiety (Jantos & 
White, 1997) or even sexual phobia (Marin, King, Dennerstein, & Sfameni, 1998). Nunns 
and Mandal (1997) found their sample of women with dyspareunia had higher state and 
trait anxiety scores than controls. In one study, participants with PVD reported 
experiencing phobic anxiety to vaginal touch or entry (Brotto, et al., 2003). Women with 
PVD have also been found to score higher in the dimension of harm avoidance (a 
tendency to react with pessimistic worry and increased anxiety to future problems), to be 
passively avoidant, fearful, shy with strangers, and to have rapid fatigability (Danielsson, 
Eisemmann, Sjoberg, & Wikman, 2001). It has been hypothesized that anxiety and stress 
may magnify the symptoms of dyspareunia (Marin, et al., 1998). 
Sexual. 
Dyspareunia is also highly comorbid with other sexual problems, namely deficits in 
desire, arousal, and orgasmic capacity (Graziottin, Caliari, & Nicolosi, 2001). Women 
with dyspareunia have a higher incidence of engaging in sexual intercourse with 
reportedly low levels of lubrication, arousal, and desire, all of which can produce and or 
exacerbate the experience of pain during intercourse (Marin, et al., 1998; Nunns, & 
Mandal, 1997). Wounda, Hartman, Bakker, Bakker, van de Wiel, and Schultz (1998) 
found low physiological arousal and Marin, et al. (1998) found a lack of subjective 
arousal in women with dyspareunia. Payne, Binik, Amsel, and Khalife (2005) considered 
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the pain to act as a distraction from sexual cues, thus explaining the decrease in arousal 
for women with PVD. 
It is possible that the arousal and desire problems of many women with dyspareunia 
are linked exclusively to fear of penetration rather than to pre-existing sexual aversion 
that gave rise to dyspareunia. In other words, the generalized sexual dysfunction may be a 
consequence rather than a cause of intercourse pain. Marin, et al., (1998) measured the 
arousal of women with dyspareunia and controls when exposed to erotic scenes and 
found that women with dyspareunia experienced as much physical and subjective arousal 
to the visual stimuli as did control women. However, when viewing coitus scenes 
specifically, women with dyspareunia experienced a decrease in vaginal vasocongestion, 
although they subjectively found the coitus scenes arousing. Brauer, ter Kuile, Janssen 
and Laan (2007) found a reduction in subjective and genital sexual responding when they 
induced pain-related fear in women with and without dyspareunia; however, women with 
dyspareunia reported significantly more negative affect than the control group. Although 
women with dyspareunia are capable of engaging in many forms of painless, non-
penetrative sexual expression and foreplay, many avoid all types of sexual activity. They 
may be generalizing the pain to all forms of sexual activity or it could be that all non-
penetrative sexual activity carries the risk of future penetration (Gates & Galasky, 2001). 
Solitary masturbation may be the exception, as women with dyspareunia have reported 
less frequent problems and distress with masturbation than with sexual interaction (van 
Lankveld, et al., 1996). It is also possible that negative thoughts regarding sex are related 
to this lack of sexual interaction, since some women with dyspareunia report more 
negative cognitions about or aversion to sex (Nunns & Mandal, 1997). It is important to 
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note, however, that one other study did not find that women with dyspareunia had more 
negative cognitions (van Lankveld, et al., 1996).  
Relational. 
 Women with dyspareunia have reported less marital satisfaction than women who do 
not experience pain (Masheb, Brondolo, & Kerns, 2002; Meana, et al., 1997). The extent 
to which dyspareunia may contribute to the dissolution of relationships and marriages is 
unknown; however, in Gordon, Panahian-Jand, McComb, Melegari, and Sharp‟s (2003) 
vulvar pain study, 76% of respondents endorsed fear that the pain would ruin their 
relationship. Interestingly, the more adjusted the couple, the lower the pain rating 
(Meana, et al., 1998). Results from a recent study on couples with PVD have shown that 
both solicitousness and hostility on the part of the husband were related to higher pain 
ratings in the women (Desrosiers, Bergeron, Meana, Leclerc, Binik, & Khalife, 2008). 
How the partner reacts to the situation, how much empathy is present and the ways in 
which they solve problems together may be important facilitators of healthy adjustment 
to the problem of intercourse pain. It is also possible that more adjusted couples have 
sexual stimulation techniques that are more sexually satisfying and less pain producing. 
The Special Case of Dyspareunia in Young Women 
Clearly dyspareunia is associated with significant negative sequelae ranging from 
mood disturbances, to generalized sexual dysfunction, to relationship difficulties. This 
configuration of deleterious correlates is concerning for all women; however, we believe 
it may be particularly devastating for young women who are starting to develop their 
sexual self-concept and starting romantic relationships and sexual lives. These are 
defining experiences wherein young women develop their sense of self as sexual beings 
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and romantic partners. Young women are also at the crossroads of important life 
transitions that could be seriously disrupted by sexual pain. It is doubly concerning 
because young women appear to have the highest prevalence of dyspareunia according to 
the best estimates we have (22%: Laumann, et al., 1999). 
In our study of college women with dyspareunia we found evidence of the negative 
impact of dyspareunia on both their romantic relationships, as well as on their feelings of 
self-worth (Donaldson & Meana, 2011). In terms of their sexuality, participants reported 
lower sexual desire, difficulties with physiological and subjective arousal, interference 
with their ability to experience orgasm and a tendency to actively avoid sexual contact 
with their partners. In terms of the non-sexual aspects of their relationships, they reported 
impairments in being able to connect on an intimate and physical level, resulting in an 
emotional distancing on the part of both members of the couple.  Many reported an 
increase in conflict and in the level of emotional distress expressed by their partners. 
These women worried their partners would not remain sexually faithful to them and/or 
simply leave the relationship.  
The stress of the real and imagined impact of intercourse pain on their relationships 
compounded the negative emotions these women were already experiencing. They 
reported feeling angry at themselves and their partners, frustrated at the impact of the 
pain on their lives, embarrassed that they had a problem with their sex life, and depressed 
about the whole situation. Having dyspareunia also negatively affected how these women 
viewed themselves. Many reported feeling abnormal when they compared themselves to 
other women, especially their peers, and they reported self-doubt, insecurity and 
decreases in self-confidence.  
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Although dyspareunia can have a serious negative impact on the lives of women of all 
ages, we are particularly concerned about its early onset in young women. We believe 
there may be an important difference between the impact of a dyspareunia onset at the 
age of 50 rather than at the age of 20. In the case of the older woman, there may be a 
bigger chance that the onset of pain will not seriously derail her self-concept. It is also 
more likely that she is either in a stable relationship or that the maturity of relationships 
she might have will better weather the difficulties posed by this problem. In the case of a 
young woman, dyspareunia may have a more lasting and pervasive impact on the 
development of self-concept and healthy romantic relationships. This is, of course, an 
empirical question yet to be answered. 
The Question of Treatment-Seeking 
Despite the negative consequences of dyspareunia, it appears that treatment-seeking 
may not be happening as quickly as it should. The delay may be resulting in a further 
exacerbation of symptoms and associated problems. There are a number of strong 
theoretical reasons to posit that targeting the symptoms of dyspareunia early may be 
important in order to arrest or at least manage the instatement of lifelong pain. The 
pairing of pain with sex in a classical conditioning dynamic, the instatement of 
hypersensitization, increases in hypervigilance, and a general pattern of avoidance can all 
combine to complicate the pain problem in the long term. And yet, the little data 
available on treatment-seeking in women with dyspareunia is disheartening. 
Donaldson and Meana (2011) found that 12 of the 14 college aged women with 
dyspareunia they interviewed had not sought professional help for the problem. 
Participants articulated a number of barriers to seeking professional health care for this 
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problem. Some believed in spontaneous remission, that the pain would improve on its 
own without any major intervention. Most expressed a lack of confidence in a medical 
solution, lacking faith that the medical profession could possibly have an effective 
intervention. Since most of the women in this study had no idea what the source or cause 
of their pain could be, they doubted the existence or possibility of a cure for dyspareunia. 
Another barrier to seeking treatment was the fear that the pain was a symptom of a severe 
health condition, like cancer. They did not want to go to the doctor because they were 
afraid to find out what condition they might have. Additionally, others feared the pain 
would never go away and they delayed consulting a doctor as they did not want that 
suspicion confirmed definitively.  
The Donaldson and Meana (2011) sample consisted of young women still heavily 
influenced by their family and the religious values in which they were raised. Going 
away to college may have given them the opportunity to engage in sexual activity for the 
first time, but many had not told their parents, siblings and/or friends that they had had 
premarital sex. One major barrier to seeking treatment was a fear that their parents might 
discover that they were sexually active. A number of these women reported worrying 
about how other people would judge them if they told them they experienced pain with 
intercourse.  Some participants lumped sexual and relational problems together and 
defined these as existing outside the realm of medicine. They did not believe the medical 
profession would be able to assist them because they did not judge themselves to be 
suffering from a strictly medical problem.  
Some research on women over 30 also exists in relation to treatment seeking. In one 
survey study, only a quarter of Chinese women with reported dyspareunia and urinary 
14 
symptoms indicated they had sought treatment (Stones, Padmadas, & Guo, 2006). 
Women of increasing age with vaginal symptoms, including dyspareunia, have been 
found to have a lower rate of treatment seeking than their younger counterparts (Pastore, 
Kightlinger, & Hullfish, 2007). In a qualitative study conducted by McGowan, Luker, 
and Creed (2007), women with chronic pelvic pain initially sought treatment but then 
disengaged from the process when they found that treatment did not resolve their pain. 
One study conducted at a sexually transmitted infection clinic in Norway examined the 
prevalence rate of long-standing vulval problems and entry dyspareunia.  Of the 114 who 
reported vulvar problems (burning, post-coital soreness, dryness and fissures with a 
duration of at least three months), 68.4% reported having seen a doctor due to the 
symptoms (Edgardh & Abdelnoor, 2003).    
In summary, we know very little about the determinants and barriers of treatment-
seeking in women with dyspareunia.  Although the treatment of the sexual pain disorders 
is by no means perfect, there is an increasing number of studies indicating significant 
rates of success with both surgical and psychosocial interventions for sexual pain 
(Bergeron, Binik, Khalife, Meana, Berkley, & Pagidas, 1997; Bergeron, et al., 2001; 
Bergeron, Khalife, Glazer, & Binik, 2008). It behooves us to better understand what 
keeps women from seeking treatment for this disorder, as treatment has the potential to 
stem a tide of negative sequelae. It is useful here to turn to the literature on the 
determinants of help-seeking for other health problems as this may help us understand 
factors that lead some individuals to seek help for health problems and others not. Some 
of these factors may be portable to the study of treatment-seeking in dyspareunia. 
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Influences on Treatment Seeking in General 
Health Beliefs 
In an attempt to provide insight into the attitudes and beliefs associated with health 
behaviors, Hochbaum, Leventhal, Kegeles, and Rosenstock introduced the Health Belief 
Model (HBM) (Rosenstock, 1966). The original theoretical framework posited that an 
individual‟s decision to perform a health behavior is influenced by a wish to avoid 
becoming ill and a belief that a specific health action will prevent illness or reduce the 
risk of contracting it. The HBM elaborated on the beliefs that might impact this illness-
avoidance motivation into four main appraisals: (1) perceived personal vulnerability to or 
subjective risk of a health condition (Susceptibility), (2) perceived personal harm of the 
condition (Seriousness), (3) perceived positive consequences of a health behavior 
(Benefits), and (4) perceived negative aspects related to engaging in a health behavior 
(Barriers). In a later revision, Rosenstock, Strecher and Becker (1988) recommended the 
addition of Self-Efficacy (SE) as a predictive factor of health promoting behaviors, 
suggesting that people are motivated to engage in a behavior based on efficacy 
expectations, defined as their perceived competence in the enactment of the specified 
health behavior. Health Motivation, the generalized state of intent that results in 
behaviors to maintain or improve health, was later added to the HBM, the addition of 
which has shown to increase the predictive validity of the model (Champion, 1984; 
1993).  
The revised HBM has been used in the context of a variety of health prevention and 
intervention strategies to assess patients‟ motivations in performing health behaviors. The 
impact of each HBM dimension appears to be partly dependent upon the type of health 
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behavior being considered. Millar and Millar (1995) asked half of their 96 participants to 
think of disease detection behaviors (i.e., cholesterol level checks, regular dental exams, 
regular eye exams, skin cancer checks, blood pressure checks) while the other half were 
asked to think of health promotion behaviors (i.e., adhering to a low-fat/low-cholesterol 
diet, brushing and flossing teeth on a regular basis, wearing sunglasses or applying 
sunscreen when exposed to bright sunlight, participating in vigorous exercise 3-4 times a 
week). Participants were given 20 seconds to imagine performing the behavior and then 
were asked to spontaneously generate statements regarding the behaviors imagined which 
were then content analyzed for elements of the HBM. Individuals considering health 
detection behaviors produced more statements about the severity (Seriousness) of and 
Susceptibility to the illness than individuals who considered health promotion behaviors. 
Additional responses regarding other benefits not related to the disease were also 
generated, suggesting the perceived Benefits of behaviors aimed at improving one‟s 
general health. For example, one participant mentioned that sunscreen “moisturizes her 
skin” and another mentioned that low-fat/low-cholesterol diet “tastes good.”  
One study of young college women examined osteoporosis-preventive behaviors such 
as the consumption of calcium (CA) and performance of weight-bearing exercise (EX) 
(Schmiege, Aiken, Sander & Gerend, 2007). Baseline measures of intention at the time of 
the study as well as behavioral measures six months later were assessed. Perceived 
Barriers were negatively related to intention and they were the only significant predictor 
of behavior. Another study using the expanded health belief model on CA and EX in 
college women found that exercise Self-Efficacy and Barriers to exercise were most 
predictive of overall CA and EX behaviors (Wallace, 2002). It is possible that because of 
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the distal nature of developing osteoporosis, Barriers tend to be most predictive of health 
behavior as they immediately affected the lives of these women. Seriousness of and 
Susceptibility to a condition that these women were not likely to develop for many years 
not surprisingly failed to predict behavior. Other studies have addressed osteoporosis-
preventing behaviors (OPB; i.e., calcium intake and use of osteoporosis medication) in 
postmenopausal women, whose lives are more immediately impacted by bone density 
loss. After receiving their bone density scan results, women showed an increase in 
perceived Susceptibility to osteoporosis as well as an increase in OPB when compared to 
women who did not receive bone density scans (Estok, Sedlack, & Doheny, 2007; 
Sedlack, Doheny, Estok, Zeller, & Winchell, 2007).  
Some research on the extent to which the HBM can predict smoking cessation has 
found that perceived Susceptibility is linked to smoking cessation behaviors (Manfredi, 
Lacey, Warnicky, & Petraitis, 1998; Norman, Conner, & Bell, 1999; Tessaro, et al., 
1997). In older individuals with chronic-obstructive pulminary disease (COPD), 
Schofield, Kerr and Tolson (2007) found that approximately 60% of participants 
accurately perceived smoking as directly linked to the progression of their disease and yet 
they continued to smoke. Only one participant listed a benefit to quitting while the 
remaining 21 participants listed a variety of Barriers such as it was harmful to quit, they 
would become more anxious and have difficulty breathing, and that it would be too hard 
to quit because they were addicted.  
In another study investigating smoking cessation in community college students 
(Prokhorov, et al., 2007), participants were assigned to receive either standard smoking 
cessation advice or computer-assisted smoking cessation counseling. Participants 
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completed a computerized questionnaire assessing a wide range of factors associated with 
smoking and smoking cessation, including four health belief model variables: perceived 
vulnerability (Susceptibility) to the effects of smoking, perceived Seriousness of the 
consequences of smoking, and costs (Barriers to quitting) versus Benefits of quitting 
smoking. Regarding Susceptibility, most participants (93%) reported their health had 
been negatively affected by smoking; although 79% indicated they had no symptoms or 
illness caused by smoking. Also, participants reported more Benefits to smoking and 
more Barriers to quitting. In a study of male Chinese smokers, teachers, factory workers 
and medical workers were randomly selected to complete questionnaires that queried 
their attitudes, beliefs and environmental factors associated with smoking, as well as their 
intentions to quit (Wang, Borland, & Wheland, 2002). Susceptibility and Seriousness 
were found to be predictive of outcome expectancy (how strongly they believed they 
would quit smoking in the next six months) and outcome incentive (how important it was 
to them that they quit smoking in the next six months).  
The HBM has also been applied to the study of breast self-examination (BSE) 
(Champion, 1984). Champion and Miller (1992) asked 362 women 35 years and older to 
participate in two telephone interviews regarding attitudes, knowledge, intent and 
experience regarding BSE. The second interview was conducted a year after initial 
contact. They found that Health Motivation and Susceptibility were positively related to 
BSE and Barriers were negatively related to BSE. Contrary to expectations, 
Susceptibility was also positively related to Barriers, suggesting that the greater women 
assessed their breast cancer susceptibility to be, the more fear acted as a Barrier. Women 
may identify more Barriers to BSE when they are apprehensive that performing the exam 
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might likely reveal a malignant lump. Talbert (2007) assessed breast cancer screening in 
African American middle class women and found the Barriers of fear and fatalism to be 
negatively related to breast cancer detection compliance. In a study on Jordanian women, 
Health Motivation and Susceptibility were positively and Barriers negatively related to 
BSE in the previous year whereas Benefits, Susceptibility and Health Motivation were 
positively associated with intention to perform BSE in the future (Petro-Nustus & 
Mikhail, 2002). In regards to mammography, an increase in perceived Benefits (belief 
that a mammogram can find breast lumps early) has been found predictive of forward 
movement in terms of Prochaska and Diclemente‟s (1982) stages of behavior change 
(e.g., Precontemplation, Contemplation, Preparation, Action, Maintenance) (Menon, 
Champion, Monahan, Daggy, Hui, & Skinner, 2007).  
In summary, the HBM has provided a reliable theoretical framework with which 
researchers can assess some of the factors influencing health behaviors. Although there is 
variability in the extent to which HBM dimensions predict health detection versus health 
promotion behaviors, many of the health behaviors that have been studied have been 
found to be partly contingent on HBM dimensions. Barriers and Susceptibility appear to 
be the most robust and predictive dimensions in terms of commitment to most health 
behaviors. However, results tend to vary depending upon the specific type of 
disease/illness and behavior being addressed.  
Cognitive and Emotional Styles 
The HBM has been applied primarily to health promotion and disease prevention or 
detection behaviors. Turning our attention specifically to treatment seeking, studies have 
found disease severity (Seriousness) positively linked to treatment seeking behaviors, 
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such as diagnostic testing (Dawson, Savitsky, & Dunning, 2006). However, factors other 
than those covered by HBM dimensions have been implicated in the determination of 
treatment seeking. Research focusing on mediators of treatment seeking behavior has 
concentrated more on dispositional, cognitive and emotional processing styles (i.e., 
tendencies toward health anxiety, depression, hypochondriasis, hypervigilance, 
catastrophization, negative mood states and neuroticism).  
Depression and Negative Affect. 
Research pertaining to how depression impacts treatment-seeking has revealed 
findings suggesting higher use of health care services and the bidirectional relationship 
between depression and medical illnesses may explain the higher use (Benton, Staab, & 
Evans, 2007). One study examined data from non-institutionalized individuals over the 
age of 50 who participated in the Survey of Health, Ageing, and Retirement in Europe 
(Peytremann-Bridevaux, Voellinger, & Santos-Eggimann, 2008). Those evidencing 
depressive symptoms were more likely to utilize health care services (e.g., outpatient 
visits, medication, hospitalization, surgery, and home healthcare) over the previous 12 
months. Another study investigated the incremental effect of major depression on health 
care utilization in patients with chronic medical conditions; hypertension, diabetes 
mellitus, coronary artery disease, congestive heart failure, stroke or cerebrovascular 
event, chronic obstructive pulmonary disease, and endstage renal disease (Edege, 2007). 
The 12-month prevalence and odds of major depression was high in individuals with 
chronic medical conditions, and major depression was associated with significant 
increases in utilization (ambulatory visits and emergency room visits), lost productivity 
and functional disability. A similar study compared the health-related quality of life, 
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disability/work productivity, and health care utilization in a variety of medical disorders 
with and without comorbid major depressive disorder (MDD) (Baune, Adrian, & Jacobi, 
2007). Medical diagnoses included respiratory, cardiovascular, allergic, 
endocrine/metabolic, gastrointestinal, and neurological diseases. When there was 
comorbidity of these conditions with MDD, outpatient doctor visits over the prior 12 
months was found to be significantly higher (24-42%), except for those with respiratory 
diseases.  
Affect in general has been found to be related to adjustment to chronic illnesses and 
pain disorders.  Negative affect in patients suffering from hypertension, diabetes, cancer 
and rheumatoid arthritis, has been related to lower self-esteem and poorer overall 
adjustment to illness (Felton, Revenson, & Hinrichsen, 1984). Heart patients with higher 
levels of positive affect have been found less likely to be readmitted for cardiac issues 
(Middleton & Byrd, 1996), while negative affect in heart transplant patients has been 
associated with poor adjustment: increased neurological symptoms, lower mobility 
function, more health uncertainty, more sleep problems, poorer recreational functioning 
and more physical limitations (Rybarczyk, 2007). Negative affect may also play a 
significant role as a risk factor for prostate, colorectal, and lung cancer (White, English, 
Coates, Lagerlund, Borland, & Giles, 2007). Prostate cancer survivors with high negative 
affect were found to be more adversely affected by the disease years after treatment and 
to continue to engage in a range of coping strategies to attenuate the negative 
psychological impact and intensity of the disease‟s effects (Blank & Bellizzi, 2006). 
Similar findings related to adjustment have also been found in breast cancer patients 
(Beckham, Burker, Lytle, Feldman, & Costakis, 1997; Bower, Meyerowitz, Desmond, 
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Benaards, Rowland, & Ganz, 2005). Negative affect has been found to impact adjustment 
in pain disorders as well. In patients suffering from scleroderma, individuals with higher 
negative affect scores engaged in maladaptive coping strategies and reported greater 
disease-related pain (Hansdottir, Malcarne, Furst, Weisman, & Clements, 2004). Similar 
results have been found in the adjustment of patients with rheumatoid arthritis and 
fibromyalgia (Reich, Johnson, Zautra, & Davis, 2006; Revenson, & Felton, 1989). 
Pain appears to be particularly sensitive to an individual‟s emotional state. Even the 
temporary experimental induction of a negative mood can result in increased reports of 
pain (Davis, Zautra, & Reich, 2001). Several studies have shown a positive relationship 
between neuroticism and pain experience (Goubert, Crombez, & van Damme, 2004; 
Gracely, et al., 2004; Sullivan, Lynch, & Clark, 2005), with a high comorbidity of 
depression and anxiety in pain patients (Tan, Jensen, Thornby, & Sloan, 2008). The 
expression of emotions can also impact the experience of pain. Conflict over emotional 
expression and inhibition of emotions regarding pain can lead to obsessive thoughts about 
the pain, increasing the risk of developing stress related diseases such as heart disease, 
ulcers, cancer (King & Emmons, 1990; Pennebaker, 1985).  
If affect impacts the individual‟s experience of disease or pain, then one would expect 
that affect would also have some influence on an individual‟s treatment-seeking behavior. 
There is some data supporting the relationship between negative mood states and health 
care utilization. Patients who sought treatment for irritable bowel syndrome (IBS) 
reported higher levels of emotional distress and greater health worries than those who had 
not sought treatment (Drossman, et al., 1988). A study investigating the effects of 
therapeutic writing of emotional disclosure for women with fibromyalgia found that the 
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exercise led to decreases in negative affect which was consequently linked to a reduction 
in health care utilization (Gillis, Lumley,Mosely-Williams, Leisen, & Roehrs, 2006). In 
another study, arthritis patients with higher levels of negative affect reported 
experiencing greater perceived pain and those with higher levels of positive affect 
utilized health care services less frequently (Villanueva-Torrecillas, 2004). Negative 
affect has also been found to be positively correlated with health care utilization in a 
sample upper-middle class, Caucasian adults aged 73 years and above who suffered from 
a wide variety of medical conditions (Maher, 2005). Overall, the current literature 
suggests that for a variety of pain disorders, the greater the psychological distress or 
negative affect a person experiences, the more likely they are to use health care services.  
Neuroticism has also been found to be a psychological determinant in treatment 
seeking. In an evaluation of factors associated with the use of healthcare several years 
after a severe burn injury, Wikehult, et al., (2005) found that patients treated in a burn 
unit from 1980-1995 who were still utilizing healthcare due to their burn injury, 
approximately nine years later (SD=4.8), scored significantly higher on Neuroticism than 
those who were not still utilizing healthcare. Another study investigating the relationship 
of neuroticism to health and use of services in an elderly community sample found a 
positive correlation between neuroticism in elderly women and the number of different 
professionals consulted in the previous six months (Jorm, Christensen, Henderson, 
Korten, Mackinnon, & Scott, 1993). Van Hemert, Bakker, Vandenbrouke and 
Valkenburg (1993) studied baseline psychological distress, as measured by a neuroticism 
scale, as a predictor of self-reported use of medical care (treatment by a physician and 
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current use of medication) nine years after initial treatment. They found neuroticism and 
health care treatment to be positively associated in women between the ages of 45 and 64.  
In summary, a variety of psychological factors appear to influence treatment-seeking. 
Health anxiety, depression, somatic amplification and hypervigilance, catastrophization, 
negative mood states have all been found to be related to health care utilization. The 
attentional bias towards health related information and symptoms, associated with both 
health anxiety and catastrophization, may help explain the tendency toward treatment-
seeking. However, individuals evidencing these emotional and cognitive styles do not 
appear to experience much relief or benefit from this treatment-seeking behavior. It is 
possible that an individual‟s reaction to their disease or illness may contribute to how 
they respond to attempts at treatment.    
Health Anxiety. 
Health anxiety, defined as a significant concern about health in the absence of 
pathology or excessive concern when there is some degree of pathology, shares 
substantial overlap in symptomatology with other disorders, such as hypochondriasis, 
panic disorder, generalized anxiety disorder (GAD), and obsessive-compulsive disorder 
(Walker & Furer, 2006; Wheaton, Berman, Franklin, & Abramowitz, 2010). Researchers 
and clinicians have generally considered hypochondriasis to be an extreme form of health 
anxiety (Sacco & Olczak, 1996; Warwick & Salkovskis, 1990) and the DSM-IV-TR 
(APA, 2000) has specific diagnostic criteria for diagnosing hypochondriasis. The 
characteristics of health anxiety and hypochondriasis are similar and the terms are often 
used interchangeably. Differentiating sub-clinical levels of health concern from 
hypochondriasis, however, allows for a better understanding of the degree of impact the 
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individual‟s health focus may be having on the presentation of symptoms (Salkovskis, 
Rimes, Warwick, & Clark, 2002). In terms of general health behavior, the focus in the 
literature has been primarily on health anxiety. 
Cognitive-behavioral conceptualizations of health anxiety propose that it is 
characterized by maladaptive cognitive biases for illness-related information and 
selective attentional bias for externally and internally occurring information. It is posited 
that these biases maintain health anxiety (Warwick & Salkovskis, 1990). Lees, Mogg and 
Bradley (2005) assessed whether individuals with high levels of health anxiety (in this 
study conceptualized as general health anxiety as well as anxiety sensitivity, which is a 
fear that symptoms of anxiety are harmful), showed enhanced attentional bias for external 
health-threat cues. This was assessed through the use of a visual probe task in which 
health-threat and neutral pictures and words were presented. Individuals with high levels 
of anxiety sensitivity, but not general health anxiety, demonstrated enhanced initial 
attentional bias towards pictorial health-threat stimuli compared with low anxiety 
sensitivity individuals. This may indicate that anxiety sensitivity responds more to 
suggestions of immediate threat (e.g., increased heart rate appraised as leading to an 
imminent heart attack) than general, long-term threats (e.g., getting a serious illness in the 
future). Similar results regarding attentional bias were found using a modified Stroop 
task, in which individuals with high anxiety had slower response times (indicating 
salience and cognitive interference) to illness-related stimuli than to other emotionally 
laden stimuli (Owens, Asmundson, Hadjistavropoulos, & Owens, 2004). This type of 
attentional bias has also been implicated in a tendency to ignore positive health 
information in favor of more catastrophic information and to increase intensity of anxious 
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feelings (Owens, et al., 2004). There also appears to be a memory bias for health words in 
high health anxious individuals, suggesting a negative emotional association for all that is 
health-related (Ferguson, Moghaddam & Bibby, 2007).  
The health threat cognitive bias appears to ultimately have an impact on treatment-
seeking behavior. Health anxiety has been linked to more frequent health care utilization, 
such as frequent doctor visits, doctor shopping, requests for expensive diagnostic tests 
and adhering to unnecessary treatments (Barsky, Ettner, Horsky, & Bates, 2001; Hiller, 
Fichter & Rief, 2003; Lucock & Morley, 1996; Salkovskis & Warwick, 2001; 
Seivewright, et al., 2004). This pattern of health-care utilization is also reflected in the 
seeking out of health information online more often and in the higher frequency of 
medical appointments evidenced in individuals with high health anxiety (Eastin & 
Guinsler, 2006). However, high health anxiety has also been found to have a paradoxical 
effect such that certain individuals thus afflicted avoid healthcare professionals altogether 
for fear of being diagnosed with a serious disease or because they are dissatisfied with 
their previous healthcare experiences (Walker & Furer, 2006).   
Interestingly, seeking and receiving treatment often fails to improve the psychological 
condition of individuals with high levels of health anxiety (Lucock, White, Peake, & 
Morley, 1998; Miles & Wardle, 2006), even when queried a year after initial treatment 
seeking (Fernandez, Fernandez & Amigo, 2005). It appears that they fail to be reassured 
by health professionals. In a study focusing on reactions of women who had received a 
benign diagnosis of breast symptoms, those who were not reassured had higher levels of 
health anxiety, perceived stress, fear about breast cancer treatment, and general anxiety 
than women who had felt reassured by their medical consultation (Meechan, Collins, 
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Moss-Morris, & Petrie, 2005). This phenomenon is concerning given that women 
experiencing continued distress after such a diagnosis have been shown to be reluctant to 
adhere to recommended follow-up after receiving a benign breast symptom diagnosis 
(Andrykowski, et al., 2001). The tendency to avoid continued care in those with health 
anxiety may be a common trend across health conditions, contributing to a poor 
prognosis for treatment (Luconi, et al., 2007).  
Somatic Amplification and Hypervigilance. 
Other than in the case of preventive health care, somatic symptoms are usually what 
compel individuals to consult a medical professional. This otherwise functional 
awareness of one‟s body can, however, develop into a maladaptive perceptual and 
cognitive process that has been termed somatosensory amplification (Barsky, 1992). 
Somatosensory amplification refers to the tendency to experience somatic sensations as 
intense, noxious and disturbing. The process of this amplification is considered to be 
mediated by the belief that one has a disease, suggestibility and negative expectations 
about the future course of the disease, adoption of the sick role, and stressful events. 
Three components of somatosensory amplification have been described: (1) bodily hyper-
vigilance that involves heightened self-scrutiny and increased attention to unpleasant 
bodily sensations; (2) the tendency to select and focus on certain relatively weak or 
infrequent sensations; and (3) the tendency to appraise visceral and somatic sensations as 
abnormal, pathological, and symptomatic of disease, rather than as normal bodily 
functioning (Barsky, Goodson, Lane, & Cleary, 1988; Barsky, 1992).  
Somatic amplification has been found to be related to increases in reporting of 
somatic symptoms (Duddo, Isaac & Chaturvedi, 2006), with a mediating effect of affect 
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and mood states (i.e., anxiety, depression and negative affectivity/neuroticism) (Barsky, 
et al., 1988; O‟Brien, Atchison, Gremillion, Waxenberg, & Robinson, 2008). There also 
tends to be a high comorbidity with hypochondriasis (Barsky and Wyshak, 1990), 
although amplification may only be one facet of hypochondriasis (Barsky, Wyshak, & 
Klerman, 1990). And although a link exists between somatization and psychological 
symptoms, a person‟s appraisal of their symptoms may have a significant impact on their 
physical and psychological well-being. Robbins and Kirmayer (1991) found that a 
somatic attributional style is predictive of the number of somatic complaints presented to 
family physicians. Individuals with a somatic attributional style may focus their attention 
on bodily symptoms of emotional distress and may also exhibit an attentional bias 
towards illness-related information (Takayanagi, & Fujiu, 2008). By pursuing the 
physical and somatic remedy, patients and physicians fail to address the psychological 
source and symptoms of the emotional conflict (Bridges, Goldberg, Evans, & Sharpe, 
1991; Kirmayer, 1984; Verhaak & Tijhuis, 1994).  
Some research on somatic amplification in the context of pain has focused on the 
relationship between somatization and alexithymia (difficulty identifying and describing 
feelings, having an impoverished fantasy life, and excessive preoccupation with physical 
symptoms and external events), hypothesizing that alexithymic individuals amplify 
unpleasant internal symptoms (Kano, Hamaguchi, Itoh, Yanai, & Fukudo, 2007). Chronic 
pain patients have been found to be significantly more alexithymic than controls (Celikel 
& Saatcioglu, 2006). One study examining the effect of emotion-regulation strategies in 
women with fibromyalgia found that the intense experience of emotions was related to 
more pain in those women who had greater levels of alexithymia (van Middendorp, 
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Lumley, Jacobs, van Doornen, Bijlisma, & Geenen, 2008). Another study investigating 
the prevalence of mood, anxiety and disability disorders in patients who experience daily 
headaches or migraines found high levels of anxiety and depressive symptomatology to 
be associated with alexithymia (De Filippis, Salvatori, Coloprisco, & Martelletti, 2005).   
Treatment-seeking behavior in individuals with high levels of somatic amplification 
has been characterized as consisting of frequent use of health services and specific illness 
attitudes including excessive health related worry, bodily preoccupation, a conviction of a 
more sinister disease-related cause for symptoms and a fluctuating resistance to 
reassurance (Duddo, et al., 2006). Often, medical consultations result in null findings for 
organic causes, thus frustrating the patient who will then search for another doctor 
(“doctor shopping”) in search of a definitive answer. This cycle contributes to further 
amplification of symptoms and high rates of utilization of health care resources (Duddo, 
et al., 2006). For example, one study found that somatizing patients in primary care 
practice had almost twice the outpatient utilization in the preceding year than that of non-
somatizing patients (Barsky, et al., 2001). Similar results have been found regarding 
outpatient and inpatient medical care utilization with the accrual of twice the medical 
care costs in somatizing patients than in non-somatizing patients (Barsky, Orav, & Bates, 
2005). Jackson, et al., (2006) investigated referred patients seeking consultation from 
neurology, gastroenterology or cardiology clinics and found that number of bodily 
symptoms was associated with number of medical consultations within the six months 
after these patients‟ referral. A Dutch study investigating the impact of mental illness on 
non-psychiatric health care utilization found that patients with mental illness reported 
more frequent use of primary care (Hansen, Fink, Sondergaard, & Frydenberg, 2004). 
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However, those with somatoform disorders had the highest risk for increased utilization, 
much as has been found in other studies (e.g., Grabe, et al., 2003). 
Catastrophization. 
The construct of catastrophization is closely related to health anxiety and somatic 
amplification but refers specifically to one type of appraisal – an exaggeration of the 
negative aspects of the illness or pain experience and of the potential deleterious 
consequences of the experience. This construct has been studied primarily in regard to 
pain. According to Chaves and Browne (1987), pain catastrophization occurs when 
individuals magnify or exaggerate the threat value or seriousness of pain sensation. The 
construct is broadly considered to be an exaggerated negative orientation towards actual 
or anticipated pain experiences (Sullivan, Bishop, & Pivik, 1995). It is characterized by 
an experience of heightened pain intensity, increased disability, and difficulty 
disengaging from pain (Sullivan, et al., 2005; Sullivan, et al., 2001; van Damme, 
Crombez, & Eccleston, 2004).  
The disruptive impact of pain on attention is amplified in those who catastrophize 
pain (Crombez, Eccleston, Baeyens, Vansteenwegen, Lysens, & Eelen, 1998; Crombez, 
Eccleston, Van den Broeck, Housenhove, & Goubert, 2002; Vancleef & Peters, 2006). 
Neuroimaging data in individuals with chronic fibromyalgia has shown that 
catastrophizers show greater activity in the dorsolateral prefrontal cortex (DLPF), rostral 
anterior cingulated cortex (ACC), and medial prefrontal cortex (MFC) (Gracely, et al.,  
2004). These regions have been implicated in pain vigilance, attention, and awareness, 
suggesting attentional interference. Persons with high catastrophization scores have 
shown difficulty suppressing pain-related thoughts and behaviors, lending support to the 
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“attention model” associated with pain, in which acute attention to pain underlies pain 
catastrophization (van Damme, et al., 2004). A study involving fMRI‟s performed on 
healthy individuals during two pain intensity levels evoked by electrical median nerve 
stimulations add support to this model (Seminowicz & Davis, 2006). When mild pain 
was administered, there was a positive relationship between catastrophization and cortical 
regions in the brain associated with attention. 
Pain catastrophization also has a significant impact on the phenomenological 
experience of the pain itself and on pain behavior. Pain catastrophization scores in those 
with sickle cell pain have been found to predict pain sensitivity, as these individuals tend 
to overestimate the pain they will experience in the following six months (Gil, 
Thompson, Keith, Tota-Faucette, Noll & Kinney, 1993). Elevated levels of self-reported 
pain and pain-related disability in those who catastrophize may be amplified by pain-
related fear as reflected in a cognitive-behavioral model of chronic pain (Crombez, et al., 
1998; Severeijns, et al., 2005; Sullivan, Stanish, Waite, Sullivan, & Tripp, 1998).  
Not surprisingly, individuals who catastrophize pain utilize health care services more, 
have longer hospital stays and report higher use of medication than those who do not 
catastrophize (Goubert, et al., 2002). One study addressing the relationship between 
attachment style, catastrophization and health care utilization reported interesting results 
in regards to two attachment styles: preoccupied and fearful (Ciechanowski, Sullivan, 
Jenson, Romano, & Summers, 2003). The preoccupied style, characterized by excessive 
vigilance in relationships and intense support-seeking to the point of „clinginess‟, was 
compared to the fearful style, which involves the desire for social support inhibited by the 
fear of rejection and a pattern of approach-avoidance behavior. Chronic pain patients 
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with a fearful attachment style scored higher on catastrophization and had higher levels 
of health care utilization as compared to those with a preoccupied attachment style. 
Another study used the High Risk Model of Threat Perception to address predisposing 
factors of health care utilization in a primary care population (McGrady, Lynch, Nagel & 
Zsembik, 1999). They found somatization and catastrophization to be related to higher 
levels of treatment seeking. However, some conflicting evidence exists. Gil, Abrams, 
Phillips and Williams (1991) did not find a relationship between psychological coping, 
including catastrophization, and health care utilization in a sample of sickle cell anemia 
patients. These conflicting results may be related to cultural factors, considering that most 
sickle anemia patients are African-American and there may be both structural (e.g., 
access, financial concerns) and cultural barriers (e.g., distrust of medical professions) 
interfering with the influence of catastrophization on health care utilization.  
Evidence of Health Beliefs and Cognitive/Emotional States and Styles 
Specific to Dyspareunia 
Susceptibility, Seriousness and Health Behavior Barriers 
As afore-illustrated, research has shown that health promoting behaviors in regard to 
a number of health challenges (e.g., breast cancer, osteoporosis, smoking, cardiac 
rehabilitation) is mediated by HBM dimensions and by a number of dispositional 
psychological factors. The question of particular relevance to us is: to what extent do 
these HBM dimensions and cognitive/emotional styles predict help-seeking behavior in 
the case of dyspareunia? Currently, we simply do not know the answer to that question as 
no research has targeted it directly. Dyspareunia shares some characteristics with other 
health challenges, but it is also substantially different. Most of the research using the 
HBM has focused on early detection or preventive health behaviors, neither of which is 
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applicable to dyspareunia. Dyspareunia does not require detection as there is no hidden 
component to its onset. It involves pain and a woman knows in short order when she is 
afflicted with it. Prevention is not relevant either as we do not know enough about the 
etiology of dyspareunia to hypothesize preventive behaviors. There are, however, some 
aspects of the HBM that may be helpful in understanding incentives and barriers to 
treatment-seeking for women who experience pain with intercourse.  
The dimension of Susceptibility is not applicable to dyspareunia as there are no 
known risk factors that should make one woman any more worried than another about the 
possibility of developing the disorder. The dimension of Seriousness, however, may play 
an influential role in whether treatment for dyspareunia is sought. According to the HBM, 
if an individual considers the symptoms to be significantly harmful, it is more likely that 
he/she will commit to a given health behavior. However, we have also reviewed research 
suggesting that Seriousness may have a paradoxical effect. Consulting a medical 
professional carries the risk of discovering a serious illness. The fear of this potential 
discovery may contribute to the avoidance of the health behavior altogether. We found 
support for this paradoxical effect as participants in our study reported fear of 
Seriousness as a reason to avoid medical consultation (Donaldson & Meana, 2011).   
The HBM dimension of Barriers is likely to be a major factor in women‟s treatment-
seeking behavior for pain with intercourse. The women in our study (Donaldson & 
Meana, 2011) clearly identified a number of barriers to treatment-seeking, including faith 
in spontaneous remission, lack of confidence in a medical solution, belief in incurability, 
fear of severity, guilt regarding admission of premarital sex, fear of the stigma associated 
with sexual problems, and the belief that sexual problems fall outside the realm of 
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medicine. Finally, perceived Benefits of treatment seeking are also likely to be important 
mediators of whether women with dyspareunia consult a health care professional. The 
little data available suggests that they may have serious doubts about the benefits of 
seeking treatment (Donaldson & Meana, 2011). In the Donaldson and Meana study, some 
women doubted that a cure existed, others were fairly confident that health professionals 
would not know what to do with their pain, and yet others did not believe that sexual and 
relational problems were amenable to health interventions.  
Curiously, the doubts women in the afore-mentioned sample expressed about the 
power of health interventions to resolve intercourse pain are not entirely ungrounded. The 
treatment of dyspareunia is difficult and complete resolution of the pain and associated 
sexual dysfunction are elusive. Treatment outcome studies have shown reductions in pain 
without improvement of sexual function, illustrating there is no guarantee that treatment 
will completely resolve their symptoms (Bergerson, et al., 2001). On the other hand, that 
same study demonstrated that treatment appears to provide relief for a significant number 
of women.  
Affect and Somatic Reactivity 
Although no studies to date have examined psychological mediators of treatment-
seeking in dyspareunia, some of the psychological correlates of dyspareunia may provide 
clues to treatment seeking propensity. Women with dyspareunia have been found to have 
some of the psychological characteristics, including mood disturbances, somatic focus 
and catastrophization, linked to health care utilization in the context of other medical 
conditions.  
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Negative Affect and Mood States. 
Research has fairly consistently found elevated levels of negative affect in women 
who have pain with intercourse. One study examining the prevalence and type of 
psychological distress in women with PVD found the most frequently endorsed 
psychological states included negative affect: experience of personal distress, 
unhappiness and apprehension (Brotto, et al., 2003). Anxiety, in particular, has been 
found in a number of samples over the years (Gates & Galasky, 2001; Granot & Lavee, 
2005, Jantos & White, 1997; Johannesson, de Boussard, Brodda, & Bohm-Starke, 2007; 
Meana, et al., 1997; Nunns & Mandal, 1997; Nylanderlundqvist & Berghahl, 2003; 
Payne, Binik, Pukall, Thaler, Amsel, & Khalife, 2007). In addition to anxiety, some 
women with dyspareunia develop phobic anxiety. In a study of women who experience 
introital pain with all attempts at penile vaginal entry, their scores were significantly 
higher on the Phobia Rating Scale when compared to age-matched healthy women 
(Brotto, et al, 2003). They also reported significant phobic anxiety to vaginal touch and, 
specifically, vaginal entry. Women in Meana, et al.,‟s (1997) dyspareunia-with-no-
physical-pathology group reported more phobic anxiety and erotophobia than controls. 
However, van Lankveld, et al., (1996) and Bergeron, et al., (1999) found that women 
with PVD in their samples did not experience any higher levels of fear/anxiety than 
controls. It is thus important to note that not all samples exhibit anxiety, although cross 
study comparisons are complicated by the use of different measures. 
The extent to which heightened levels of anxiety, when they are present, impact 
treatment-seeking in women with dyspareunia is unknown. However, we do know that 
anxiety has been found to be related to treatment-seeking, predicting more daily pain, 
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medicine usage and health care utilization in other health problems (Levenson, et al., 
2008). Meana, et al.‟s (1998) study of 76 married or cohabitating women with 
dyspareunia found anxiety to be positively related to pain ratings. The magnified 
experience of pain may prompt highly anxious women with dyspareunia to seek 
treatment. Health anxiety, specifically, was found to be significantly higher in college 
women who experienced pain with intercourse than in no-pain controls (Meana & 
Lykins, 2009). Considering that health anxiety has also been found to be associated with 
avoidance of health care professionals (Walker & Furer, 2006), higher levels of anxiety 
may predict similar avoidant behavior in women with intercourse pain. It is thus difficult 
to hypothesize whether anxiety predicts or interferes with treatment-seeking in 
dyspareunia. Only research can clarify the dynamics of that relationship in the context of 
intercourse pain. 
Depression has also been linked to higher use of health care services (Benton, et al., 
2007). In one critical review of empirical findings, evidence suggests a higher prevalence 
of depression and pain in women (Meana, 1998). Well before research started addressing 
the relationship between depression and the sexual pain disorders, Jarvis (1984) posited 
that depression was a cause of dyspareunia. Premature though this conclusion may have 
been, there was clearly a sense that dyspareunia seemed to be accompanied by depressive 
affect. In a systematic review, Latthe, Migninni, Gray, Hills and Khan (2006) evaluated 
risk factors predisposing women to chronic and recurrent pelvic pain and found 
depression to be a significant factor in women with dyspareunia. Using the Beck 
Depression Inventory (BDI), Nylanderlundqvist and Berghahl (2003) found over half 
(58.6%) of the women with dyspareunia scored in the mild to severe depression range. 
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Jantos and White (1997) found that a large percentage of women with dyspareunia scored 
high on suicidal ideation and depression. Depressive symptomatology has also been 
associated with more severe pain reports for women who appraised their dyspareunia to 
be of non-organic etiology (Meana, et al., 1998). One study investigated women with 
PVD and healthy controls and found that depression was more often reported by those 
experiencing PVD (Johannesson, et al., 2007). In our qualitative study, women who 
experienced pain with intercourse expressed that they were often sad, cried a lot, worried, 
lost sleep over their concern about the pain, were disappointed and depressed (Donaldson 
& Meana, 2011). Meana, et al., (1997), found that depressive symptomatology was 
elevated in women with dyspareunia, but only in those with no obvious physical 
pathology. It thus appears that there is a strong link between depression and dyspareunia, 
although the direction of that relationship has not been established. 
Not all studies, however, have found that women with dyspareunia suffer more from 
depressive symptomatology. In a sample of patients from a sexually transmitted 
infections clinic in Norway, no difference was found between patients with vulvar 
problems (burning, post-coital soreness, dryness and fissures for duration of at least three 
months) and asymptomatic patients with regard to having seen a doctor because of 
depression (Edgardh & Abdelnoor, 2003). Also, Meana, et al., (1998) found that 
depression (in contrast to anxiety) was not predictive of pain ratings in dyspareunia and 
van Lankveld, et al., (1996) and Bergeron (1999) did not find elevated levels of 
depression in their samples of women with PVD.  
Considering the potentially negative impact of dyspareunia on women‟s relationships 
and self-esteem, it is not surprising that depressive symptoms are found in many samples 
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of women with dyspareunia. The comorbidity of depressive symptoms and dyspareunia 
mirrors the comorbidity of depression and pain found in other chronic pain conditions 
(Weisberg & Boatwright, 2007). Research on other pain conditions and health problems 
would suggest that the depression experienced by women with dyspareunia would be 
linked to higher health care utilization, although, again this has yet to be investigated in 
the case of dyspareunia (Edege, 2007).  
Neuroticism has also been found to be a psychological determinant in treatment 
seeking. Current research suggests a link between neuroticism and sexual dysfunctions in 
young adults (Ernst, Foldenyi & Angst, 1993). Using the NEO-Five Factor Inventory, 
Meana and Lykins (2009) found their group of dyspareunia women scored higher on 
neuroticism than pain-free controls. Donaldson and Meana (2011) found that college-
aged women who experienced pain with intercourse reported emotional reactivity 
generally associated with neuroticism: anger, depressive symptoms, frustration, and 
declines in self-confidence. One study addressing the psychological profiles of women 
with PVD found that of the 50 women they surveyed, 37% reported difficulties in 
managing their anger, 35% endorsed having a need for control and inflated self image 
and 16% had problems with impulsivity or sensation-seeking (Brotto, et al., 2003). 
Another study found women experiencing intercourse pain to endorse having 
perfectionistic traits, difficulty in expressing their feelings and higher levels of irritability 
and anger (Jantos & White, 1997). Using the Temperament and Character Inventory, 
Lundqvist and Bergdahl (2005), found that women with PVD in their sample had a 
personality profile characterized as cautious, careful, insecure, and pessimistic. Another 
study evaluated 57 women with self-identified vulvar pain and found that they reported 
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greater distress than controls on measures of negative mood, although there was no 
relationship between pain severity and affective distress (Masheb, et al., 2002).  
It is difficult to ascertain whether these supposed personality traits existed prior to 
onset of pain or were a consequence of the pain. Research suggests that personality 
characteristics measured after onset of chronic pain may not be vulnerability factors, per 
se, as personality scores have been shown to change and improve after treatment 
(Fishbain, Cole, Cutler, Lewis, Rosomoff, & Rosomoff, 2006). Considering the link 
between neuroticism and treatment seeking in other conditions (van Hemert, et al., 1993), 
it is not unreasonable to posit that women experiencing pain with intercourse who also 
exhibit characteristics of neuroticism may seek out treatment more often. It is possible 
that the relatively successful treatment may lessen the negative affect of women who 
developed these seemingly trait-like mood states after the onset of pain.  
Somatic Amplification and Hypervigilance. 
  As mentioned previously, frequent use of health services has also been found to be 
associated with somatic amplification (Duddo, et al., 2006). A study conducted with 
Israeli women with PVD found that they demonstrated higher levels of somatization than 
controls (Granot & Lavee, 2005). One study focusing on the psychological profiles of 
women with PVD found significant differences between women with PVD and a normal 
population on somatization, indicating that these women may more often use physical 
complaints to manage psychological stress (van Lankveld, et al., 1996). In one sample of 
women with dyspareunia, 42% met criteria for a somatization disorder (Schover, Youngs 
& Cannata, 1992). Another study examined prevalence and type of psychological distress 
in 50 women with PVD and found that 27% expressed somatic complaints and health 
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concerns (Brotto, et al., 2003). Danielsson, et al., (2001) investigated personality 
differences and the occurrence of somatic symptoms between women suffering from 
PVD and a non-symptomatic control group. Utilizing the Giessen Subjective Complaints 
List, a questionnaire on general well-being, vegetative disturbances, pains, and 
emotionalism, they found that women with PVD in their sample reported significantly 
more occurrences of somatic symptoms (e.g., pain in the back, neck or shoulders, 
gastrointestinal symptoms, headache, urinary tract infection, asthma, allergic 
conjunctivitis, and skin problems or other eczema) than controls. Women who 
experienced pain with intercourse also scored higher than pain-free controls on 
somatosensory amplification in another sample of young women (Meana & Lykins, 
2009). However, Meana, et al., (1997) found no difference between women with 
dyspareunia and controls on the Brief Symptom Inventory (Derogatis & Melisaratos, 
1983) somatization scale nor on the number of other non-genital pains reported.  
Hypervigilance, defined as increased attention to unpleasant sensations, is considered 
to be an integral part of somatic amplification (Barsky, 1992). Payne, et al., (2005) had 
seventeen women suffering from PVD and an equal number of controls complete an 
emotional Stroop and memory recall task, in addition to a series of questionnaires 
assessing pain-hypervigilance, state and trait anxiety, fear of pain, and anxiety sensitivity. 
They found that PVD sufferers reported hypervigilance for coital pain and also exhibited 
a selective attentional bias toward pain stimuli on the emotional Stroop task as compared 
with controls. In a cross-sectional study conducted by Pukall, Baron, Amsel, Khalife, and 
Binik (2006), 16 women with PVD and 16 age-matched controls were examined by a 
rheumatologist, who palpated 9 nonvulvar areas to assess for sensitivity. Women with 
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PVD reported more pain when palpated and had significantly higher pain sensitivity and 
unpleasantness ratings. Another study involved the application of different sensations of 
vibration, warmth, cold, heat, cold pain, and pressure to elicit pain at the posterior and 
anterior parts of the vulvar vestibule (Bohm-Starke, et al., 2001). They found increased 
pain sensitivity (allodynia) in these patients when compared to controls. Pukall, et al., 
(2004) used a vulvalgesiometer, a mechanical device containing springs of varying 
compression rates which allows for standardized pressure application, to assess tactile 
and pain thresholds in women with PVD. They found no difference between the women 
with PVD and control in regards to vestibular tactile thresholds but did find significantly 
lower pain thresholds and higher unpleasantness ratings in women with PVD. Another 
study comparing 20 women with PVD and 20 controls on arm and leg pressure pain 
thresholds (PPT‟s) before and during a cold pressor test found that women with PVD 
displayed lower PPT‟s than controls, implying hypersensitivity in these women 
(Johannesson, et al., 2007).  
Even though several studies suggest that women with dyspareunia report more 
somatic complaints and show tendencies towards pain sensitivity and hypervigilance, 
conflicting evidence suggests that not all of these women are more likely to amplify their 
somatic symptoms. One study found women with dyspareunia did not report more non-
genital pains than controls (Meana, et al., 1997). In line with these findings, Bornstein, 
Zarkati, Goldik and Abramovici (1999) suggest that women with PVD do not differ from 
those suffering from somatization other than in the fact that they are more outspoken 
about the bodily inconveniences that are impacting their lives. It is unclear how 
amplification may influence treatment-seeking in dyspareunia. According to the literature 
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on somatic amplification, if women with dyspareunia tend to amplify their symptoms, 
then they might also be prone to “doctor shopping” (Duddo, et al., 2006; Barsky, et al., 
2001).  
Catastrophization. 
Pain catastrophization has been linked to longer hospital stays and reports of higher 
use of medication (Goubert, et al., 2002; McGrady, et al., 1999) as well as heightened 
pain intensity (Sullivan, et al., 2001). One study of PVD patients in Israel administered 
quantitative sensory tests with a Thermal Sensory Analyzer to assess pain threshold via 
warm sensation produced by the thermode (Granot & Lavee, 2005). The PVD women 
demonstrated lower pain thresholds and higher magnitude estimation of phasic 
suprathreshold (level at which heat is of sufficient intensity to produce a physiological 
effect) stimuli, than women in the control group. They also found that catastrophization 
scores were significantly higher for coital pain than for experimental pain and that 
catastrophization was positively associated with a lower pain threshold and higher pain 
perception. In another study, women with PVD were interviewed, given a gynecological 
exam and then underwent sensory and tactile thresholds tests (Pukall, et al., 2002). 
Tactile and pain thresholds were measured on the inner thigh, labium minus and vestibule 
using modified von Frey filaments. Pressure-pain tolerance was measured on the deltoid 
muscle and tibia with a pressure tolerance meter. Vestibular tactile thresholds and pain 
thresholds around the vestibule were lower in the PVD group as compared with controls. 
Also, in the women with PVD, distress levels increased systematically with the pain 
ratings. Participants were also administered the Pain Catastrophizing Scale (PCS; 
Sullivan, et al., 1995) and women with PVD reported significantly higher scores for 
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intercourse pain than for general pain. Payne et al.‟s (2005) sample of 20 women with 
PVD underwent genital and non-genital sensory testing of the vulvar vestibule, inside the 
labia minora and on the volar surface of the forearm. On the PCS, women with PVD 
reported higher pain catastrophizing and vigilance for intercourse pain and non-
intercourse pain as compared with healthy participant ratings.  
Attention bias to pain, which is hypothesized to maintain pain catastrophization (van 
Damme, et al., 2004), also appears to play a significant role in women with dyspareunia. 
Payne, et al., (2005) found that PVD sufferers reported hypervigilance for coital pain and 
also exhibited a selective attentional bias towards pain stimuli on the emotional Stroop 
task as compared with controls. The hypervigilance of women experiencing pain with 
intercourse appears to be a manifestation of this attentional bias. The pain stimuli may be 
distracting them from sexual stimuli during sexual activity, thus impairing sexual arousal 
and potentially exacerbating the pain.  
Research has found pain catastrophization to be a predisposing factor to treatment 
seeking (McGrady, et al., 1999). The reported tendency for women with dyspareunia to 
catastrophize intercourse pain would suggest high levels of treatment seeking as well. 
However, conflicting evidence related to catastrophization in sickle anemia patients 
suggests moderating influences, such as culture (Gil, et al., 1991). The fact that 
dyspareunia is a disorder that involves the socio-culturally loaded area of sexuality 
suggests that the mediating effect of factors such as catastrophization may be diminished 
or altered in the case of this unique health problem. Embarrassment or stigma related to 
having a sexual problem may override catastrophization or other factors as mediators of 
treatment-seeking. 
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In summary, although the HBM has been effective in illuminating factors related to 
early detection and preventive health behaviors, some of its dimensions do not appear to 
be relevant to dyspareunia; with the exceptions of Seriousness and Barriers. The little 
data that does exist suggests that Seriousness could work to either facilitate or interfere 
with treatment seeking while it seems that there are significant Barriers to help-seeking 
in the case of dyspareunia. Some of the psychological correlates of dyspareunia also 
happen to coincide with characteristics that have been found to be predictive of treatment 
seeking in other disorders. Again there is no current research that has directly addressed 
dyspareunia treatment seeking predictors. The anxiety, depression, and neuroticism 
evidenced in women with dyspareunia might suggest higher levels of health care 
utilization; however, negative affect may lead them to avoid health care professionals for 
reasons of fear, pessimism or even embarrassment. It remains unclear whether women 
with dyspareunia engage in somatic amplification; however, there is sufficient evidence 
to suggest that this potential propensity may lead to frequent health care use. 
Catastrophization could be a predisposing factor to treatment seeking although it may be 
mediated by other factors, such as the sexual nature of the problem and a whole host of 
inhibitors of treatment-seeking related to the stigma associated with sexual problems. 
Research is needed to aid our understanding of the complex set of conditions involved in 
the experience of dyspareunia and enable us to start teasing apart which factors are 
related to treatment seeking in what ways.  
The Sexual Dysfunction Reporting Dilemma 
An investigation of the psychological correlates of treatment seeking in a variety of 
health problems is useful in the generation of hypotheses about the factors that might be 
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associated with treatment seeking in the case of dyspareunia. However, these other 
conditions do not involve sexuality. Extrapolations from them to dyspareunia may thus 
fail to capture important treatment barriers related specifically to sexual problems.  
Dyspareunia is not the only under-reported sexual concern. Women‟s sexual problems in 
general appear to be under-reported and under-treated (Yadav, Gennarelli, & Ratakonda, 
2001). To better assess how the sexual nature of dyspareunia affects treatment seeking, it 
is useful to review the relevant treatment-seeking literature in relation to sexual 
dysfunctions. 
A number of studies have investigated the percentage of individuals who discuss their 
sexual concerns with their physicians. For example, Moreira, Glasser, and Gingell, 
(2005) found that of the 1500 participants, aged 40 to 80, with whom they conducted 
phone interviews in Spain, only 17.7% of men and 18.6% of women reported speaking to 
a doctor about their sexual concerns. Of 1080 patients surveyed at 37 north London 
practices, only 30% women and (21%) men reported having consulted their doctor for 
sexual advice (Nazareth, Boynton, & King, 2003). Studies using telephone help-lines for 
information on sexual and reproductive health issues have found similar percentages of 
doctor consultation: 32% of men calling in and reporting sexual problems (Papaharitou, 
et al., 2006) and 34.3 % of women calling a help-line dedicated to sexual health 
awareness, education and research had consulted with a doctor (Papaharitou, 
Nakopoulou, Kirana, Iraklidou, Athanasiadis & Hatzichristou, 2005). Ansong, Lewis, 
Jenkins, and Bell (1998) randomly selected 5198 men between 50 and 76 years of age 
who were living in four rural counties in central New York State. Of the 649 men who 
reported having experienced impotence 6 months prior, 66.6% indicated they had not 
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sought treatment. A telephone survey conducted in Canada was completed by 500 men 
and 507 women between the ages of 40 and 80 (Brock, Moreira, Glasser, & Gingell, 
2006). Of the sexually active respondents who reported experiencing at least one sexual 
problem, 38.4% of men and 30.6% of women had not taken any action.  Yet another 
study asked a nationally representative probability sample of community-dwelling 
Americans aged 57 to 85 years, “Since you turned 50, have you ever discussed sex with a 
doctor?” Overall, only 38% of men and 22% of women reported having discussed sex 
with a physician since the age of 50 (Lindau, Schumm, Laumann, Levinson, 
O‟Muircheartaigh, & Waite, 2007). 
One Spanish study conducted telephone surveys between 2001 and 2002 to ascertain 
how individuals sought help for sexual problems (Moreira, et al., 2005). Both men (750) 
and women (750) between the ages of 40 and 80 years were asked whether they had 
sought help or advice from a series of sources: talked to a medical doctor, taken 
prescription drugs/devices or talked to a pharmacist, talked to a psychiatrist or 
psychologist or marriage counselor. The majority of men (79.4%) and women (80.2%) 
had not sought help from any type of health professional. Of the respondents who were 
sexually active and reported at least one sexual problem, 38.9% did not take any action, 
i.e., they did not seek help or advice. Similar results have been found in a Canadian 
telephone survey of individuals between the ages of 40 and 80 (Brock, et al., 2006). 
Reporting may be lower in non-Western countries. Moreira, Kim, Glasser, and 
Gingell (2006) conducted a survey in Korea during 2001 and 2002 as part of the Global 
Study of Sexual Attitudes and Behaviors (GSSAB). The vast majority of the 1,200 
participants had not sought help from a health professional (92.7% of men and 96.8% of 
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women). Only 2% had talked to a medical doctor about a sexual problem. It is possible 
that cultural beliefs in Korea may interfere with medical help-seeking. This study also 
found that 1) thinking it is OK to use medical treatment for sexual problems and 2) a 
belief in religion guiding sexual behavior were attitudes positively associated with 
seeking medical help. 
Much research has focused on the reporting of the two most common male sexual 
dysfunctions, erectile dysfunction (ED) and premature ejaculation (PE) (Ansong, et al., 
1998; Berner, Leiber, Kriston, Stodden, & Gunzler, 2008; Papaharitou, et al., 2006, 
Shabsigh, Perelman, Laumann, & Lockhart, 2004). Considering the sensitive nature of 
these disorders, it is not surprising that reporting is low. Porst, Montsori, Rosen, Gaynor, 
Grupe and Alexander (2006) found that out of 2,754 men with PE, only 9% reported 
having consulted a physician for the condition. Over half (52.2%) of those who had not 
talked to a physician about their PE indicated that they had never considered speaking to 
a physician about this problem. Of those who had consulted a physician, 69.5% had 
initially presented with a different health-related concern.  
It is possible that the low reporting percentages for sexual complaints may be 
explained by individuals preferring to utilize informal sources of assistance for sexual 
issues. In a study on PE, approximately 80% reported they tried to get as much 
information as possible about health problems, but only one in two agreed that their 
doctor was the best source of information (Porst, et al., 2006). Catania, Pollack, 
McDermott, Qualls, and Cole, (1990) asked 503 women attending “pleasure parties” in 
the California Bay Area and women attending church meetings and college classes in 
Colorado how they sought information to address difficulties interfering with a satisfying 
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sexual relationship. “Pleasure parties” referred to private gatherings of friends and 
acquaintances in which representatives of companies selling sexual aids (i.e., massage 
oils, vibrators, books, etc.) displayed, discussed and sold their products. The church 
meetings consisted of Christian-sponsored adult education classes for married couples. 
The university classes were Introductory Psychology courses at the University of 
Colorado, Colorado Springs. Of the informal sources they utilized, 56% consulted their 
sexual partner, 48% consulted friends, and 19% consulted relatives. Despite a high 
prevalence of sexual problems (43%) in this group, few women employed formal help 
(psychotherapy, 3%; medical, .5%). Other studies have also found that talking to one‟s 
partner about sexual concerns is the most common action taken by both men and women 
(Brock, et al., 2006). These findings reflect the theory posited by Gross and McMullen 
(1983) regarding the normative sequence to help-seeking actions: i) people will first 
consider self-help actions; ii) if that fails, decisions regarding social help sources are 
made; iii) the most convenient and least “costly” social sources will be considered/used 
first; and iv) if informal help fails, then formal help is considered.  
Factors Influencing Reporting/Treatment Seeking of Sexual Dysfunctions 
Gender. 
Gender of the patient may be a factor in reporting sexual concerns to a physician. 
Women have been found to be less likely than men to discuss sex with a physician 
(Lindau, et al, 2007). In relation to treatment, this finding is especially disconcerting as 
one study found that men who reported a problem were twice as likely to have received 
help as were women with an equivalent problem (Dunn, Croft, & Hackett, 1998). A 
possible reason for women‟s reluctance to report their sexual symptoms may be concern 
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about being diagnosed with a sexual disorder and the stigma related to such a diagnosis. 
Nazareth, et al. (2003) found that significantly fewer men (22%) than women (40%) in 
their sample of 1080 patients who consecutively attended 37 north London general 
practices received at least one ICD-10 diagnosis of sexual dysfunction. Also, women in 
this study were significantly more likely to receive a diagnosis of lack or loss of sexual 
desire and dyspareunia than men. At least in term of sexual desire, it is possible that 
women‟s sexual concerns may be more often pathologized than those of men.  
Other researchers have offered additional explanations for why women do not report 
their sexual problems as often. Ferenidou, Kapoteli, Moisidi, Koutsogiannis, 
Giakoumelos, and Hatzichristou (2008) surveyed 164 women visiting a general hospital 
for symptoms unrelated to sexual function. Although 69.5% reported experiencing at 
least one sexual problem, only 26.2% of all women indicated they would like to talk to 
their doctor about it. More importantly, only a little over half (58.5%) reported not being 
bothered by their sexual problem. According to the authors, experiencing more than one 
sexual problem, as well as the perception that their sexual function and satisfaction is 
hindered may be necessary for women to report their sexual concerns to their doctor. 
Gender of the physician may also play a role in treatment seeking of sexual concerns. 
Dunn, et al. (1998) found that 54% of women prefer help from a female professional 
whereas only 24% of men preferred help from a male professional in regards to sexual 
concerns.  
Education. 
It is possible that an individual‟s level of education may influence whether they seek 
medical help for their sexual concerns. One study found that both college education and 
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gender influenced the likelihood of whether men and women sought assistance from a 
health care professional (Glasser, Nicolosi, Duarte, & Gingell, 2007). A college 
education was negatively associated with the likelihood of seeking medical help in men 
whereas the association was positive in women. 
Attitudes and Beliefs Regarding Sexual Dysfunctions 
Particular attitudes and beliefs have been found to correspond with not seeking help 
for sexual dysfunctions. Participants have reported not seeking medical counsel for 
sexual problems because they thought the issue was not very serious or that they were 
waiting for the problem to go away (42.7% of men and 44.1% of women) (Moreira, et al., 
2005). One study addressing attitudes associated with not discussing PE with a physician 
found that participants experienced embarrassment at discussing their condition, doubted 
that any medication could help them control their ejaculation, worried about becoming 
dependent on medication to perform sexually, and were resigned to living with the 
condition (Porst, et al., 2006). In another study investigating why men with ED refrained 
from seeking treatment, participants reported they were either not aware of effective 
treatment for ED or believed available treatments were risky or harmful (Ansong, et al., 
1998). Similar beliefs and attitudes have been found in other studies on PE and ED 
(Dunn, et al., 1998).  
Older adults have also reported attitudes regarding sexuality that interfere with the 
reporting of sexual concerns. A study of individuals between the ages of 40 and 80 found 
that respondents did not consult a medical professional because they felt the sexual 
problem was a part of normal aging, they were comfortable as they were, they did not 
think it was severe enough, they were waiting for the problem to go away, and they did 
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not believe the doctor would be of much help (Brock, et al., 2006). Interesting there are 
also age-related attitudes that interfere with treatment seeking in young populations. In 
one study addressing barriers to ED treatment, the youngest group (20-39 years) was least 
likely to seek treatment and indicated they believed that their ED would resolve 
spontaneously.  
In contrast, research has also found that certain attitudes and beliefs actually promote 
treatment seeking. One study found that general attitudes which significantly increased 
the likelihood of seeking medical advice for sexual problems included thinking that a 
doctor should routinely ask patients about their sexual function (among men), being very 
or somewhat dissatisfied with their sexual function, and the belief that sex is a very 
important part of overall quality of life (among women) (Moreira, Glasser, Nicolosi, & 
Duarte, & Gingell, 2007).  
Embarrassment. 
A more generic factor commonly cited by patients for not discussing sexual concerns 
with their doctors is a sense of overarching embarrassment and discomfort (Ansong, et 
al., 1998; Moreira, et al., 2005; Porst, et al., 2006). Having a sexual dysfunction 
paradoxically appears to make it more difficult to discuss sexual concerns. In one study, 
men with PE reported feeling less comfortable discussing sensitive issues with their 
doctor than men without PE (68.6% vs. 75.6%) (Porst, et al., 2006). In an attempt to 
circumvent initial embarrassment of reporting sexual problems to physicians, Berner, et 
al., (2008) sent written information about erectile dysfunction and follow-up 
questionnaires to 1,392 (1,188 reported having ED). As a result of the written information 
material, 89.4% of the men took some action. Of these men, 64.7% decided to talk to 
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their partner, 72.7% to a physician, and 11.1% to another specialist, i.e., psychologist or 
counseling center. Over one third reported receiving some kind of treatment from their 
physician. It would appear that, although embarrassment in discussing sexual concerns 
with a physician prevents many from reporting, there may be feasible ways to encourage 
patients to seek help. 
Physicians’ Role  
Physicians share in the responsibility of perpetuating the silence on sexual concerns, 
as there appears to be a mutual reluctance on the part of both health care professionals 
and patients to initiate discussions about sex (Lindau, et al., 2007). One study looked at 
barriers to treatment seeking for sexual problems with older people and found that a good 
relationship with their general practitioner and satisfaction with past consultations were 
important for seeking treatment (Gott & Hinchliff, 2003). Other factors included the 
physicians‟ gender or age and their perceived attitude towards later life sexuality, 
attributions of sexual problems to „normal aging,‟ shame/ embarrassment and fear, 
perceiving sexual problems as „not serious,‟ and lack of knowledge about appropriate 
services.  
By and large, there is ample evidence to indicate that many doctors may not be asking 
patients about their sexual health. One study found that very few participants had been 
asked by a doctor about possible sexual difficulties during a routine visit in the past 3 
years (5.9% of men and 6.5% of women in Spain; 3.7% of men and 4.2% of women in 
the United Kingdom) (Moreira, et al., 2005). This is concerning given that it has also 
been shown that individuals who had been asked about possible sexual difficulties during 
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a routine visit in the past 3 years were significantly more likely to seek medical help for 
sexual problems (Brock, et al., 2006; Moreira, et al., 2006). 
When surveyed, most patients report that they feel it is the physician‟s responsibility 
to inquire about sexual symptoms. In a study aimed at men‟s expectations of primary care 
physicians in treating sexual health concerns, 65% said they depended on the physician to 
initiate the discussion (Metz & Seifert, 1990). More than one-half (51.6%) of men and 
39.5% of women in another sample thought that a doctor should routinely ask patients 
about their sexual functioning (Moreira, et al., 2005). About a third (36.9% of men and 
29.2% of women) of all respondents in a study conducted in the UK thought that the 
doctor should routinely ask patients about their sexual function and very few of the 
participants reported having been asked (Moreira, et al., 2007). Porst, et al., (2006) found 
that men with PE believed that physicians should inquire about the sexual health of their 
patients during routine visits to create a comfortable reporting environment. In a study of 
a sample of minority women aged 40 to 80, 43% of those with sexual problems (108) 
indicated they would like to discuss their problems with their clinician (Sadovsky, et al., 
2006). However, the way a clinician asks may also be crucial in determining whether 
patients report on their sex lives. In this same study, participants were asked whether they 
preferred a more direct inquiry type such as, “Do you have a problem during sex,” or a 
ubiquity-style question such as, “Many women with diabetes have sexual problems, how 
about you?” More women preferred the ubiquity-style probe to initiate a discussion of 
problems with sex, suggesting that patients become more comfortable about answering a 
sexual problem question once the universality of various sexual experiences are stated.  
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Doctors themselves may be uncomfortable talking about sexual issues. Nazareth, et 
al. (2003) reviewed practice records on consultation rates and entries about sexual health 
over two years in 1080 patient files. They found that, although up to 30% of individuals 
reported seeking sexual advice from their doctor, only 3-4% had an entry in their charts 
relating to sexual difficulties. Doctors may be reluctant to record sensitive material and so 
records do not accurately reflect involvement. Wiggins, et al., (2007) asked 35 physicians 
how comfortable they were taking sexual histories and almost all responded with “very” 
or “somewhat.” However, only 49% indicated that they make a point of obtaining a past 
sexual history more than half of the time. When queried as to whether they felt they had 
adequate time to discuss their patients‟ sexual issues, 80% reported they did not. 
Interestingly, there appears to be a sex difference as 85% of male and 73% of female 
physicians reported they did not have enough time to discuss sexual issues.  
It is difficult to blame the doctors, per se, since most residency training programs do 
not include formal training aimed at sexuality assessment, diagnosis, and therapies 
(Wiggins, et al., 2007). Some experts recommend physicians receive additional training, 
provide patients with information, and expand the role of nurses in this regard. However, 
similar factors appear to impact the provision of sexual health care (SHC) by nurses. 
Gamel, Hengeveld, Davis and van der Tweel (1995) reported that in a sample of Dutch 
nurses, SHC was rarely provided, although they indicated that sexuality issues are a focus 
for nursing care in the Netherlands. Out of a list of 24 SHC-related behaviors, nurses in 
this study reported adequate and/or more than adequate knowledge for only 14 of them.  
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Summary 
The difficulty in reporting symptoms of and seeking treatment for a sexual 
dysfunction appears to lie in the discomfort and embarrassment associated with having a 
sexual problem. Attitudes and beliefs regarding sexual concerns also appear to influence 
whether or not individuals consult a physician. The patient‟s relationship with their 
physician seems to play a key role, as patients often expect the doctor to initiate 
discussion regarding their sex lives. Faced with the discomfort of sharing intimate details 
about their sexual health, many individuals seek counsel from informal sources.  
This combination of factors interfering with reporting and seeking treatment is 
especially disconcerting for women with dyspareunia, since these women indicate 
hesitancy about seeking even informal sources for help (Donaldson & Meana, 2011). 
Considering that dyspareunia and vaginismus are the only sexual dysfunctions involving 
pain, one might expect that this sexual dysfunction would have higher reporting rates 
than others. After all, pain normally signals tissue damage and one would think that 
dyspareunia would quicker lead women to a doctor than low sexual desire. We do not 
have comparative figures on reporting across sexual dysfunctions, but the overall picture 
that emerges is that inhibition about matters of sexuality overpowers the impulse to seek 
help for a pain problem. In addition, the literature suggests that women may also be more 
reluctant to report out of a concern of being pathologized. The result is a set of conditions 
that inhibit treatment seeking for the very common and distressing problem of 
dyspareunia. 
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Summary and Aims of the Study 
In comparison to other women‟s health problems, there is a dearth of research into the 
health beliefs, help seeking attitudes and treatment barriers of women with dyspareunia.  
Our qualitative foray into such questions indicated that young women who start to 
experience pain with intercourse early in their sexual lives face a confusing situation and 
significant obstacles to health provider consultation (Donaldson & Meana, 2011). This is 
concerning as there is theoretical support for the contention that the longer the problem 
goes unaddressed, the more difficult it may be to resolve (a classical conditioning 
paradigm whereby sexual activity becomes associated with pain). The Health Belief 
Model (Rosenstock, 1966) has been helpful in the investigation of factors that may 
interfere with treatment seeking for a variety of conditions for which early detection is 
important to treatment outcomes (e.g., breast cancer, cervical cancer). However, its 
usefulness in the case of dyspareunia is limited by a number of factors that differentiate 
dyspareunia from other more heavily researched women‟s health conditions. First, 
dyspareunia is not a hidden condition requiring detection via special tests: it is really the 
woman who is responsible for detection once she identifies recurring pain. Second, unlike 
in the case of breast cancer, women have little knowledge or exposure to information 
about painful intercourse and, thus, are perplexed about what to do once they realize they 
have the problem. Finally, dyspareunia is a women‟s health problem that involves 
sexuality and thus it is susceptible to all of the socio-cultural inhibitions and stigma 
associated with sex. It is thus likely that the help-seeking attitudes and treatment barriers 
for dyspareunia may be unique, or at the very least, specific to sexual disorders. With the 
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exception of our qualitative investigation, this question has yet to be empirically 
investigated. 
Our main aim in this study was to investigate treatment-seeking barriers in 
dyspareunia, as well as cognitive and emotional styles associated with these barriers. 
Because there was no dyspareunia relevant measure of treatment-seeking influences, we 
first sought to construct such a measure. The construction of the measure was guided by 
1) treatment barriers mentioned specifically by participants in the Donaldson and Meana 
(2011) qualitative study; 2) rationally derived items based on the clinical and research 
experience of the investigators and colleagues; and 3) an attempt to adapt these items to 
the structure provided by the Barriers to Help-Seeking Scale (Mansfield, Addis, & 
Courtenay, 2005). This measure was then factor analyzed on the combined sample 
consisting of sexually active women with dyspareunia, sexually active women without 
dyspareunia, and those who had yet to have sex. This study also explored the 
relationships between treatment-seeking barriers as endorsed on this measure and 
psychological predispositions that have been theoretically and empirically linked to 
treatment-seeking behavior; health anxiety, somatosensory amplification, pain 
catastrophization, and negative affect.  
The construction of a new measure does not lend itself easily to the formulation of 
hypotheses. Based on the existing literature, however, we ventured hypotheses related to 
potential factors and to the validity and reliability of the new measure. Analyses relating 
to factor structure were conducted on the entire sample (dyspareunia, sexually active no-
pain, and not sexually active). Group differences on the Sexual Health Treatment Barriers 
Scale – Dyspareunia Exploratory Version (SHTBS-DyspEXPV) total score were 
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accounted for via the mean deviation of SHTBS-DyspEXPV item scores prior to the 
principle component analysis.  
Hypothesis #1:   
The Sexual Health Treatment Barriers Scale – Dyspareunia Exploratory Version 
(SHTBS-DyspEXPV) will yield a factor structure consisting of at most seven factors 
representing barriers as follows; 1) minimizing the problem, 2) distrust of health 
professionals, 3) feelings of shame, 4) fear of severity, 5) desire to maintain privacy, 6) 
problems identifying whether there is problem, and 7) lack of resources.  
Hypothesis #2: 
The SHTBS-Dysp (version in which items with inadequate factors loadings are deleted) 
will demonstrate adequate internal consistency. 
Hypothesis #3:  
The SHTBS-Dysp will demonstrate adequate test-retest reliability. 
Hypothesis #4: 
 SHTBS-Dysp total score will correlate negatively with health anxiety.  
Hypothesis #5: 
SHTBS-Dysp total score will correlate negatively with somatosensory amplification. 
Hypothesis #6: 
SHTBS-Dysp scores will correlate negatively with negative affect.  
Hypothesis #7: 
For participants reporting dyspareunia, SHTBS-Dysp scores will correlate negatively 
with pain catastrophization.  
Hypothesis #8: 
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For participants reporting dyspareunia, SHBTS scores will correlate negatively with 
actual attempts at seeking treatment. 
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CHAPTER 3 
METHODOLOGY 
The study consisted of three phases. Phase 1 involved the rational construction of a 
measure of potential help-seeking barriers for dyspareunia and subsequent refinement of 
that measure; Phase 2 consisted of 1) the empirical investigation of the measure‟s 
properties using exploratory principal component analysis in a sample of college women,  
and 2) the investigation of the validity of our new measure to the extent that it correlated 
in expected ways with theoretically associated constructs; in Phase 3 we  assessed the 
test-retest reliability of our new measure with a smaller second sample of women. 
Phase 1 - Construction of a Measure of Dyspareunia Treatment-Seeking Barriers 
Broadly fashioned after Mansfield, et al.'s (2005) Barriers of Help Seeking Scale 
(BHSS), this measure presents participants with a hypothetical health scenario and then 
presents them with a list of possible barriers to their help-seeking. More specifically, in 
our measure the hypothetical scenario was the experience of pain with intercourse as 
follows: Imagine that you begin to experience pain in your genitals or pelvic area while 
having sexual intercourse. The pain prevents you from enjoying sex and sometimes it 
hurts so much that you want to or have to stop having sex. You notice that this is now 
happening regularly whenever you have intercourse. You consider seeking help from a 
health professional. Below are several reasons or attitudes that make you hesitate to seek 
help. Please read each statement and decide how true it is for you. The use of 
hypothetical scenarios is a well-accepted measurement technique designed to examine 
people‟s decision-making for treatment options (Corso, Hammitt, Graham, Dicker, & 
Goldie, 2002; Crawford, Meana, Stewart, & Cheung, 2000; Fagerlin, Wang & Ubel, 
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2005). One of the assumptions of this hypothetical scenario technique is that it would 
also capture individuals for whom the scenario was not hypothetical at all. 
Item generation was then conducted via three methods and then revised: 1) a review 
of the literature on help-seeking influences; 2) a more specific review of the treatment 
seeking barriers outlined by participants in Donaldson and Meana's (2011) qualitative 
study of young women with dyspareunia; 3) rational item generation among the two 
investigators and a group of other sexuality researchers; and then 4) comprehension, 
readability and redundancy review of initial items by a group of graduate and 
undergraduate students. Items were edited to improve comprehension and readability and 
redundancies were deleted. Items generated fell into seven hypothesized categories: 1) 
minimizing the problem, 2) distrust of health professionals, 3) feelings of shame, 4) fear 
of severity, 5) desire to maintain privacy, 6) difficulty identifying symptoms as a health 
problem, and 7) lack of resources (Table A1). The specific items in the measure were 
designed and worded to be theoretically applicable to any sexual health problem; 
however, the scenario provided in this study was dyspareunia-specific. The possibility 
remains that this measure would be valid for any sexual health problem, as long as the 
hypothetical scenario that precedes the items is adapted to the sexual health problem in 
question. Once item generation and review was completed, the measure was named the 
Sexual Health Treatment Barriers Scale-Dyspareunia-Exploratory Version (SHTBS-
DyspEXPV) (see Exhibit A1).  
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Phase 2 – Investigation of SHTBS-DyspEXPV Properties and Associated Constructs 
Participants 
Tabachnick and Fidell (2007) state that a sample size of 300 is “comfortable” when 
conducting a factor analysis, and Comrey and Lee (1992) indicate that 500 is very good 
and 1000 is excellent. By these standards, our sample contained an adequate number of 
participants. A total of 1,246 women started the protocol in Survey Monkey, here defined 
as having at least indicated “Proceed” on the informed consent. Data was only considered 
from those participants who completed the survey packet, as indicated by their closing of 
the browser window. From the completed surveys, analyses were first limited only to 
those who indicated their age to be between 18 and 29. One hundred and forty-two 
participants (11.40%) were excluded based upon their failure to meet this criterion. Data 
analyses were further limited to participants who did not have missing data on more than 
30% of applicable items on any one of the measures used in this study. Sixty participants 
were excluded because they had missing data on more than 30% of applicable items on 
any one of the measures. An additional ten participants were excluded due to conflicting 
information related to their sexual functioning, i.e., participants indicating they had yet to 
have sexual intercourse AND also that they experience pain with sexual intercourse.  
The final sample on which analyses were conducted was thus 1034. Table A2 
presents the demographic characteristics of the final sample of 1034 women. Participants 
ranged in age from 18 to 29 (M = 20.08; SD = 2.63) and all major ethnic minorities were 
represented. In terms of relationship status, approximately 50% of the sample was 
partnered (steady boyfriend, married or cohabiting) but only a small minority had 
children (4.8%). Almost 80% had already engaged in sexual intercourse, with the mean 
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age of first intercourse being 16.71. The Female Sexual Function Index (FSFI: Rosen, et 
al., 2000; Appendix B) was utilized to ascertain which women experienced symptoms of 
dyspareunia. The last three items on the FSFI inquire whether participants experience 
discomfort or pain during and/or after vaginal penetration, as well as the degree of 
discomfort. Participants indicating that 1) they experienced pain with intercourse 
approximately half of the time or more, and 2) that the pain was moderate or more severe, 
were considered to have dyspareunia. Thus, the three groups of interest to this study 
consisted of 728 sexually active women without dyspareunia, 102 women with 
dyspareunia, and 204 women who had not yet become sexually active.   
Materials 
Socio-Demographic Questionnaire.  
A brief sociodemographic questionnaire inquiring about age, ethnicity, relationship 
status, parity was administered. The questionnaire contained a separate section for those 
reporting pain with intercourse to choose descriptions of the pain they experienced and to 
indicate whether they had sought treatment for their pain and what types of treatment (see 
Appendix C).  
 Female Sexual Functioning Inventory (FSFI: Rosen, et al., 2000; Appendix B).  
The FSFI was used to identify women with dyspareunia. This instrument is composed 
of 19 questions pertaining to six domains: desire (items 1 and 2), arousal (items 3 though 
6), lubrication (items 7 through 10), orgasm (items 11 through 13), satisfaction (items 14 
through 16) and pain (items 17 through 19). Each item represents a separate component 
of the domain (i.e., frequency, difficulty, and satisfaction). Scores for the full scale range 
from 2 to 36 with higher scores indicating higher levels of sexual function. The items 
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addressing sexual pain query the frequency of discomfort or pain during vaginal 
penetration, frequency of discomfort or pain following vaginal penetration, and the 
intensity of pain during or following vaginal penetration during the past four weeks. 
Response options on the frequency of pain questions are: Did not attempt intercourse, 
Almost always or always, Most times (more than half the time), Sometimes (about half 
the time), A few times (less than half the time), Almost never or never. For the item 
regarding intensity of pain, response options are: Did not attempt intercourse, Very high, 
High, Moderate, Low, Very low or none at all. The range of scores for the domain of pain 
is 0 to 6. Participants were assumed to have dyspareunia if they responded with 
“Sometimes (about half the time)” or above to items 17 and/or 18 and “Moderate” to item 
19. The FSFI has been found to have high test-retest reliability (r = .79 - .86), high 
internal consistency (Cronbach‟s alpha values of 0.82 and higher) and acceptable 
discriminate validity, as demonstrated by significant difference between scores of women 
with female sexual arousal disorder, female orgasmic disorder, hypoactive sexual desire 
disorder, and control groups (Meston, 2003; Rosen, et al., 2000). The overall internal 
consistency alpha in this sample was .98. 
Sexual Health Treatment Barriers Scale – Dyspareunia - Exploratory Version 
(SHTBS –DyspEXPV; Exhibit A1).  
 
The SHTBS-Dysp EXPV consisted of 58 items generated as described in Phase 1 of 
the study. Items addressed seven categories of potential barriers: Minimizing the Problem 
– 10 items; Distrust of Health Professionals – 8 items; Shame – 9 items; Fear of 
Severity/Impact – 7 items; Privacy – 7 items; Problem Identity Confusion – 9 items; and  
Lack of Resources – 8 items. The measure instructs respondents to imagine they begin to 
experience pain with intercourse and then indicate the extent to which each item would 
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be or is true for them. Each item represents a treatment barrier, but they are not identified 
as such for the participants. Responses are given on a 5-point Likert scale ranging from 
“not at all true” to “very true,” higher scores indicating the reason to be more of a barrier 
to their treatment seeking. Items were randomized for presentation. The possible range of 
scores for the SHTBS-DyspEXPV is 58 to 290. After responding to the list of barriers, 
the measure then instructs participants to indicate how likely they would be to seek help 
for this problem from eight different sources, although the answers to these questions are 
not part of the measure score.  
Somatosensory Amplification Scale (SSAS; Barsky, Wyshak, & Klerman, 1990; 
Appendix D).  
 
The SSAS is composed of ten items assessing the degree to which an individual 
experiences ordinary bodily sensations as intense and disturbing. Individuals are asked to 
respond using a Likert-type scale in which 1 is labeled “not at all true,” 2 “a little bit 
true,” 3 “moderately true,” 4 “quite a bit true,” and 5 “extremely true.” Higher scores 
indicate higher levels of distress regarding somatic symptoms. The possible range of 
scores is 10 to 50. The SSAS has been found to have good reliability and validity with 
test-retest coefficients of .79, Cronbach alphas ranging in the low .80‟s (Barsky, et al., 
1990; Sayar, Kirmayer, & Taillefer, 2003) and the ability to distinguish hypochondriachal 
patients as well as those who make frequent use of medical services from other patients 
(Barsky, et al., 1990; Barsky & Wyshak, 1990). Internal consistency for the measure with 
this sample was moderate with Cronbach alpha = .74. 
Health Anxiety Questionnaire (HAQ; Lucock & Morley, 1996; Appendix E). 
 The HAQ was designed to identify individuals with high concern about their health. 
The 21 items on the HAQ focus on health worry and preoccupation, fear of illness and 
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death, reassurance-seeking behavior and interference with activities. Individuals are 
asked to respond using a Likert-type scale in which 0 is labeled “not at all or rarely,” 1 
“sometimes,” 2 “often,” and 3 “most of the time.” Higher scores indicate more worry 
about health. The possible range of scores is 0 to 63. The HAQ has been found to have 
high reliability with test-retest coefficients ranging between .87 to .95 and high internal 
consistency of .92 (Lucock & Morley, 1996). The scale also has adequate discriminant 
validity in distinguishing clinical and non-clinical populations (Lucock & Morley, 1996). 
Internal consistency for the measure with this sample was good with Cronbach alpha = 
.92. 
Pain Catastrophizing Scale (PCS; Sullivan, et al., 1995; Appendix F). 
The PCS was constructed as a self-report measure that provides an index of 
catastrophization in clinical and nonclinical populations and is composed of 13 items, 
which fall in one of three dimensions: rumination, magnification, or helplessness. 
Individuals are asked to reflect on past painful experiences and then indicate the degree to 
which they have experienced the thoughts and feelings described in the 13 items. 
Response options are on a 5-point scale from 0 (“not at all”) to 4 (“all the time”) with 
higher scores indicating greater pain catastrophization. The possible range of scores is 0 
to 52. The PCS has been demonstrated to be reliable (Cronbach‟s alpha = .87). The PCS 
has also been found to have criterion-related, concurrent and discriminatory validity 
(Osman, Barrios, Gutierrez, Kopper, Merrifield, & Grittmann, 2000). In this sample, 
internal consistency of the measure was good with a Cronbach alpha of .94. 
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Mental Health Inventory (MHI; Veit & Ware, 1983; Appendix G).  
The MHI is a 38-item measure of psychological distress and well-being for use in 
general populations. Items address the following constructs: psychological distress, well-
being, anxiety, depression, emotional ties, general positive affect and loss of behavioral 
emotional control. Individuals are asked questions related to how they have felt in the 
past month (i.e, Have you felt calm and peaceful? Were you able to relax without 
difficulty?). Participants respond to each question by indicating how much of the time 
they have experienced these feelings in the last month on a 6-point Likert scale ranging 
from “all of the time” (scored as 6) to “none of the time” (scored as 0) for items related to 
psychological distress. Items for psychological well-being are reverse scored such that 
higher scores indicate greater mental health. The possible range of scores is 0 to 100. The 
MHI has been found to have good internal reliability (ranging from .83-.91). Stability 
coefficients in the .56 to .64 range indicate stable reliable variance over a 1-year interval. 
The MHI has shown to have good discriminant validity in distinguishing those with and 
without mental disorders (Weinstein, et al., 1989). In this sample the internal consistency 
of the measure was good with a Cronbach alpha of .85. 
Procedure  
Participants were recruited through the Psychology 101 Subject Pool. Potential 
participants were given a link and password to access the consent form and study 
questionnaires on computers using Survey Monkey software, which records all data 
points entered by participants. Upon entering the link into a browser and providing the 
required password, participants were presented with the informed consent. Upon agreeing 
to participate (by clicking “Proceed”) participants were presented with the following 
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measures: the Socio-demographic Questionnaire, the SHTBS-DyspEXP, the FSFI, the 
SSAS, the HAQ, the PCS, and the MHI. Upon completion of the survey, participants 
were prompted to close the browser window.  
Phase 3 – Test/Re-test Reliability 
Participants 
In order to evaluate test-retest reliability, 24 women were recruited from the 
Psychology 101 Subject Pool. Participants ranged in age from 18 to 29 (M = 20.08; SD = 
2.52) with 16.7% identifying as being African American, 16.7%% Asian American, 25% 
EuroAmerican (Caucasian), 20.8% Hispanic American, and 16.7% Pacific Islander 
American. In terms of relationship status, approximately 50% of the sample was 
partnered (steady boyfriend, married or cohabiting). All were nulliparous. The majority 
(83.3%) had already engaged in sexual intercourse, with the mean age of first intercourse 
being 16.35. Questions from the pain domain of The Female Sexual Function Index 
(FSFI: Rosen, et al., 2000) was utilized to ascertain which women experienced symptoms 
of dyspareunia. Only two woman indicated having symptoms of dyspareunia (Table A3). 
Materials for Phase 3 
Socio-Demographic Questionnaire.  
An abridged version of the socio-demographic questionnaire was administered in 
Phase 2. It consisted of items 1 through 6 of the original version (see Appendix H). 
Sexual Health Treatment-Seeking Barriers Scale-Dysp (SHTBS-Dysp; Exhibit A2). 
The SHTBS-Dysp contains 28 Likert-type items that assess Minimization, Shame, 
and Fear of Severity. This measure is the principle-component-analyzed and reduced 
version of the SHTBS-DyspEXPV. Details of how the 58-item SHTBS-DyspEXPV 
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became the 28-item SHTBS-Dysp are described in the Results section. Similar to the 58-
item version, this measure instructs respondents to imagine they begin to experience pain 
with sexual intercourse and to then indicate the extent to which each item would be true 
for them. Items fall into three categories of potential treatment barriers:  Minimization – 
10 items; Shame – 10 items; and Fear of Severity – 8 items. The potential treatment 
barriers are described as reasons for hesitating to seek help and are randomly presented. 
Responses are given on a 5-point Likert scale ranging from 1 “not at all true”  to 5 “very 
true,” with higher scores indicating that the participant has or would imagine more 
barriers to treatment seeking. The range of possible scores is 28 to 140. The SHTBS-
Dysp demonstrated good internal consistency with this sample (Cronbach‟s alpha = 
0.94). 
Procedure  
Participants were recruited through the Psychology Subject Pool at the University of 
Nevada, Las Vegas. At Time 1, participants arrived at the classroom and were presented 
with an informed consent. Upon signing the informed consent and orally indicating to the 
investigator the desire to participate in the study, participants were presented with the 
socio-demographic questionnaire, the SHTBS-Dysp and a manila envelope. Upon 
completion of the two questionnaires, participants were asked to insert the questionnaires 
in the manila envelope to ensure privacy and to schedule a time to return and complete 
the second administration of the SHTBS-Dysp approximately two weeks later. At Time 
2, participants arrived at the classroom and were presented with an informed consent. 
Upon signing the informed consent and orally indicating to the investigator the desire to 
participate in the study, participants were presented the SHTBS-Dysp and a manila 
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envelope. When they completed the questionnaire, they inserted it in the manila envelope 
and handed it to the investigator. 
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CHAPTER 4 
RESULTS 
Phase 1 – Construction of Sexual Health Treatment Barriers Scale – Dyspareunia 
(SHTBS-DyspEXPV) 
Phase 1 of this study entailed the construction of the Sexual Health Treatment Barriers 
Scale–Dyspareunia–Exploratory Version (SHTBS-DyspEXP), the details of which can be 
found in the Method section (Exhibit A1). 
Phase 2 – Investigation of SHTBS-DyspEXPV Properties & Validity of the SHTBS-
Dysp 
Overview 
To assess the factor structure of the SHTBS-DyspEXPV, a principle components 
analysis (PCA: Kaiser, 1970) was performed including all fifty-eight questionnaire items 
relating to potential health seeking barriers (the last eight items on the SHTBS did not 
pertain to treatment barriers but rather to preferences for a variety of potential treatment 
or assistance sources). To address missing data, scores were first imputed using the 
expectation maximization algorithm model. Before conducting the PCA, scores were also 
mean deviated to account for the differences between the three groups (sexually active 
with no pain, sexually active with pain, not sexually active) in our combined sample. A 
number of strategies to determine the original factor solution were considered. After 
examining several factor solutions, a four-factor solution was determined to be optimal 
and an Oblique rotation (Promax; Kappa=2.5) was applied. However, considering that the 
fourth factor had only 3 items and that these items pertained to general help-seeking 
barriers that were not specific to sexual health problems (e.g., lack of insurance, no 
regular primary care provider, no time to go see doctor), we chose to retain only three of 
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the four factors. This final version of the questionnaire was named the Sexual Health 
Treatment Barriers Scale – Dyspareunia (SHTBS-Dysp) (see Exhibit A2). Detailed 
information regarding the analyses follows.  
Missing Data 
Missing scores were imputed using the expectation maximization algorithm model for 
any questionnaire with less than 30 percent missing data (Tabachnick & Fidell, 2007). 
For participants with less than 30% missing data on any measure, we utilized the Missing 
Values Analysis module for SPSS to conduct imputations using the expectation 
maximization algorithm model (Tabachnick & Fidell, 2007). Of the final sample of 1034 
participants with less than 30% missing data on any one measure, 872 participants had 
less than 5% missing on any of the measures (748 had no missing data points at all), 80 
had 5-10% missing, 36 had between 11-20% missing and four had between 21-30% 
missing data on any one measure. 
Investigation of Group Differences Prior to PCA 
Because we collected data from three groups of women (women who had not yet 
become sexually active, sexually active women who did not experience pain with 
intercourse, and sexually active women who reported symptoms of dyspareunia), we 
assessed 1) group differences in three separate variance-covariance matrices, and 2) 
group mean differences on the items. The Bartlett-Box procedure was used to determine 
if there was a significant difference between the three variance-covariance matrices. 
Results indicated that the variance-covariance matrices were significantly different 
(Box‟s M = 5141.69, p < .001), suggesting that PCA should be conducted separately for 
each group of women. However, after examining preliminary PCA's for each of the 
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groups and finding similar factor structure and item loadings for each, we decided to 
explore the underlying factor structure of the SHTBS-DyspEXPV with the combined 
sample, taking the appropriate measures as follows. A test of Between-Subject Effects 
determined there was a significant difference between the group of women with 
dyspareunia and women who were sexually active and did not experience pain, F(1,830) 
= 13.49, p<.001. There was also a significant difference between women who were 
sexually active and did not experience pain and those who were not yet sexually active, 
F(1, 932) = 6.05, p<.05. Consequently, the data from the three groups of women was 
mean-deviated before a PCA was conducted with the combined sample.  
Item Descriptive Statistics and Multicollinearity 
Item descriptive statistics (means and standard deviations) were conducted to identify 
and drop items whose means were on the extreme and near 0, exhibited little variance, 
and/or had a near-zero or negative-item correlation with the total score (see Table A4). 
Means for all items varied from 1.75 to 3.25.  Two items with low variance (below 1) 
were dropped because low item variance is associated with decreased internal 
consistency (Wester, Willse & Davis, 2008) and has the potential to negatively impact 
factor structure (Ekkekakis & Petruzzello, 2000) (in SHTBS-DyspEXPV: item 16. Would 
not want the sort of help available and item 28. Would not trust health professionals to 
help with it). Next, item-total correlations were computed. There were no items that had 
negative item-total correlation or item-total correlations of <.1. To address issues of 
multicollinearity, we examined inter-item correlations equal to or greater than .7, as 
recommended by Tabachnick and Fidell (2007). Out of the ten pairs that met that 
criterion, we discarded those items in each pair with the lowest item-total correlation. 
74 
This resulted in the dropping of 10 additional items from the SHTBS-DyspEXPV as 
follows: item 1. Believe that the problem is temporary; item 8. Delay getting treatment 
because I do not have health insurance; item 9. Believe that problems like this are part of 
having sex; item 27. Believe this problem does not require treatment; item 35. Not want a 
health professional to examine my private parts (genitalia); item 37. Have difficulty 
fitting an appointment with a health professional into my busy schedule; item 45. Worry 
that the health professional would think that I am abnormal; item 49. Be concerned that I 
could not afford treatment; item 51. Believe that individuals can fix this type of problem 
on their own and; item 57. Be concerned about there being a record (e.g., medical record 
or insurance record) of my seeking help for this type of problem. This process thus 
resulted in the reduction of the measure from 58 items to 46 items. 
Determining the number of factors 
To determine the number and nature of the factors underlying the SHTBS-
DyspEXPV, we conducted a PCA with multiple factors. Number of factors to be retained 
for rotations was guided by a consideration of three criteria (Kaiser-Guttman rule, Scree 
Test and Parallel Analysis). A description of each criterion considered follows.  
 First, the Kaiser-Guttman rule dictates that the number of factors is determined by 
counting the number of eigenvalues > 1.0. This criteria is based on the rationale that each 
factor that has an eigenvalue > 1.0 also has a positive value for coefficient alpha and thus 
accounts for at least as much variance as one of the original factors. Second, with the 
scree test (Cattell, 1966) a scatterplot is obtained through SPSS with the number of the 
factors on the x-axis and the value of the eigenvalue on the y-axis. A line is drawn 
through the dots, beginning at the bottom right side of the graph and the first dot above 
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the line indicates the number of factors. Finally, parallel analysis (Cota, Longman, 
Holden, & Fekken, 1993; Horn, 1965) involves comparing obtained eigenvalues against 
randomly generated datasets that have the same number of variables and participants 
(Thompson, 2004). 
After employing the above criteria to determine the number of factors, it was 
observed that the Kaiser-Guttman criterion suggested the retention of seven factors, while 
both the scree plot and parallel analysis suggested the retention of five factors. Loadings 
with structure coefficients of ≥ .40 were considered to be salient so as to retain only those 
loadings that were both statistically (p < .05) and practically significant (Stevens, 2002). 
We had originally hypothesized seven factors before administration of our measure; 
however, after examining statistical suitability, we found that several factors were 
considered trivial because they did not have a unique set of defining variables (Gorsuch, 
1983). Thus, we ran multiple factor solutions to determine which had maximum 
interpretive potential. The four-factor solution maximized simple structure and was the 
most interpretable as it had the greatest number of unique defining variables on each 
factor. This 4-factor solution was initially retained.  
To determine the optimal rotation, three orthogonal rotations (Varimax, Quartimax, 
and Equamax) and four oblique rotations (Direct Oblimin {Δ = 0; Δ = -1} and Promax 
{Kappa = 2.5; Kappa = 3.5}) were run. We judged the quality of each rotation based on 
how well the rotated factor pattern matrix matched the criterion of “simple structure.” 
Simple structure was defined as having few complex variables (salient coefficients), 
having a high number of hyperplanar coefficients (this indicates that each factor is 
measuring only some specific content), and lower correlations between factors (high 
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correlations obscure the difference between factors). For each rotation, the number of 
hyperplanar pattern matrix coefficients and the number of complex items were counted. 
For the oblique rotations, the correlations among the factors were summarized also. An 
oblique rotation (Promax, Kappa=2.5) was found to be optimal and resulted in one 
complex item and 77 hyperplanar pattern matrix coefficients (see Table A5). 
 The resulting model retained 35 items, explained 49.48% of the variance after 
rotation and reflected moderate interfactor correlations (see Table A6).  The first factor 
(internal consistency: alpha = .89) consisted of items we interpreted as and titled 
Minimization. The second factor (alpha = .91) consisted of items we interpreted as and 
titled Shame. The third factor (alpha = .86) consisted of items we interpreted as and titled 
Fear of Severity. The fourth factor (alpha = .84) consisted of items we interpreted as and 
titled Structural Problems (non-sexuality related reasons for not seeking health care [e.g. 
can't afford to see a doctor]). However, when internal consistency was measured for the 
fourth factor, the alpha-if-item-deleted analysis indicated the necessity the removal of one 
item (see Table A7). After removal of this item, the factor‟s alpha was .86. Considering 
the fact that Structural Problems related to general healthcare obstacles (e.g., not having a 
regular general medical doctor, not having sufficient health insurance coverage, etc.), 
which are not specific to sex-related problems (the main aim of our measure), we decided 
to remove the fourth factor from further analysis. This yielded a final scale with 28 items 
and an overall internal consistency of .94. The standard error of measurement was also 
computed (SEM = 4.92).  
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Interpretation of Factors (SHTBS-Dysp Scales) 
 The resulting 3-subscale measure was titled the Sexual Health Treatment Barriers 
Scale -Dyspareunia (SHTBS-Dysp: see Exhibit A2) and consisted of 28 items. A 
description of each of the subscales follows.  
 The first subscale consisted of 10 items we interpreted to be related to Minimization 
which corresponded to our first hypothesized dimension: Minimizing the Problem. 
Minimization was defined as dismissing the significance of the symptoms (pain) 
sufficiently to deem treatment unnecessary (e.g., think that this is not a big enough 
problem for a consultation with a health professional; consider this to be a minor 
problem that does not require treatment). Reasons for minimizing included believing that 
the pain is simply something to endure (e.g., believe that problems like this are just 
something you deal with) or not severe enough to warrant taking any action requiring a 
health professional (e.g., prefer to wait until I was sure the problem was serious enough 
to seek assistance) (Table A8).    
The second subscale consisted of 10 items assessing items that we interpreted as 
being related to Shame. Shame was defined as feelings associated with the possible 
stigma of having a sexual problem (e.g., find it embarrassing to disclose to a health 
professional that I was having a problem with sex), issues surrounding maintaining one‟s 
privacy (e.g., be afraid the health professional might tell others about my problem), and 
concern about being negatively evaluated by others (e.g., worry that the health 
professional would judge me negatively). This subscale is related to our third 
hypothesized dimension: Feelings of Shame (Table A8).  
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 The third subscale consisted of eight items assessing items that we interpreted as 
being related to the Fear of Severity. This was defined as a concern that the symptom of 
pain could be indicative of a severe health problem (e.g., worry that the health 
professional might find I had a serious health problem; worry that I would be told that I 
have a sexually transmitted infection). In addition to worry about a foreboding diagnosis, 
the subscale also included the consideration of the potential negative consequences of the 
symptom (e.g., be afraid to find out that this problem may impact my ability to have 
children in the future; be afraid that the treatment for this would affect my relationship 
with my partner). This subscale also encompassed apprehension related to the potential 
treatment for the underlying problem (e.g., be afraid that they might tell me there is no 
treatment or cure for it) and the possibility that a treatment may not even exist (e.g., be 
afraid that they might tell me there is no treatment or cure for it). This subscale was 
related to our fourth hypothesized potential barrier dimension: Fear of Severity (Table 
A8). 
 A series of bivariate correlations (see Table A9) were conducted to examine the 
relationship between the SHTBS-Dysp total score and its three subscales. Results 
indicated a significant (p <.005) positive correlation between the SHTBS-Dysp Total 
Score and Minimization (r = .80), Shame (r = .89), and Fear of Severity (r = .82). 
Significant relationships were identified between the subscales of Shame and 
Minimization (r = .56), Shame and Fear of Severity (r = .66), and Minimization and Fear 
of Severity (r = .44).  
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Convergent Validity 
A series of bivariate correlations were computed between the SHTBS-Dysp Total 
Score and subscale (Minimization, Shame, Fear of Severity) scores, and the study 
measures designed to test convergent validity: Somatosensory Amplification Scale 
(SSAS) (Table A9), Health Anxiety Questionnaire (HAQ) (Table A10), Pain 
Catastrophizing Scale (PCS) (Table A11), and Mental Health Inventory (MHI) (Table 
A12). The SHTSB-Dysp total score was significantly and positively related to the total 
score of all of our convergent validity measures: SSAS (r = .14, p < .005), HAQ (r = .27, 
p < .001), PCS (r = .27, p < .002), and MHI (r = .27, p < .001). Each of the subscales of 
the SHTBS-Dysp also correlated significantly and positively with the total score of each 
of the convergent validity measures, as illustrated in the aforementioned Tables A9-A12.  
 The subscales of the SHTBS-Dysp correlated significantly with subscales of the HAQ 
in both expected and paradoxical fashions. Minimization and Shame were positively 
associated with Worry and Health Preoccupation, Fear of Illness and Death, and Extent to 
Which Symptoms Interfere with the Person‟s Life.  Neither the Minimization nor Shame 
subscales were associated with Reassurance-seeking Behavior. Fear of Severity was 
positively associated with all HAQ subscales except Extent to Which Symptoms Interfere 
with the Person's Life. Minimization, Shame, and Fear of Severity all correlated 
positively with the three PCS subscales; Rumination, Magnification, and Helplessness. 
Regarding the MHI, Minimization was positively associated with all MHI subscales, 
while Shame and Fear of Severity were positively associated with all MHI subscales 
except for Positive Affect.  
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To further explore the nature of the association between the SHTBS-Dysp and 
potentially associated constructs, the sample was divided into thirds in terms of their 
scores on each of the associated measures (SSAS, HAQ, PCS, & MHI). ANOVAs were 
conducted to compare SHTBS-Dysp scores among low scorers, medium scorers and high 
scorers for each convergent validity measure. No significant pattern of differences was 
found between the three groups for any one of the measures. Participants with lower 
scores on the measures endorsed fewer treatment seeking barriers and participants with 
higher scores endorsed more treatment barriers as the initial correlations indicated. 
 To test our hypothesis pertaining to the correlation between SHTBS-Dysp total score 
and self-reported attempts at seeking treatment in women with dyspareunia, a point 
biserial correlation was executed with the dyspareunia sample only. A statistically 
significant negative correlation was found between the SHTBS-Dysp total score and the 
number of times that participants with dyspareunia consulted with a health provider about 
this problem, (r = -.21, p < .05). Independent-samples t-tests were also conducted to 
compare SHTBS-Dysp total scores for women with dyspareunia who indicated they had 
reported their symptom to a heath professional and those who had not. Results indicated 
that women who indicated having reported their symptoms to a health professional were 
less likely to endorse barriers than women who had not reported the problem. Significant 
differences were found in SHTBS-Dysp total score for those who had reported symptoms 
to a health professional (M = 68.24, SD = 19.55) and those who had not (M = 78.74, SD = 
17.52); t (102) = -2.73, p = .008). Regarding the SHTBS-Dysp subscales, significant 
differences were found in scores on the Minimization subscale between reporters (M = 
25.43, SD =6.84) and non-reporters (M = 29.23, SD = 7.63); t (102) = -2.44, p = .017 and 
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on the Shame subscale between reporters (M = 20.99, SD = 9.59) and those who 
indicated they had not reported symptoms (M = 25.09, SD = 8.89); t (102) = -2.13, p = 
.036. The difference on the Fear of Severity subscale score between women who had 
reported symptoms (M = 21.82, SD = 6.85) and those who had not (M = 24.42, SD = 
6.64) was not significant t (102), p = .07).  
Group Differences in SHTBS-Dysp Scores 
As our sample consisted of women who were not sexually active, women who were 
sexually active but had no pain, and sexually active women with symptoms of 
dyspareunia, we explored group differences in treatment barriers. Table A13 presents the 
means and standard deviations in SHTBS-Dysp subscales and total score as a function of 
group membership. Separate analyses of variance (ANOVA) indicated significant group 
differences on the total SHTBS-Dysp score and all subscales, although effect sizes were 
very small (see Table A14).  Post-hoc comparisons using the Scheffe‟ test indicated that 
on the Minimization subscale, women with dyspareunia scored higher than women who 
did not experience pain with sex (p < .01) or women who had not yet become sexually 
active (p < .01). On the Shame subscale, women with dyspareunia scored significantly 
higher than women who did not experience pain with intercourse (p < .01), while the 
latter scored significantly lower than women who had yet to be sexually active (p < .01). 
On the Fear of Severity subscale, women with dyspareunia did not differ from the other 
two groups, but sexually active women with no intercourse pain scored significantly 
lower than sexually inactive women (p < .01). In terms of the SHTSB-Dysp Total Score, 
women with dyspareunia scored significantly higher than sexually active women who did 
not experience pain (p < .01) (see Table A13).  
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Help-Seeking Sources. 
 In addition to investigating the properties and convergent validity of the SHTBS-
Dysp, we also collected data on the most likely sources of help for women who might in 
the future or already have problems with painful intercourse. Participants were instructed 
to respond how likely they would be to seek help from a list of sources: sex therapist, 
psychologist, medical doctor, friend, sexual partner, relative, internet, and clergy 
member. Response options were on a 5-point Likert scale from 1 (“not at all likely”) to 5 
(“very likely”). Table A15 presents the means and standard deviations for the entire 
sample in terms of the likelihood of seeking help from the list of sources provided.  A 
medical doctor was considered the most likely source of help for this problem followed 
by the Internet, a sex partner, and a friend. Relatives, a sex therapist, a psychologist, and 
a clergy member found themselves at the bottom of the list in the order here presented. 
Table A16 presents the means and standard deviations of the likelihood of consulting 
with any of the afore-mentioned sources of help as a function of group membership. 
Separate analyses of variance (ANOVA) for each help-seeking source were conducted to 
assess group differences (see Table A17).  Group differences were found for likelihood of 
seeking help from a psychologist, F(2, 1017) = 5.07, p<.05; a medical doctor, F(2, 1017) 
= 4.68, p<.05; and a relative F(2, 1017) = 5.36, p<.05, although all effect sizes were very 
small. Posthoc comparisons using the Scheffe‟ test indicated that women with 
dyspareunia were more likely to seek help from a psychologist than women who did not 
report experiencing pain with intercourse (p < .05). Women with dyspareunia also 
reported being less likely to seek help from a medical doctor than women who did not 
experience pain with intercourse (p < .01) and women who were not yet sexually active 
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(p < .05). Women who had yet to have sexual intercourse reported being more likely to 
seek help from a relative than those who were sexually active without pain (p < .001) and 
more likely than women with dyspareunia (p < .05). Finally, women who did not 
experience pain with intercourse indicated they would be more likely to seek help from 
the Internet than women who were not yet sexually active (p < .05) (see Table A16).  
Phase 3 – Examining Test-retest Reliability 
Test–retest stability was evaluated using intraclass correlation coefficients (ICCs). 
An intraclass correlation coefficient of < .39 indicates poor agreement, .40 indicates fair 
agreement, .41–.60 indicates moderate agreement, .61–.80 indicates good agreement and 
> .80 indicates excellent agreement (Bartko, 1996). The ICC for the SHTBS-Dysp 
subscales (Minimization: r = .83; Shame: r =.86; and Fear of Severity: r =.80) and the 
SHTBS-Dysp total score (r = .84) suggested excellent agreement. 
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CHAPTER 5 
DISCUSSION 
The purpose of this study was to explore barriers to treatment-seeking for dyspareunia 
in young women. In order to do so, we created a measure consisting of rationally derived 
items based on the general help-seeking literature, as well as items drawing on treatment 
barrier themes found in Donaldson and Meana‟s (2011) qualitative study of young 
women with dyspareunia. The structure of the measure was modeled on Mansfield, et 
al.‟s (2005) general Barriers to Help-Seeking Scale (BHSC), which uses the hypothetical 
health problem scenario as a prompt. The measure was administered to three groups of 
young women: women currently experiencing painful intercourse, sexually active women 
who do not experience pain with intercourse, and women who have yet to become 
sexually active. The main statistical analyses were conducted on the combined sample, 
after within-group mean deviation of scores on the developed measure was applied. 
Exploratory principal component analysis of this measure yielded three psychometrically 
sound components (subscales): Minimization, Shame, and Fear of Severity. The resulting 
measure contained 28 items and was titled the Sexual Health Treatment Barrier Scale – 
Dyspareunia Version (SHTBS-Dysp).  
The SHTBS-Dysp was found to be a psychometrically sound measure. After 
administration of the principle component analysis, this measure‟s components accounted 
for almost 50% of the variance after rotation. With regards to reliability, results indicated 
that the SHTSB-Dysp has good internal consistency among its items and demonstrated 
good test-retest reliability. In regards to convergent validity, the SHTBS-Dysp total and 
sub-scale scores correlated (in expected and unexpected ways) with all of the measures 
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administered: the Somatosensory Amplification Scale (SSAS), the Health Anxiety 
Questionnaire (HAQ), the Pain Catastrophization Scale (PCS), and the Mental Health 
Inventory (MHI). It also correlated with Self-reported attempts at treatment-seeking in 
women with dyspareunia. This indicates that the SHTBS may be a good predictor of 
actual behavior, although this was not directly tested in this study. Significant differences 
in treatments barriers between the three groups of women were evident, although the 
effect sizes of the differences were small. And, finally, participants indicated a distinct 
preference for sources of help-seeking, identifying medical doctors as the most preferred, 
followed by the Internet, sex-partners and friends.  The following sections will describe 
and interpret the results in detail. 
Treatment Barriers 
Minimization 
The Minimization component of the SHTBS-Dysp reflected the tendency to dismiss 
the significance of the hypothetical or real symptom of pain, so as to render help-seeking 
unnecessary. This barrier included beliefs that this type of pain is a natural part of 
sexuality which women just have to endure, that the pain would simply resolve or 
disappear on its own without intervention, and that the pain would not be or was not 
sufficiently severe to require remedial action. This subscale thus captured the tendency to 
underestimate the negative consequences of pain with intercourse and to identify the 
problem as unworthy of serious concern. Dyspareunia is not the only health problem in 
which we witness this type of strategy. 
Symptom minimization has been shown to be a common help-seeking barrier for a 
number of health problems. It has also been shown to interfere with recommended or 
desirable health-related behaviors related to prevention, detection, and adherence to 
86 
medical regimens. Specifically, minimization has been linked to information avoidance in 
cardiac patients and lower medication adherence in asthmatic patients, as well as in 
individuals diagnosed with hypertension and diabetes (Adams & Carter, 2010; McGann, 
Sexton & Chyun, 2008; Rosenfield, Lindauer, & Darney, 2005). Minimization has also 
been found to be a barrier to seeking additional medical assessment among college 
students and community members who received borderline-high cholesterol results 
(Croyle, Sun & Louie, 1993).  Denial, which is an extreme form of minimization, has 
been associated with the reluctance to pursue help-seeking in diabetic patients and in 
patients with Hepatitis B (Gazmararian, Ziemer & Barnes, 2009; Tan, Cheah, & Teo, 
2005). Denial of potential cancer symptoms has also been identified as a barrier to 
mammogram utilization in African-American women and colorectal screening in men 
(Bajracharya, 2006; Peek, Sayad, & Markwardt, 2008).  Overall, minimization and denial 
are common explanations as to why individuals confronted with a wide variety of 
symptoms avoid diagnostic testing, investigation of etiology, and treatment-seeking and 
adherence.  
The state of the literature does not allow us to compare the influence of minimization 
on treatment seeking in dyspareunia versus other health concerns. Although the vast 
majority of physical etiologies for dyspareunia do not pose the risk of more life-
threatening conditions, such as heart disease or asthma, dyspareunia does involve 
considerable deterrents to accessing help. Seeking treatment for dyspareunia necessarily 
involves the disclosure of an intimate and generally private aspect of life, as well as 
invasive, unpleasant pelvic examinations. On the other hand, most professional medical 
societies recommend annual cervical cancer screenings or triennial screenings and the 
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disclosure of dyspareunia could occur at that time (American Cancer Society, 2010; U. S. 
Preventative Task Force 2004). Research has shown that more women receive annual 
screenings (55%) than biennial (17%) or triennial screenings (16%) (Sirovich & Gilbert, 
2004). There even appears to be a peak in screening for women between the ages of 20 
and 24 (62.4%) which would suggest that young women experiencing pain with 
intercourse have ample opportunity to share their concerns during annual pelvic 
examinations that most already undergo.  
Another potential reason minimization may be a barrier of particular relevance to 
dyspareunia is the fact that the pain occurs only during the act of sexual intercourse. 
Since the pain is limited to this specific activity, women may attribute the symptom to the 
mechanics of penetration, rather than to any tissue damage in their own bodies. It might 
also be easier to dismiss a pain that does not interfere with activities of daily living 
(ADL's). The pain of dyspareunia is also recurrent rather than chronic and thus easy to 
forget about, most of the time. The fact that the pain dissipates after termination of sexual 
activity may also explain why many women with dyspareunia report that they expect that 
the pain will somehow disappear spontaneously over time (Donaldson & Meana, 2011).  
Finally, it is common for young women to anticipate and expect first coitus to be 
painful. The expectation of pain appears to be communicated to women informally via 
family members and/or  peers or it is a conclusion they reach independently upon 
learning, either in a health education class or through other sources, about the probable 
tearing of the hymen at first intercourse (Tsui & Nicoladis, 2004). Thus, if pain happens 
at first intercourse, it is probably very easily dismissed. If the pain continues past the first 
or second sexual encounters, women might ascribe the pain to a period of continued 
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adjustment for their bodies, especially if they do not have sex regularly. Given that there 
is such little awareness or information about dyspareunia available to the general public, 
most women have no prior knowledge or readily-accessible resources to assist in 
determining when the discomfort ceases to be considered normal. Even if the onset of the 
pain occurs months or even years after first coitus, there remains little common 
understanding about what is considered “normal” pain or discomfort, what potentially 
may be causing it, or at what point the pain requires medical attention. Such uncertainty 
and paucity of available information may contribute to young women more easily 
disregarding a symptom about which they know very little.  
There may be numerous reasons why women might dismiss the importance and 
potential consequences associated with intercourse pain. From shyness about disclosing 
sexual details, to apprehension about genital examinations, to misinformation or no 
information about dyspareunia, to expectations that delay the identification of a problem, 
it is not surprising that many young women engage in the minimization of the symptoms 
of dyspareunia, whether they actually have them or not.  
Shame 
The second component, Shame, comprised feelings associated with the perceived 
stigma of having a sexual problem. The Shame subscale focused on the complex 
experience of shame associated with having a symptom related to one‟s sexuality. The 
desire to keep such intimate information about the symptoms private, especially out of 
the fear of negative evaluation by others, was subsumed under this component. The scale 
also encompassed a sense of embarrassment, as well as a tendency toward self-blame for 
the problem. The literature confirms that shame is a help-seeking barrier for a number of 
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disorders, although this may be particularly true of those that involve the genitals or other 
parts of the body associated with sexuality in general. Embarrassment, stigma and self-
blame appear to feature prominently therein. Shame and embarrassment have been found 
to prevent people from seeking medical assistance even when there has been sufficient 
concern about the seriousness of the symptoms (Consedine, Krivoshekova, & Harris, 
2007; Consedine, Magai, & Neugut, 2004). Research has also found that embarrassment 
impedes health behaviors such as treatment-seeking for incontinence, and cancer 
screenings, including those for breast, testicles, cervix, and colon (Consedine, et al., 
2004; Emmons, et al., 2005; Gascoigne, Mason & Roberts, 1999; Goldman & Risica, 
2004; Horrocks, Somerset, Stoddart, & Peters, 2004; Robb, Solarin, Power, Atkin, & 
Wardle, 2008; Waller, Bartoszek, Marlow & Wardle, 2009).  
The fear of stigma and self-blame, another component of shame, have been identified 
as barriers to general health promotion (Corrigan, 2004; Fortenberry, et al., 2002). The 
existing literature on the shame barrier suggests that individuals hesitate to perform 
important health-related actions due to embarrassment, fear of a negative evaluation by 
others, and self-blame. Similar reasons for avoidance have been found in detection and 
help-seeking behavior for genitourinary- and sexually-related health problems, such as 
long-term urinary incontinence and sexually transmitted infections (Carr & Grambling, 
2004; Hagglund & Wadensten, 2007). It is thus not difficult to see why pain with sexual 
intercourse might be a strong candidate for the experience of shame-related reluctance to 
seek help. Again, comparisons about the extent to which shame is a barrier in 
dyspareunia versus other health problems are not currently possible. Our societal 
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discomfort with sexuality in general, however, certainly suggests that shame might be 
particularly relevant to investigate in regard to the treatment of sexual difficulties. 
Indeed, shame has been found to be a barrier for certain sexual health issues.  For 
example, conditions involving the genitals appear to generate the fear of embarrassment 
as noted in patients with urinary stress incontinence (STIs) and premenstrual symptoms 
(Cunningham, Kerrigan, Jennings & Ellen, 2009; Hagglund & Wadensten, 2007; 
Hemachandra, Najapaksa, & Manderson, 2009; Ireland, Reid, Powell, & Petrie, 2005; 
Robinson & Swindle, 2000). This fear has been shown to impede those patients‟ 
treatment-seeking behaviors. Contributing to their fear of embarrassment, patients 
attending a sex-related medical visit reported having the concern that they might be 
negatively judged by their physician because of their symptoms (Consedine, et al., 2007). 
For those experiencing sexual dysfunction, embarrassment is among the most common 
reason that patients do not broach the topic with their doctors (Marwick, 1999).  A related 
concern appears to be the fear that clinicians and other health-care providers might be 
dismissive of their self-reported sexual dysfunction symptoms. Female sexual 
dysfunction, in particular, remains the most oft-ignored concern, often due to 
embarrassment or discomfort with gender mismatched patient-doctor dynamics (Burd, 
Nevadunsky, & Bachmann, 2006; Goldstein, Lines, Pyke, & Scheld, 2009). The National 
Health and Social Life Survey found that only 20% of women who experienced 
symptoms of sexual dysfunction sought medical evaluation (Laumann, Gagnon, Michael, 
& Michaels, 1995).  
Some women experiencing pain with intercourse of varying etiologies have indicated 
they experience shame about the problem. Women with vulvodynia have reported feeling 
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a sense of self-blame and inadequacy, such as the subjective experience of being an 
“inadequate woman” (Ayling & Ussher, 2008). The following quotes from different 
participants in the Donaldson & Meana (2011) study clearly illustrate the experience: 
"When it starts to come up or if we’re with friends and they start to talk about their sex 
lives, then I kind of want to walk away, I don’t even want to be around cause I just kind of 
feel embarrassed and I’m just like oh please . . . cause I know what he’s thinking. He’s 
probably thinking oh she’s in pain all the time.  Our sex life isn’t that great. So I just kind 
of feel embarrassed, and so I just kind of want to walk away when someone talks about it 
(p. 819).  "I went into this thinking like, I am abnormal. I am different. Like, something’s 
wrong. I’m just not normal like everyone else" (p. 819). It is hardly surprising that this 
high level of embarrassment would be a detriment to seeking assistance from any type of 
health care provider (Donaldson & Meana, 2011). In the current study, even women who 
did not experience pain with intercourse or who were not even sexually active endorsed 
shame as being a significant barrier for them.  
Although it is impossible to tease apart the extent to which this shame is a hard-wired 
evolutionarily adaptive attitude or whether it emanates strictly from societal norms, it is 
clear that there is an overall societal discomfort about sexual issues.  This discomfort is 
particularly pronounced in the case of female sexuality which is routinely controlled to a 
larger extent than male sexuality, cross culturally (DeLamater, 1989; Frank, Bauer, 
Arican, Fincanci, & Iacopino, 1999; Reiss, 1986). There may thus be some gender-
specific shame associated with reporting sexual problems (which necessarily denote 
sexual activity) or with the symptoms of dyspareunia (which happen to interfere with the 
most socially condoned sexual behavior - intercourse).  
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Fear of Severity/Seriousness 
The Fear of Severity component addressed the concern that pain could be indicative 
of a severe health problem or have the potential to result in seriously negative 
consequences. The subscale also included items related to fear about what treatments 
might involve, as well as the apprehension that a treatment may not even exist. While 
fear of severity could theoretically be just as easily an incentive to seek treatment, in this 
study it represented a barrier. A health care provider might confirm women's worst-case 
fears about the gravity of the symptom and some simply preferred not to know. 
Being concerned about the potential severity of a condition can be beneficial, as 
illustrated by research on the Seriousness dimension of the Health Belief Model (HBM) 
(Champion, 1993; Rosenstock, 1966). This particular dimension has been shown to 
increase health behaviors such as diagnostic testing (Dawson, et al., 2006). However, 
when the fear of severity surpasses a certain high level, it can interfere with health 
behaviors and help-seeking, contributing to the HBM Barrier dimension.  The fear of test 
results confirming cancer has been found to be a barrier to screenings for cervical, breast 
and colorectal cancer (Bajracharya, 2006; Kang, Thomas, Kwon, Hyun & Jun, 2008; 
Waller, et al., 2009).  Many breast and cervical cancer survivors report avoiding follow-
up diagnostic testing because they worry that they will discover the cancer has returned 
(Ashing-Giwa, Lim, &Gonzalez, 2010). Fear of treatment and negative treatment effects 
has prevented many cancer patients from accessing quality care (Burg, et al., 2010). 
Individuals with Hepatitis C also report fear of treatment as a reason for avoiding medical 
consultation (Swan, et al., 2010). The fear of treatment also extends to individuals 
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undergoing dental procedures (Garcha, Shetiya, & Kakodkar, 2010), although it is 
important to consider that fear of going to the dentist may be a separate component.  
In regard to dyspareunia, which rarely has a life threatening etiology or consequence, 
concerns may include the potential life impact of the problem, were it not to resolve. 
Generally speaking, pain with sexual intercourse can potentially wreak havoc on 
relationships (Donaldson & Meana, 2011; Meana, Binik, Khalife, & Cohen, 1997). 
Perhaps women are afraid to discover that their symptoms cannot be resolved medically 
and do not want to learn that they may potentially be facing a lifetime of relational 
challenges. On the other hand, because of the scarcity of public health information about 
dyspareunia, a significant number of women may fear that the pain experienced with 
intercourse indicates a serious disease or disorder related to internal organs, and that it 
may require invasive examinations and/or potentially even more painful treatment. Given 
the paucity of information available about intercourse pain, possible diagnoses, and 
treatment procedures, women may be left with a fear of 1) the unknown, 2) all known 
disorders that have pain as a symptom, 3) potential future consequences of the pain and 
any related disorders, 4) possibly gruesome treatment options and/or 5) the potential lack 
of any treatment options. Fear of dyspareunia being linked to a serious disease and fear 
that there may not be a cure were themes expressed repeatedly by women with 
dyspareunia in the Donaldson and Meana (2011) study. Whether hypothetical or 
experienced firsthand, dyspareunia clearly evokes a significant amount of fear pertaining 
to what the underlying problem, treatment, and consequences might be. This fear is 
sufficiently distressing for women to avoid investigating the actual severity of the 
problem, which unfortunately precludes finding a possible solution. 
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Correlations Between Barriers 
All three subscales of the SHTBS-Dysp positively correlated with one another, the 
highest correlation being between Shame and Fear of Severity, followed by Shame and 
Minimization and, finally, Fear of Severity and Minimization. The combination of shame 
and fear of diagnosis has been reported as a potential barrier to health-promoting 
behavior in men receiving prostate cancer screenings and breast cancer screening in 
African-American patients with self-detected breast changes (Gullatte, Brawley, Kinney, 
Powe, & Mooney, 2010; Naccarrato, & Piccoloto, 2011).  For those experiencing 
symptoms and already avoiding seeking assistance, there may also be shame associated 
with not seeking treatment. Despite the fact that the majority of our sample did not 
experience pain with intercourse, many still indicated that concerns about the pain‟s 
etiology, such as an STI, which could lead to feelings of shame. Women might be 
hesitant to seek help if they feel embarrassed and at fault for symptoms that they fear may 
additionally indicate a severe health condition. 
Even more understandable is the connection between Shame and Minimization. This 
combination has been identified as a treatment-seeking barrier in women with long-term 
urinary incontinence and as a barrier to health-related guideline adherence in patients 
with diabetes and hypertension (Adams & Carter, 2010; Hagglund & Wadensten, 2007). 
It would seem that in health conditions in which symptoms are of an intimate nature and 
include a type of internalized or externalized stigma, individuals might be more inclined 
to negate the severity of their symptoms as a way to avoid seeking help from a 
professional whom they fear may reinforce that experience of stigma or shame. In our 
hypothetical case scenario depicting dyspareunia, women imagined that they would be 
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embarrassed by experiencing pain with sexual intercourse and that they would be inclined 
to minimize their symptom. Our interpretation is that if these women could convince 
themselves that the pain is trivial and that it does not require assistance, they would be 
able to decrease the associated shame of having a problem with sexual intercourse. In 
addition, by minimizing the pain and avoiding seeking treatment, they would potentially 
avoid added shame and embarrassment involved with disclosing their symptoms to a 
health care professional.  
The more apparently paradoxical result from our study is the positive relationship 
between Minimization and Fear of Severity. How could one think something is 'no big 
deal' and concurrently be afraid that it might be very serious? This combination has 
actually been recorded previously in the health psychology literature. Minimization, in 
the form of denial, has been found in conjunction with the fear of severity as twin barriers 
to care-seeking for breast cancer symptoms and colorectal screenings (Bajracharya, 2006; 
Reifenstein, 2007). Although these studies did not examine the correlation between the 
barriers, it is interesting to note that in screenings for cancer, which is known to have 
improved prognosis with early detection, individuals are simultaneously fearful that they 
might have cancer and skeptical that their symptoms could possibly indicate such a 
serious condition. The fact that women in our study acknowledged and feared the 
potential severity of their pain, while at the same time dismissing its significance, is a 
finding parallel to those in the afore-mentioned studies. It appears that Minimization can 
serve as a type of coping mechanism against the anxiety and worry incorporated in the 
Fear of Severity barrier.  
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The use of minimization as a cognitive coping strategy has been found in various 
other health related conditions such as Alzheihmer‟s disease, cancer, HIV/AIDS, 
myocardial infarctions, and physical disability (Brink, Karlson, & Hallberg, 2002; 
Commerford, Gular, Orr, & Resnikoff, 1994; MacQuarrie, 2007; Orr & Meyer, 1990; 
Persson & Ryden, 2006). It appears that minimization facilitates coping with the negative 
emotional consequences of fear and shame. Denial and minimization may in fact be 
useful in the initial stages of discovering a concerning diagnosis. It may allow the 
individual to fully integrate the health threat without feeling overwhelmed by it. 
However, the benefits do not last long. Persistent minimization is maladaptive when it 
interferes with eventually getting the needed help in a timely fashion.  
Associated Constructs: What Are the Dyspareunia Treatment-Seeking Barriers Related 
to? 
In this study, barriers to treatment-seeking for dyspareunia correlated positively with 
our selected measures of somatic amplification, (SSAS), health anxiety (HAQ), pain 
catastrophization (PCS) and negative affect (MHI). Women in our study who experienced 
generally benign bodily symptoms as more intense and disturbing more strongly 
endorsed barriers to seeking treatment for the hypothetical or real prospect of having pain 
with intercourse. Those who indicated experiencing substantial general anxiety about 
their health were also more likely to endorse treatment-seeking barriers.  The tendency to 
exaggerate any experience of pain was associated with a greater likelihood to endorse 
barriers. And, finally, the more general distress a woman reported regularly, the more 
likely she was to endorse barriers to help-seeking. A more detailed interpretation of these 
findings follows.  
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Somatic Amplification and Health Anxiety 
We hypothesized that the SHTBS-Dysp would correlate negatively with 
somatosensory amplification and health anxiety based on evidence supporting the related 
frequency of higher symptom reporting and higher rates of health care utilization 
(Barsky, et al., 2001; Duddo, et al., 2006; Hiller, et al., 2003; Jackson, et al., 2006; 
Lucock & Morley, 1996; Salkovskis & Warwick, 2001; Seivewright, et al., 2004). 
However, contrary to our hypotheses, we found that women who were hypersensitive to 
bodily sensations and who had higher levels of health anxiety were more likely to 
endorse reasons to avoid seeking help for painful sexual intercourse. There is some recent 
research to support the paradoxical effect of high levels of health anxiety resulting in less 
help-seeking, although our results for somatization appear to stand alone. Walker and 
Furer (2006) found that individuals will avoid situations which cause them to experience 
discomfort, such as informing themselves about illnesses or having physicians confirm a 
feared diagnosis. Even in those who receive treatment, high levels of health anxiety have 
been associated with poor prognosis in some patients (Luconi, et al., 2007). 
One possible interpretation of our partly paradoxical findings is that hypervigilance, 
involved with somatic amplification and health anxiety, results in a type of enhanced 
attentional bias (Lees, et al., 2005). This attentional bias toward bodily sensations, which 
are perceived as being threatening and fearful, can increase pain severity and impairment 
and negatively impact understanding, problem-solving and decision making (Borkovec, 
Ray, & Stober, 1998; White, Craft, & Gervino, 2010). When the threat of pain is high and 
an individual‟s main concern is to escape and avoid the pain (Crombez, van Damme, & 
Eccleston, 2005), anything that might exacerbate the symptoms or increase anxiety, such 
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as treatment-seeking, may be avoided. This supports the hypervigilance-avoidance 
hypothesis which posits that anxious individuals initially attend to and then avoid 
threatening stimuli, including positive health information (Mogg, Bradley, DeBono, & 
Painter, 1997; Owens, et al., 2004). Women with provoked vestibulodynia (a sub-type of 
dyspareunia in which acute pain is experienced in the vulva during penetration) have in 
fact been found to be hypervigilant for pain (Desrochers, Bergeron, Khalife, Dupuis & 
Jodoin, 2009; Pukall, et al., 2002). If one combines this type of attentional bias with a 
lack of accurate public knowledge about dyspareunia, it is not that difficult to conceive of 
how fear and anxiety could also be a substantial barrier.  
The addition of shame about having a sexual problem may further magnify reasons to 
avoid a health-care consultation. Health anxiety correlated most strongly with the Shame 
barrier, suggesting that women with high levels of health anxiety might prefer to avoid 
treatment for real or imagined pain with intercourse because they would be too ashamed 
or embarrassed. Similar to the women who amplify their somatic symptoms, those with 
high levels of health anxiety might seek help more often for most general health-related 
concerns but not for concerns related to sexuality. In the case of dyspareunia, they may 
worry that they will be negatively judged. If this were an older sample, one might have 
wondered if it was also possible that these women may have over-utilized medical 
services for minor ailments in the past and may have been treated as overly sensitive by 
their health care providers having their symptoms dismissed. If a history of having 
symptoms minimized and being negatively evaluated exists, women with high levels of 
health anxiety and somatic amplification would be more hesitant to risk a similar 
99 
encounter with a more intimate health concern. However, considering the mean age of 
our sample, this is an unlikely explanation for these results. 
Pain Catastrophization 
We hypothesized that the SHTBS-Dysp scores would correlate negatively with the 
PCS, as suggested by the literature on the impact of pain catastrophization on treatment 
seeking (Goubert, et al., 2002; McGrady, et al., 1999). Individuals who generally 
interpret pain as a sign of serious hearth threats tend to seek help more often. However, 
our results indicated that individuals who made catastrophic interpretations of their pain 
were more likely to endorse barriers to treatment-seeking. There is limited research to 
offer an explanation of this finding. In an attempt to discover possible correlates in 
patients with somatoform disorders, Rief, Hiller and Margraf (1998) found that 
catastrophization of bodily symptoms, including pain, was not related to general health-
seeking behavior. Unfortunately, this study did not provide information as to the impact 
of catastrophization on health care utilization. We are then left to focus on our findings to 
help us better understand the connection between treatment avoidance and pain 
catastrophization.  
Pain catastrophization correlated highest with the Fear of Severity subscale, which 
suggests that the more negative the interpretation of what the pain might indicate, the 
more worried and concerned these women might be about the severity of the problem 
underlying the dyspareunia. This surmises the views of Asmundson, Vlaeyen, and 
Crombez (2004) who posit that fear and catastrophization can influence the experience of 
pain, creating additional psychological distress. In an attempt to cope with the 
repercussions of such an experience of even hypothetical pain, women in our study might 
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also minimize their symptoms and avoid help seeking. Catastrophization of pain during 
intercourse has been found to impact the experience negatively and contribute to the 
negative assessment of sexual stimuli (Brauer, de Jong, Huijding, Laan, & ter Kuile, 
2009; Pukall, et al., 2006) in women with dyspareunia. Again, despite the fact that most 
women in our sample did not experience pain with sexual intercourse, those who had a 
general pain catastrophizing style were more likely to endorse treatment-seeking barriers.  
Negative Affect 
Evidence supports the view that individuals high in negative affect tend to be more 
likely to seek help for physical problems. Health care utilization has been shown to be 
positively related to negative affect and emotional worries (Drossman, et al., 1988; 
Edege, 2007; Villanueva-Torrecillas, 2004). Based on these findings, we hypothesized 
that women who experience higher levels of negative affect would be less likely to 
endorse barriers to seeking help. However, we found that women with high levels of 
negative affect were more likely to endorse barriers to help-seeking, whether they 
experienced pain with sexual intercourse or only imagined themselves to. Considering 
that higher levels of mood disturbances, such as depression and anxiety, are associated 
with lower internal locus of control and self-efficacy, it is possible that these women did 
not feel they would be capable of acquiring the help needed (Heath, Saliba, Mahmassani, 
Major, & Khoury, 2008). Locus of control and self-efficacy also influence coping 
strategies and clinical outcomes such as health behaviors and pain perception (French, 
Holroyd, Pinell, Malinoski, O‟Donnell, & Hill, 2000; Rollnik, Karst, Fink, & Dengler, 
2001). Based on the magnitude of correlations of the SHBTS-Dysp subscales with the 
MHI, it appears that women with greater distress were more likely to minimize or deny 
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real or imagined symptoms, possibly as a way to avoid interacting with a health care 
provider they felt hopeless about or afraid of. This minimization could also serve as a 
coping mechanism for their lack of self-efficacy related to managing the pain.  
Hypothesized Barriers and Self-reported Treatment-Seeking Behavior 
 In our study, women with dyspareunia who indicated they would be more likely to 
endorse barriers to treatment seeking also reported fewer attempts at actually seeking 
assistance from health care providers. Women who had reported their symptoms to a 
health professional were less likely to endorse barriers than women who had not reported. 
This suggests that the barriers endorsed by women with dyspareunia in our study actually 
reflected what was preventing them from seeking help. However, it is important to 
consider that these women provided self-reports of their contacts with health care 
professionals and care must be taken in interpretation of this data.  Future research should 
avail itself of documented treatment-seeking attempts to truly test if the SHBTS is indeed 
predictive of actual behavior. 
Group Differences 
 The three groups of women in our study (women with dyspareunia, women who were 
sexually active but did not experience pain, and women yet to be sexually active) differed 
somewhat in the particular barriers they were more likely to endorse. Women who were 
sexually active but did not experience pain with sex scored lower on the subscale of 
shame than the other two groups of women. Perhaps shame was harder to imagine when 
they did not experience the problem. However, women who had yet to have sex scored 
higher than sexually active and pain-free women on the shame subscale. It is hard to 
interpret this finding other than to speculate that these young women who have delayed 
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their sexual debut are likely more conservative, or perhaps, religious and consequently 
more likely to attach shame to potential sexual problems and their disclosure. This group 
of sexually inactive women also scored higher on the subscale of fear of severity than the 
sexually active and pain-free women. This may reflect some apprehension about an 
activity they know little about. Women who have had sexual intercourse may be more 
familiar with the occasional discomfort experienced during sexual activity and be less 
likely to ruminate over potentially negative consequences of the symptom.  
The most surprising, and concerning, group difference found in this study was the 
fact that women with dyspareunia were more likely to endorse barriers to treatment 
seeking than the other two groups of women. One would intuit that the actual presence of 
the symptom would promote help-seeking, but it was quite the opposite in this study. 
Women actually experiencing dyspareunia indicated a greater tendency to minimize the 
pain than did other women. Despite their real experience, these young women tended to 
consider the pain sufficiently 'trivial' to avoid seeking assistance. This is despite the fact 
that research clearly indicates that these young women have substantial levels of 
associated distress, relationship difficulties, and physical discomfort (Donaldson & 
Meana, 2011).  
Significance of Research on Treatment Barriers in Dyspareunia 
Implications for Physicians 
Unfortunately, the history of individuals not reporting their sexual symptoms to 
medical professionals and of medical professionals not asking their patients about sexual 
concerns is a long one. Patients have reported that the reluctance to broach the topic of 
sexuality is due to their own embarrassment and the worry that their health care 
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professional will be embarrassed by such a conversation (Marwick, 1999). A study of 
physicians' willingness to assess sexual risk behaviors reinforces this worry, as 
physicians cited feeling embarrassed as a significant barrier to inquiring about patients' 
sexual practices (Khan, Plummer, Hussain, & Minichiello, 2007). These physicians 
admitted that further training in sexuality would help improve their skill in sexual health 
history-taking. Yet other literature documents the general lack of adequate sexuality 
training in medical school, which naturally inhibits physicians‟ willingness to broach the 
topic (Tsimtsiou, Hatzimouratidis, Nakopoulou, Kyrana, Salpigdis, & Hatzichristou, 
2006). In addition to the lack of training and embarrassment regarding sexually-related 
topics, medical professionals may experience frustration with the paucity of treatment 
options for sexual disorders and their lack of confidence in the available ones 
(Abdolrasulnia, et al., 2010). This might also contribute to their hesitancy to discuss 
sexual concerns with their patients (Goldstein, et al., 2009).   
The reluctance physicians experience in opening a dialogue about sexuality is 
particularly concerning because, according to our study, doctors were in fact reported to 
be the most likely health-care professionals women would turn to, a strong preference 
over sex therapists or psychologists also reflected in the literature (Spector & Carey, 
1990). However, it is crucial for all health care providers, including nurses, psychologists 
and physical therapists, to demonstrate comfort with the topic of sexuality. Considering 
that there is a current movement toward a more integrated, multidisciplinary, and 
systematic approach to treating pain with sexual intercourse (Meana, 2009; Weeks, 
2005), these women may need to disclose the nature of their symptoms to more than one 
type of health-care professional. 
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In order to overcome barriers to treatment-seeking, substantial changes in the way 
health care professionals address sexual concerns need to be considered. First of all, it is 
crucial that health care providers ask directly about sexual function, even if that is not the 
presenting concern during an office visit. It is also important that the exchange be a 
positive one. The health care provider needs to be knowledgeable about the disorder and 
enterprising about the assessment of pain and the full consideration of available treatment 
options, given the woman's specific symptoms and psychosocial profile. It is particularly 
important for physicians to take reports of pain with sexual intercourse seriously. They 
cannot become co-conspirators in the minimization of this problem. While women need 
to be informed that recurrent pain with sexual intercourse is not normal, they also need 
reassurance and hope. Considering the fear many women have about the cause of their 
pain and the procedures that might be required to treat it, women would benefit from 
having information about possible etiologies and treatments explained to them. Reaching 
all women before pain begins, would be ideal and thus public health care education needs 
to be brought into the equation.  
Implications for Public Health Care Provision 
Increased education about this disorder may be a critical component to breaking down 
the barriers to treatment-seeking for dyspareunia, especially considering that promotion 
of attention to health information has been associated with positive health behaviors 
(Shim, Kelly, & Hornik, 2006). In Donaldson and Meana's (2011) study of dyspareunia 
in college women, not one of them reported ever having heard of intercourse pain as an 
identifiable disorder. It is much easier to deny symptoms when there is limited or no 
awareness of the condition. To help women recognize their symptoms, and decrease the 
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tendency towards minimizing, there needs to be an emphasis on increasing public 
awareness of this distressing women's health condition. In our study, the Internet was the 
most popular source cited for help-seeking. Since women have been known to avoid 
other informal sources of health information, such as family and peers (Ward & Ogden, 
1994), the Internet may be an easier way of acquiring information since it avoids the 
potential embarrassment of disclosure. Either through the creation of individual websites 
or as part of public health advertisements for health care facilities, utilizing the Internet as 
a conduit could potentially reach those individuals who may still possess significant 
barriers to seeking help from an actual person.   
Ideally, public awareness attempts need to target women before they experience pain 
with sexual intercourse. As evident in this study, even women who are not sexually active 
already endorse a significant level of reluctance to seeking treatment of a potential health 
problem. It would be possible to include information about sexual pain disorders via sex 
education classes or health classes, where such curricular material is appropriate. 
Additionally, gynecologists may have the best opportunity to provide information to their 
patients either through signage and pamphlets in their offices or as part of their inquiries 
during annual examinations. Especially for women who have already started to 
experience pain with intercourse, the role of the gynecologist becomes even more crucial 
in providing the necessary information to facilitate increased disclosure about the 
specifics of the pain and to offer a knowledgeable perspective about the disorder and 
possible treatments. Primary care doctors also could be instrumental in providing 
information, if they included sexual health as part of their typical history-taking. This 
would require training in medical school and continuing education programs for doctors. 
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And, finally, considering that the highest prevalence of vulvovaginal pain has been found 
in young women (Laumann, et al., 1999), education efforts on college campuses would 
target the population at a time when treatment-seeking has the potential of being the most 
beneficial - early after onset.   
Limitations 
 This study had a number of limitations. First, the women who participated in this study were 
Psychology 101 students who volunteered for the study to receive research credit. It is not 
possible to ascertain what possible biases may have been included by the self-selection of these 
participants. However, two can be inferred. The first of these is the fact that, generally speaking, 
volunteers in sexuality-related studies tend to be more liberal. The second is that these young 
women were already more highly educated than the majority of the general population. 
Considering that liberality and education are more highly correlated with comfort with sexuality 
and with positive health behaviors, one can only surmise that the barriers to treatment seeking in 
the case of dyspareunia would be even more significant if a general population had been sampled 
(Lefkowitz, Boone, & Shearer, 2004; Sanders, Graham, Yarber, Crosby, Dodge, & 
Milhausen, 2006). Second, because our sample of women who actually had dyspareunia 
was much smaller than those who were sexually active without pain and not yet sexually 
active, we cannot be as confident as we might be about group differences or lack thereof. 
Third, the hypothetical health problem scenario, although widely used in the literature 
clearly has its limitations. For example, how scenarios are worded can greatly impact 
how individuals respond. Scenarios involving end-of-life decisions regarding treatments 
find different results based upon using positive versus negative wording (Kressel & 
Chapman, 2007). Since the self-reported barriers were provided for a hypothetical 
situation and not the current experience necessarily, it is difficult to explore predictions of 
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future treatment-seeking behaviors for women with dyspareunia and those without 
(Mansfield, et al., 2005). Finally, no actual behavioral indicators were used to test the 
predictive validity of our measure in regards to actual help-seeking and/or treatment 
adherence. 
Future Research 
Through the creation of a measure of possible barriers for dyspareunia, we were able 
to investigate the reasons that might keep women from seeking help for sexual pain. 
However, the validity of results is contingent on the validity of this measure. Additional 
psychometric testing of this measure via confirmatory principal component analysis with 
a different sample would assist in determining whether the factor solution found in this 
study provides an adequate fit for other samples.  Also, administering the measure to a 
larger number of women who actually experience dyspareunia may ultimately be more 
helpful. Tracking behavioral outcomes would also be the ultimate test of the measure's 
predictive validity. This might also allow for further analyses on the extent to which these 
barriers influence treatment-seeking in dyspareunia and how that might compare to other 
health concerns. It might also be useful to compare the barriers to treatment-seeking in 
these young women versus those of an older population. Not only would it offer insight 
into the development of these barriers and potential new ones, but it could shed light on 
how the experience of dyspareunia can influence women‟s perceptions of treatment over 
time. Adapting this measure to target hypothetical scenarios or real experiences of other 
types of sexual disorders (e.g., hypoactive sexual desire disorder, erectile dysfunction, 
premature ejaculation) could provide insight into differential treatment barriers for 
different sexual dysfunctions.  
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This study focused on the barriers young women would endorse in the event or 
actuality of having pain with sexual intercourse. A useful next step would be to 
investigate factors that could facilitate help-seeking in women with dyspareunia. By 
inquiring as to what assisted them in their decision-making process to disclose their 
symptom to a health professional, particularly how they may have overcome their 
barriers, we may be able to provide more opportunities and avenues for women with 
dyspareunia to seek help. Another useful avenue would be to investigate the experiences 
of women with dyspareunia who have actually reported the symptom to health care 
professionals. How were they made to feel? How seriously were they taken? How 
effortful was the treatment approach? This type of information would be helpful in the 
development of medical school training modules. Thirdly, research involving the most 
effective types of public health messages would also be helpful, as it would be central to 
develop these in a way that drew women in rather than scare or turn them away. There is 
an art to public health messaging but it takes science to know that that is for any given 
health issue and any given population. Finally, an investigation of cultural differences in 
attitudes about dyspareunia could ensure that women from different ethno-cultural groups 
are approached in culturally informed ways that promote health behavior. Painful 
intercourse is a socio-culturally loaded sexual dysfunction clearly influenced by 
internalized social messages about sexuality. To get under the determinants of treatment-
seeking, we necessarily have to get under these messages so as to promote the sexual 
well-being of all women.   
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APPENDIX A:  
EXHIBITS & TABLES 
Exhibit A1  Sexual Health Treatment Barriers Scale-Dyspareunia-Exploratory Version 
(SHTBS-DyspEXPV) 
 
Imagine that you begin to experience pain in your genitals or pelvic area while having 
sexual intercourse. The pain prevents you from enjoying sex and sometimes it hurts so 
much that you want to or have to stop having sex. You notice that this is now happening 
regularly whenever you have intercourse. You consider seeking help from a health 
professional. Below are several reasons or attitudes that make you hesitate to seek help. 
Please read each statement and decide how true it is for you. 
 
If I had pain with intercourse regularly, I would…  
 
Not at all true        Not very true    Somewhat true    Moderately true     Very true 
1     2   3   4     5 
   
1. …believe that the problem is probably temporary. 
2. …think the pain would go away on its own. 
3. …think that health professionals would not know how to treat it.  
4. …worry that the health professional would judge me negatively. 
5. …worry that the health professional might find I had a serious health problem. 
6. …worry that others would find out about the problem if I told a health professional. 
7. …believe this is a relationship problem rather than a health one. 
8. …delay getting treatment because I do not have health insurance. 
9. …believe that problems like this are part of having sex. 
10. …believe that problems like this are just something you have to deal with. 
11. …be afraid that the health professional would not take my problem seriously. 
12. …worry that the health professional would think that I am promiscuous (loose). 
13. …worry that I would be told that I have a sexually transmitted infection. 
14. …believe this is a sexual problem rather than a health one. 
15. …think that this is not a big enough problem for a consultation with a health 
professional. 
16. …not want the sort of help available. 
17. …be afraid that I would be told my behavior had caused this problem. 
18. …think this is a private issue and would not want to tell anyone. 
19. …think that it is incurable or untreatable. 
20. …delay seeking treatment because I do not have a regular health care provider. 
21. …believe that a health professional would not be able to tell me things about this 
problem that I do not already know. 
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Exhibit A1 (cont'd) 
 
22. …feel uneasy about my partner knowing that I was having a problem serious enough 
to seek help. 
23. …be afraid of what the treatment for this problem might be. 
24. …think there is no treatment for this.   
25. …not have enough time to seek help from a health professional 
26. …believe this is just a regular woman's problem. 
27. …believe this problem does not require treatment. 
28. …not trust health professionals to help with it. 
29. …worry that I had caused this problem. 
30. …be afraid that they might tell me there is no cure or treatment for it. 
31. …be afraid that I would have to take my clothes off to be examined. 
32. …think the problem was with my partner and not me. 
33. …be afraid that the health professional would order a series of tests I could not 
afford. 
34. …prefer to wait until I was sure the problem was serious enough to seek assistance. 
35. …not want a health professional to examine my private parts (genitalia). 
36. …think it is not a big deal because I know other women with this problem who have 
not sought treatment. 
37. …have difficulty fitting an appointment with a health professional into my busy 
schedule. 
38. …be afraid that I am overreacting to a problem that is not that serious. 
39. …be afraid the health professional might tell others about my problem. 
40. …be afraid to find out that this problem may impact my ability to have children in the 
future. 
41. …not think about seeking help since I never heard about this problem. 
42. …be concerned that my health insurance would not pay for treatment. 
43. …prefer just to suck it up rather than dwell on my problems by going to a health 
professional. 
44. …not want to disclose personal information about myself to health professionals. 
45. …worry that the health professional would think I am abnormal. 
46. …be afraid that the treatment for this would involve my partner. 
47. …worry that a health professional would tell others about this problem of mine. 
48. …think there would be nothing a health professional could do about it. 
49. …be concerned that I could not afford treatment. 
50. …consider this to be a minor problem that does not require treatment. 
51. …believe that individuals can fix this type of problem on their own. 
52. …be afraid that my friends and/or relatives would find out that I was having a 
problem serious enough to seek help. 
53. …be afraid that the treatment for this would affect my relationship with my partner. 
54. …not want my problem discussed among other health professionals. 
55. …not be able to get help due to a lack of access to a health professional. 
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Exhibit A1 (cont'd) 
 
56. …find it embarrassing to disclose to a health professional that I was having a problem 
with sex. 
57. …be concerned about their being a record (e.g., medical record or insurance record) 
of my seeking help for this type of problem. 
58. …not know what type of health professional to consult with. 
 
How likely would you be to seek help for this problem from a….. 
 
Not at all true       Not very true     Somewhat true      Moderately true     Very true 
         1                          2      3            4     5 
 
59. … sex therapist? 
60. … psychologist? 
61. … medical doctor? 
62. … friend? 
63. … sexual partner? 
64. … relative(s)? 
65. … the Internet? 
66. … clergy member? 
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Exhibit A2  Sexual Health Treatment Barriers Scale – Dyspareunia (SHTBS-Dysp) 
 
Imagine that you begin to experience pain in your genitals or pelvic area while having 
sexual intercourse. The pain prevents you from enjoying sex and sometimes it hurts so 
much that you want to or have to stop having sex. You notice that this is now happening 
regularly whenever you have intercourse. You consider seeking help from a health 
professional. Below are several reasons or attitudes that make you hesitate to seek help. 
Please read each statement and decide how true it is for you. 
 
If I had pain with intercourse regularly, I would…  
 
Not at all true        Not very true      Somewhat true       Moderately true      Very true 
1     2        3                 4          5 
 
1.…think the pain will go away on its own.  
2. …worry that the health professional would judge me negatively.  
3. …worry that the health professional might find I had a serious health problem.  
4. …worry that others would find out about the problem if I told a health professional.  
5. …believe that problems like this are just something you deal with.  
6. …be afraid the health professional would not take my problem seriously.  
7. …worry that the health professional would think I am promiscuous (loose).  
8. …worry that I would be told that I have a sexually transmitted infection.  
9. …think that this is not a big enough for a consultation with a health professional.  
10. …be afraid I would be told my behavior had caused this problem. 
11. …feel uneasy about my partner knowing that I was having a problem serious enough 
to seek help.  
12. …be afraid of what the treatment for this problem might be.  
13. …believe that this is just a regular woman‟s problem.  
14. …be afraid that they might tell me there is no treatment or cure for it.  
15. …prefer to wait until I was sure the problem was serious enough to seek assistance.  
16. …think it is not a big deal because I know other women with this problem who have 
not sought treatment.  
17. …be afraid I am overreacting to a problem that is not that serious.  
18. …be afraid the health professional might tell others about my problem.  
19. …be afraid to find out that this problem may impact my ability to have children in the 
future.  
20. …not think about seeking help since I have never heard about this problem.  
21. …prefer just to suck it up rather than dwell on my problems by going to a health 
professional. 
22. …not want to disclose personal information about myself to health professionals.  
23. …be afraid that the treatment for this would involve my partner.  
24. …worry that a health professional would tell others about this problem of mine.  
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Exhibit A2 (cont'd) 
 
25. …consider this to be a minor problem that does not require treatment.    
26. …be afraid that the treatment for this would affect my relationship with my partner.  
27. …not want my problem discussed among other health professionals. 
28. …find it embarrassing to disclose to a health professional that I was having a problem 
with sex.  
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Table A1  
Hypothesized Subscales of the SHTBS-DyspEXPV 
 
Minimizing Problem 
   
1. …believe that the problem is probably temporary. 
2. …think the pain would go away on its own. 
9. …believe that problems like this are part of having sex. 
10. …believe that problems like this are just something you have to deal with. 
15. …think that this is not a big enough problem for a consultation with a health 
professional. 
26. …believe this is just a regular woman's problem. 
34. …prefer to wait until I was sure the problem was serious enough to seek assistance. 
38. …be afraid that I am overreacting to a problem that is not that serious. 
43. …prefer just to suck it up rather than dwell on my problems by going to a health    
professional. 
50. …consider this to be a minor problem that does not require treatment. 
 
Distrust of Health Professionals 
 
3. …think that health professionals would not know how to treat it.  
11. …be afraid that the health professional would not take my problem seriously. 
16. …not want the sort of help available. 
21. …believe that a health professional would not be able to tell me things about this 
problem that I do not already know. 
28. …not trust health professionals to help with it. 
44. …not want to disclose personal information about myself to health professionals. 
48. …think there would be nothing a health professional could do about it. 
51. …believe that individuals can fix this type of problem on their own. 
 
Shame 
 
4. …worry that the health professional would judge me negatively. 
12. …worry that the health professional would think that I am promiscuous (loose). 
17. …be afraid that I would be told my behavior had caused this problem. 
22. …feel uneasy about my partner knowing that I was having a problem serious enough 
to seek help. 
29. …worry that I had caused this problem. 
45. …worry that the health professional would think I am abnormal. 
47. …worry that a health professional would tell others about this problem of mine. 
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Table A1 (cont'd) 
 
52. …be afraid that my friends and/or relatives would find out that I was having a 
problem serious enough to seek help.        
56. …find it embarrassing to disclose to a health professional that I was having a problem 
with sex. 
 
Fear of Severity/Impact 
 
5. …worry that the health professional might find I had a serious health problem. 
13. …worry that I would be told that I have a sexually transmitted infection. 
23. …be afraid of what the treatment for this problem might be. 
30. …be afraid that they might tell me there is no cure or treatment for it. 
40. …be afraid to find out that this problem may impact my ability to have children in the 
future. 
46. …be afraid that the treatment for this would involve my partner. 
53. …be afraid that the treatment for this would affect my relationship with my partner. 
 
Privacy 
 
6. …worry that others would find out about the problem if I told a health professional. 
18. …think this is a private issue and would not want to tell anyone. 
31. …be afraid that I would have to take my clothes off to be examined. 
35. …not want a health professional to examine my private parts (genitalia). 
39. …be afraid the health professional might tell others about my problem. 
54. …not want my problem discussed among other health professionals. 
57. …be concerned about their being a record (e.g., medical record or insurance record) 
of my seeking help for this type of problem. 
 
Problem identity confusion 
 
7. …believe this is a relationship problem rather than a health one. 
14. …believe this is a sexual problem rather than a health one. 
19. …think that it is incurable or untreatable. 
24. …think there is no treatment for this. 
27. …believe this problem does not require treatment. 
32. …think the problem was with my partner and not me. 
36. …think it is not a big deal because I know other women with this problem who have 
not sought treatment. 
41. …not think about seeking help since I never heard about this problem. 
58. …not know what type of health professional to consult with. 
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Table A1 (cont'd) 
 
Lack of resources 
 
8. …delay getting treatment because I do not have health insurance. 
20. …delay seeking treatment because I do not have a regular health care provider.  
25. …not have enough time to seek help from a health professional. 
33. …be afraid that the health professional would order a series of tests I could not 
afford. 
37. …have difficulty fitting an appointment with a health professional into my busy 
schedule. 
42. …be concerned that my health insurance would not pay for treatment. 
49. …be concerned that I could not afford treatment. 
55. …not be able to get help due to a lack of access to a health professional. 
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Table A2 
Demographic Characteristics of Entire Sample (N=1034) 
 
______________________________________________________________ 
 
 
Characteristic        M   SD   N         % 
_______________________________________________________________ 
Age          20.08   2.63  
 
Ethnicity        
African American            128  12.4 
 
American Indian/Native American               8    0.8  
 
Asian American            184  17.8  
 
EuroAmerican             469  45.4  
 
Hispanic American            170  16.4 
 
Pacific Islander American              67     6.5 
 
Other                      53          5.0 
 
Relationship Status  
 
Single and not currently dating                 341       33.0 
 
Single and currently dating           185    17.9 
 
Steady boyfriend              397    38.4 
 
Cohabitating or married             111     10.7 
 
Ever had sexual intercourse              830     79.6 
 
Age at first intercourse     16.71  1.82      
 
Nulliparious                  985      95.2 
 
Not sexually active                204      20.2  
 
Met criteria for dyspareunia              102      10.3 
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Table A3 
Demographic Characteristics of Test-Retest Sample (N=24) 
 
 
Characteristic      M  SD      N  % 
_______________________________________________________________ 
Age        20.08  2.52  
 
Ethnicity        
African American           4   16.7 
 
American Indian/Native American       0     0.0      
Asian American           4   16.7 
EuroAmerican            6   25.0 
Hispanic American            5   20.8 
 
Pacific Islander American          4   16.7 
  
Other                    1          4.2 
 
Relationship Status  
 
Single and not currently dating          9     37.5 
  
Single and currently dating           3     12.5 
 
Steady boyfriend             11     45.8 
 
Cohabitating or married              1        4.2 
 
Ever had sexual intercourse           20      83.3 
 
Age at first intercourse   16.35  1.63      
 
Nulliparious               24     100.0 
 
Not sexually active                      4       16.7  
 
Met criteria for dyspareunia               2         8.3 
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Table A4 
Item Descriptive Statistics 
Items with item-total correlations in boldface were excluded from all further analyses. 
________________________________________________________________________ 
  corrected   alpha-if 
item-total  item- 
Item correlations deleted   M   SD 
________________________________________________________________________ 
1   0.25  0.96   3.13  1.21 
2   0.32  0.96   3.25  1.16 
3   0.29  0.96   2.24  1.24  
4   0.57  0.96   2.29  1.23 
5   0.41  0.96   3.08  1.21 
6   0.60  0.96   2.20  1.24 
7   0.39  0.96   1.90  1.04 
8   0.32  0.96   1.98  1.32 
9   0.44  0.96   2.57  1.17 
10   0.50  0.96   2.39  1.16 
11   0.54  0.96   1.98  1.07 
12   0.60  0.96   2.01  1.18 
13   0.33  0.96   3.13  1.31 
14   0.43  0.96   2.66  1.07 
15   0.52  0.96   2.44  1.13 
16   0.52  0.96   1.92  0.98 
17   0.56  0.96   2.20  1.14 
18   0.64  0.96   2.58  1.25 
19   0.55  0.96   2.05  1.03 
20   0.41  0.96   2.03  1.26 
21   0.58  0.96   2.03  1.07 
22   0.61  0.96   2.57  1.29 
23   0.60  0.96   2.83  1.20 
24   0.52  0.96   2.12  1.12 
25   0.50  0.96   2.10  1.06 
26   0.58  0.96   2.54  1.09 
27   0.56  0.96   2.28  1.05 
28   0.61  0.96   1.75  0.92 
29   0.61  0.96   2.44  1.19 
30   0.54  0.96   2.61  1.24 
31   0.58  0.96   2.42  1.37 
32   0.40  0.96   2.15  1.00 
33   0.55  0.96   2.58  1.33 
34   0.56  0.96   2.96  1.28 
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Table A4 (cont'd) 
Variables in boldface were excluded from all further analyses. 
________________________________________________________________________ 
  corrected   alpha-if 
item-total  item- 
Item     correlations deleted   M   SD 
________________________________________________________________________ 
35   0.57  0.96   2.39  1.33 
36   0.49  0.96   2.20  1.10 
37   0.42  0.96   2.28  1.17  
38   0.62  0.96   2.73  1.13 
39   0.65  0.96   1.87  1.09 
40   0.43  0.96   3.17  1.31 
41   0.64  0.96   2.10  1.04 
42   0.48  0.96   2.35  1.31 
43   0.66  0.96   2.34  1.19 
44   0.72  0.96   2.03  1.11 
45   0.70  0.96   1.93  1.05 
46   0.63  0.96   2.45  1.19 
47   0.65  0.96   1.84  1.12 
48   0.61  0.96   2.05  1.10 
49   0.48  0.96   2.45  1.35 
50   0.63  0.96   2.48  1.11 
51   0.59  0.96   2.43  1.08 
52   0.66  0.96   2.51  1.31 
53   0.63  0.96   2.74  1.28 
54   0.56  0.96   2.43  1.32 
55   0.52  0.96   1.98  1.15 
56   0.70  0.96   2.47  1.31 
57   0.67  0.96   2.28  1.28 
58   0.60  0.96   2.25  1.22 
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Table A5 
Factor Loadings from Principle-Component Analysis with an  
Oblique Rotation (Promax with Kaiser Normalization; Kappa=2.5) and Communalities. 
Note: Salient factor pattern matrix coefficients are in boldface. Structural loadings are in 
parentheses. Factor 1 = Minimization. Factor 2 = Shame. Factor 3 = Fear of Severity. Factor 4 = 
Structural Problems. h² = communality. 
________________________________________________________________________ 
              
Item       1       2       3      4     h² 
________________________________________________________________________ 
 
2    .66 (.57)        -.14 (.12)     .04 (.15)         -.16 (.02)  .36 
3       .27 (.34)   .30 (.33)          -.31 (-.05)   .14 (.23)  .23 
4    .03 (.34)     .69 (.71)      .10 (.38)   .11 (.19)  .53 
5    -.12 (-.14)     .18 (.36)      .53 (.57)        .01 (.20)  .35 
6   -.06 (.30)      .70 (.74)     .18 (.45)   .25 (.04)  .57 
7                  .23 (.36)       .30 (.39)           -.19 (.09)   .20 (.32)  .25 
10    .65 (.67)       .14 (.37)           -.10 (.17)          -.04 (.19)  .46 
11    .20 (.43)    .50 (.59)   -.17 (.19)   .21 (.40)  .43 
12   -.00 (.33)    .68 (.73)    .17 (.44)          -.06 (.24)  .55 
13            -.09 (.11)  -.04 (.21)     .74 (.66)       -.10 (.11)  .47 
14                  .49 (.52)   -.04 (.25)      .13 (.28)   .03 (.22)  .29 
15                  .73 (.73)     .13 (.38)   -.12 (.16)  -.05 (.19)  .55 
17                  .07 (.34)     .40 (.56)     .36 (.53)  -.06 (.22)  .42 
18                  .32 (.54)     .39 (.60)      .24 (.48)      -.10 (.22)  .51 
19                  .30 (.49)     .19 (.45)      .12 (.37)    .19 (.40)  .35 
20              -.01 (.21)           -.07 (.20)   -.06 (.19)     .84 (.79)  .64 
21                 .37 (.55)    .21 (.46)   -.15 (.21)    .43 (.58)  .52 
22                 .18 (.42)    .07 (.42)    .60 (.70)     .04 (.32)  .53 
23                 .09 (.36)    .04 (.41)      .68 (.75)     .08 (.35)  .59 
24                 .26 (.44)    .07 (.37)      .19 (.40)      .28 (.45)  .34 
25                 .26 (.42)    .14 (.37)        -.03 (.23)      .35 (.47)  .32 
26                 .82 (.80)        -.01 (.35)     .04 (.28)          -.08 (.20)  .65 
29                 .09 (.37)   .21 (.50)     .56 (.68)      .01 (.30)  .52 
30                 .01 (.28)   .04 (.37)    .61 (.68)      .17 (.39)  .50 
31                .08 (.36)     .37 (.55)     .29 (.50)      .04 (.30)  .39 
32                 .02 (.23)     .16 (.34)      .24 (.38)      .18 (.33)  .21 
33               -.04 (.25)  -.06 (.46)      .25 (.21)     .73 (.78)  .66 
34                 .61 (.66)          -.17 (.26)    .23 (.41)     .15 (.36)  .51 
36                 .65 (.67)      .08 (.35)   -.05 (.20)        -.01 (.21)  .46 
____________________________________________________________________________ 
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Table A5 (cont'd) 
 
________________________________________________________________________ 
 
Item   1  2  3   4      h² 
________________________________________________________________________ 
 
 
38                .67 (.73)    -.09 (.34)     .27 (.47)         .02 (.30)  .60 
39               -.06 (.33)       .82 (.83)     .08 (.42)        -.00 (.30)  .70 
40                  -.01 (.20)             -.04 (.26)     .68 (.66)    .02 (.23)  .44 
41      .47 (.63)        .24 (.52)     .06 (.36)     .12 (.37)  .48 
42               -.10 (.19)             -.04 (.27)     .15 (.37)    .80 (.80)  .66 
43      .61 (.73)       .16 (.49)      .07 (.37)     .08 (.35)  .57 
44      .13 (.48)      .65 (.77)      .05 (.42)     .12 (.41)  .63 
46      .08 (.38)       .20 (.51)      .52 (.67)    .09 (.37)  .53 
47               -.09 (.32)     .85 (.84)      .04 (.40)     .02 (.32)  .71 
48                 .27 (.51)       .31 (.54)      .02 (.34)     .27 (.48)  .44 
50      .77 (.80)       .01 (.39)      .06 (.33)    .02 (.29)  .65 
52      .07 (.40)     .41 (.63)      .41 (.62)        -.00 (.31)  .55 
53                 .05 (.36)       .18 (.50)      .60 (.73)     .08 (.36)  .57 
54               -.04 (.29)      .56 (.64)      .21 (.45)     .03 (.28)  .44 
55               -.08 (.23)    .11 (.36)      .04 (.31)     .76 (.79)  .63 
56      .04 (.40)      .55 (.72)      .32 (.58)    .03 (.34)  .61 
58                 .11 (.39)           .27 (.51)      .17 (.43)    .30 (.50)  .41 
__________________________________________________________________________ 
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Table A6 
Interfactor Correlations, Eigenvalues, and Percentage of Variance 
Factor 1 2 3 4 
1. Minimization --    
2. Shame    .45 --   
3. Fear of Severity    .33 .44 --  
4. Structural Problems    .32 .36  .33 -- 
Variance % 33.37 6.88 5.00 4.23 
Eigenvalues 15.35 3.16 2.30 1.94 
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Table A7 
Scale Descriptive Statistics 
Variables in boldface were excluded from all further analyses.  
__________________________________________________ 
 
              alpha-if- 
    Cronbach‟s    item- 
Scale     alpha  Item   deleted   
__________________________________________________ 
Minimization  .89   
   2    .89    
         10    .89 
         15    .88 
         26    .88 
         34    .89 
         36    .89 
         38    .88 
         41    .89 
         43    .88 
         50    .87 
Shame              .91           
   4     .90 
                   6          .90 
               11    .90 
                     12    .89 
                                             17    .90 
                        39    .89 
                           44    .89 
                         47    .89 
                        54    .90 
                                   56    .89 
Fear of Severity    .86   
            5     .85 
          13        .85 
          22    .84 
          23    .83 
          30    .84 
            40    .85 
           46    .84 
           53    .83 
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Table A7 (cont'd)  
 
Scale Descriptive Statistics  
Variables in boldface were excluded from all further analyses.  
_________________________________________________ 
 
                 alpha-if- 
       Cronbach‟s    item- 
Scale       alpha   Item   deleted   
_________________________________________________ 
  53    .83 
Structural Problems .84 
             20     79 
            21    .86 
            33    .79 
            42    .78 
             55    .79 
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Table A8 
Sexual Health Treatment Barriers Scale – Dyspareunia (SHTBS-Dysp) Subscales 
 
Imagine that you begin to experience pain in your genitals or pelvic area while having 
sexual intercourse. The pain prevents you from enjoying sex and sometimes it hurts so 
much that you want to or have to stop having sex. You notice that this is now happening 
regularly whenever you have intercourse. You consider seeking help from a health 
professional. Below are several reasons or attitudes that make you hesitate to seek help. 
Please read each statement and decide how true it is for you. 
 
If I had pain with intercourse regularly, I would…  
 
Not at all true      Not very true     Somewhat true        Moderately true      Very true 
1     2      3              4                 5 
 
Minimization 
 
1.   …think the pain will go away on its own.  
5.   …believe that problems like this are just something you deal with. 
9.   …think that this is not a big enough problem for a consultation with a health    
professional. 
13.  …believe that this is just a regular woman‟s problem. 
15.  …prefer to wait until I was sure the problem was serious enough to seek assistance. 
16.  …think it is not a big deal because I know other women with this problem who have 
not sought treatment. 
17.  …be afraid I am overreacting to a problem that is not that serious. 
20.  …not think about seeking help since I have never heard about this problem. 
21.  …prefer just to suck it up rather than dwell on my problems by going to a health 
professional. 
25.  …consider this to be a minor problem that does not require treatment. 
 
Shame 
 
2.  …worry that the health professional would judge me negatively.  
4.  …worry that others would find out about the problem if I told a health professional. 
6.  …be afraid the health professional would not take my problem seriously. 
7.  …worry that the health professional would think I am promiscuous (loose). 
10.  …be afraid that I would be told my behavior had caused this problem. 
18.  …be afraid the health professional might tell others about my problem.  
22.  …not want to disclose personal information about myself to health professionals. 
24.  …worry that a health professional would tell others about this problem of mine. 
27.  …not want my problem discussed among other health professionals. 
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Table A8 (cont'd) 
 
28.  …find it embarrassing to disclose to a health professional that I was having a 
problem with sex.  
          
Fear of Severity 
 
3.  …worry that the health professional might find I had a serious health problem. 
8.  …worry that I would be told that I have a sexually transmitted infection. 
11.  …feel uneasy about my partner knowing that I was having a problem serious enough 
to seek help.  
12.  …be afraid of what the treatment for this problem might be. 
14.  …be afraid that they might tell me there is no treatment or cure for it. 
19.  …be afraid to find out that this problem may impact my ability to have children in 
the future. 
23.  …be afraid that the treatment for this would involve my partner. 
26.  …be afraid that the treatment for this would affect my relationship with my partner. 
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Table A9 
Correlations for the SHTBS-Dysp Total Score, SHTBS-Dysp Subscales and the Somatosensory 
Amplification Scale (SSAS) (N=1034) 
______________________________________________________________________________ 
 
1  2  3  4  5  
______________________________________________________________________________ 
1   SHTBS-Dysp Total   -  
2    Minimization    .80* - 
3 Shame      .89* .56*      - 
4    Fear of Severity    .82* .44* .66*      - 
5   Total SSAS     .14* .13* .11* .11*      - 
______________________________________________________________________________ 
*p < .005, Bonferroni corrected alpha.  
 
 
Table A10 
Correlations for the SHTBS-Dysp Total Score and its Subscales and the Health Anxiety 
Questionnaire (HAQ) and its Subscales (N=1034) 
______________________________________________________________________________ 
 
1  2  3  4  5  6  7  8  9 
______________________________________________________________________________________ 
1   SHTBS-Dysp Total    -  
2   Minimization    .80*  - 
3   Shame     .89* .56*  - 
4   Fear of Severity   .82* .44* .66*       - 
5   Total HAQ    .27* .17* .27* .24*        - 
6   HAQ: Worry  
     and  Health     .25* .16* .25* .23* .94*       - 
     Preoccupation 
7   HAQ: Fear of Illness . 28*  .16* .28* .26* .91* .78*     - 
     and Death 
8   HAQ: Reassurance-  .11* .08  .10  .11* .73* .63* .54*      - 
     Seeking Behavior 
9   HAQ: Extent to Which  .12* .10* .13* .07  .47* .36* .28* .26*  - 
     Symptoms Interfere  
     With the Person‟s Life 
______________________________________________________________________________ 
*p < .001, Bonferroni corrected alpha. 
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Table A11  
Correlations for the SHTBS-Dysp Total Score and its Subscales and the Pain Catastrophization 
Scale (PCS) and its Subscales (N=1034) 
___________________________________________________________________________ 
 
1  2  3  4  5  6  7  8 
___________________________________________________________________________ 
1   SHTBS-Dysp  
      Total     -  
2    Minimization   .80* - 
3    Shame     .89* .56* - 
4    Fear of Severity   .82* .44* .66*  - 
5  Total PCS    .27* .18* .16*  .27* - 
6  PCS: Rumination  .21* .14* .16* .24* .92* - 
  PCS: Magnification  .30* .21* .27* .28* .84* .67* - 
8  PCS: Helplessness  .24* .16* .22* .23* .94* .77* .72* - 
______________________________________________________________________________ 
*p < .002, Bonferroni corrected alpha. 
 
 
Table A12 
Correlations for the SHTBS-Dysp Total Score and its Subscales and the Mental Health Inventory 
(MHI) and its Subscales (N=1034) 
___________________________________________________________________________ 
 
1  2  3  4  5  6  7  8  9 
___________________________________________________________________________________ 
1   SHTBS-Dysp 
     Total     -  
2   Minimization   .80* - 
3   Shame    .89* .56* - 
4   Fear of Severity  .82* .44* .66* - 
5   Total MHI    .27* . .26* .23* .17* - 
6   Anxiety Subscale  .24* .22** .20* .16* .81* - 
     (MHA) 
7   Depression Subscale  .27* .25* .24* .18* . 85*  .67* - 
     (MHD) 
8   Behavior Control   .23* .21* .23* .13* .87* .55* .72* - 
     Subscale (MHC) 
9   Positive Affect  .11  .13* .07  .06  .74* .42* . 43*  .60* - 
     Subscale (MHP) 
______________________________________________________________________________ 
*p < .001, Bonferroni corrected alpha. 
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Table A13 
Means, Standard Deviations for SHTBS-Dysp Subscales and Total Score  
as a Function of Group 
______________________________________________________________________________ 
 
                Dyspareunia      Sexually Active             Sexually Inactive  
                Without Pain       
           (N=102)                      (N=728)               (N=204) 
 
Dependent Measure  M      SD                 M           SD   M         SD       
______________________________________________________________________________ 
 
Minimization    28.03a   7.55         25.35 b      8.19       24.43b       8.10 
 
Shame      23.74a   9.25           20.54b       8.66     22.91a       8.18 
 
Fear of Severity   23.62ab   6.75           22.05b      7.19       23.97a       6.85 
 
SHTBS-Dysp.   75.39a 18.79          67.94b     20.16      71.30ab    19.83 
Total Score 
______________________________________________________________________________ 
Means with differing subscripts within rows are significantly different at the p < .05 
based on Scheffe‟ post hoc paired comparisons. 
 
 
 
Table A14 
Analyses of Variance of SHTSB-Dysp Subscales & Total Score as a Function of Group 
(N=1034) 
_____________________________________________________________________________ 
 
Source    df   SS   MS   F   w² 
_____________________________________________________________________________ 
 
Minimization  2.00        896.66   448.33     6.82*  0.01 
 
Shame    2.00  1560.33  780.17   10.49** 0.02 
 
Fear of Severity  2.00    705.93  352.97     7.05*  0.01 
 
SHTBS-Dysp.   2.00  5947.91  973.95       7.46*  0.01 
Total Score 
______________________________________________________________________________ 
*p<.05,**p<.001. 
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Table A15 
Means and Standard Deviations for Likelihood of Help Seeking Source (N=1034) 
______________________________________________________________________________ 
 
Dependent Measure  M  SD 
______________________________________________________________________________ 
 
Sex Therapist   2.18  1.22 
 
Psychologist   1.93  1.08 
 
Medical Doctor   4.05  1.07 
 
Friend     3.05  1.31 
 
Sex Partner    3.19  1.31 
 
Relative(s)    2.19  1.22 
 
Internet     3.63  1.30 
 
Clergy Member   1.31  0.66 
______________________________________________________________________________ 
  
168 
 
Table A16 
Means & Standard Deviations for Likelihood of Help Seeking Source 
as a Function of Group 
_____________________________________________________________________________ 
 
       Dyspareunia      Sexually Active        Sexually Inactive 
    Without Pain  
   (N=102)                  (N=728)            (N=204)     
  
Dependent Measure  M     SD          M        SD     M     SD       
____________________________________________________________________________ 
 
Sex Therapist   2.26   1.29          2.16     1.23              2.18        1.14 
 
Psychologist   2.20a   1.22         1.87 b   1.07    2.02ab     1.03 
 
Medical Doctor   3.74a   1.13         4.08 b   1.06    4.08b       1.04 
 
Friend     3.01   1.35         3.05     1.33       3.07    1.25 
   
Sex Partner    3.05   1.36          3.25     1.31       3.05    1.26 
 
Relative(s)    2.07a   1.22          2.14a    1.19        2.44 b      1.31 
 
Internet     3.60ab   1.44          3.70b   1.29        3.39a       1.24 
 
Clergy Member   1.36   0.63          1.30     0.65                1.31     0.70 
______________________________________________________________________________ 
Means with differing subscripts within rows are significantly different at the p < .05 
based on Scheffe‟ post hoc paired comparisons. 
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Table A17 
Analysis of Variance of Likely Help Seeking Sources as a Function of Group (N=1034) 
_____________________________________________________________________________ 
 
Source    df   SS   MS   F   w² 
_____________________________________________________________________________ 
 
Sex Therapist  2.00       0.82            0 .41  0.28  0.00 
 
Psychologist*  2.00      11.73          5.87   5.07  0.01 
 
Medical Doctor* 2.00      10.60          5.30   4.68  0.01 
 
Friend    2.00        0.21          0.10     0.06  0.00 
 
Sex Partner   2.00  8.81          4.40   2.59  0.01 
 
Relative(s)*  2.00      15.83          7.91   5.36  0.01 
 
Internet *   2.00      14.24    7.12   4.23  0.01 
 
Clergy Member  2.00  0.38    0.19   0.43  0.00 
______________________________________________________________________________ 
*p<.05. 
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Appendix B 
 
Female Sexual Function Index (FSFI)  
INSTRUCTIONS: These questions ask about your sexual feelings and responses during 
the past 4 weeks. Please answer the following questions as honestly and clearly as 
possible. Your responses will be kept completely confidential. In answering these 
questions the following definitions apply: 
Sexual activity can include caressing, foreplay, masturbation and vaginal intercourse. 
Sexual intercourse is defined as penile penetration (entry) of the vagina. 
Sexual stimulation includes situations like foreplay with a partner, self-stimulation 
(masturbation), or sexual fantasy. 
 
*CHECK ONLY ONE BOX PER QUESTION* 
 
Sexual desire or interest is a feeling that includes wanting to have a sexual 
experience, feeling receptive to a partner's sexual initiation, and thinking or 
fantasizing about having sex. 
 
1. Over the past 4 weeks, how often did you feel sexual desire or interest? 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
2. Over the past 4 weeks, how would you rate your level (degree) of sexual desire or 
interest? 
 
 Very high 
 High 
 Moderate 
 Low 
 Very low or none at all 
 
Sexual arousal is a feeling that includes both physical and mental aspects of sexual 
excitement. It may include feelings of warmth or tingling in the genitals, lubrication 
(wetness), or muscle contractions. 
 
3. Over the past 4 weeks, how often did you feel sexually aroused ("turned on") 
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during sexual activity or intercourse? 
 
 No sexual activity 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
4. Over the past 4 weeks, how would you rate your level of sexual arousal ("turn on") 
during sexual activity or intercourse? 
 
 No sexual activity 
 Very high 
 High 
 Moderate 
 Low 
 Very low or none at all 
 
5. Over the past 4 weeks, how confident were you about becoming sexually 
aroused during sexual activity or intercourse? 
 
 No sexual activity 
 Very high confidence 
 High confidence 
 Moderate confidence 
 Low confidence 
 Very low or no confidence 
 
6. Over the past 4 weeks, how often have you been satisfied with your arousal 
(excitement) during sexual activity or intercourse? 
 
 No sexual activity 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
7. Over the past 4 weeks, how often did you become lubricated ("wet") during 
sexual activity or intercourse? 
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 No sexual activity 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
8. Over the past 4 weeks, how difficult was it to become lubricated ("wet") during sexual 
activity or intercourse? 
 
 No sexual activity 
 Extremely difficult or impossible 
 Very difficult 
 Difficult 
 Slightly difficult 
 Not difficult 
 
9. Over the past 4 weeks, how often did you maintain your lubrication ("wetness") until 
completion of sexual activity or intercourse? 
 
 No sexual activity 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
10. Over the past 4 weeks, how difficult was it to maintain your lubrication 
("wetness") until completion of sexual activity or intercourse? 
 
 No sexual activity 
 Extremely difficult or impossible 
 Very difficult 
 Difficult 
 Slightly difficult 
 Not difficult 
 
11. Over the past 4 weeks, when you had sexual stimulation or intercourse, how often did 
you reach orgasm (climax)? 
 
 No sexual activity 
 Almost always or always 
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 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
12. Over the past 4 weeks, when you had sexual stimulation or intercourse, how difficult 
was it for you to reach orgasm (climax)? 
 
 No sexual activity 
 Extremely difficult or impossible 
 Very difficult 
 Difficult 
 Slightly difficult 
 Not difficult 
 
13. Over the past 4 weeks, how satisfied were you with your ability to reach orgasm 
(climax) during sexual activity or intercourse? 
 
 No sexual activity 
 Very satisfied 
 Moderately satisfied 
 About equally satisfied and dissatisfied 
 Moderately dissatisfied 
 Very dissatisfied 
 
14. Over the past 4 weeks, how satisfied have you been with the amount of 
emotional closeness during sexual activity between you and your partner? 
 
 No sexual activity 
 Very satisfied 
 Moderately satisfied 
 About equally satisfied and dissatisfied 
 Moderately dissatisfied 
 Very dissatisfied 
 
15. Over the past 4 weeks, how satisfied have you been with your sexual 
relationship with your partner? 
 
 No sexual activity 
 Very satisfied 
 Moderately satisfied 
 About equally satisfied and dissatisfied 
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 Moderately dissatisfied 
 Very dissatisfied 
 
16. Over the past 4 weeks, how satisfied have you been with your overall sexual life? 
 
 No sexual activity 
 Very satisfied 
 Moderately satisfied 
 About equally satisfied and dissatisfied 
 Moderately dissatisfied 
 Very dissatisfied 
 
17. Over the past 4 weeks, how often did you experience discomfort or pain during 
vaginal penetration? 
 
 Did not attempt intercourse 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
18. Over the past 4 weeks, how often did you experience discomfort or pain following 
vaginal penetration? 
 
 Did not attempt intercourse 
 Almost always or always 
 Most times (more than half the time) 
 Sometimes (about half the time) 
 A few times (less than half the time) 
 Almost never or never 
 
19. Over the past 4 weeks, how would you rate your level (degree) of discomfort or pain 
during or following vaginal penetration? 
 
 Did not attempt intercourse 
 Very high 
 High 
 Moderate 
 Low 
 Very low or none at all 
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Appendix C 
 
Socio-Demographic Questionnaire 
 
1. How old are you? ______ 
 
2. With which of the following groups do you most identify? (Please check one) 
____Caucasian or European-American 
____Hispanic-American/Latina/Chicana 
____Asian-American 
____African-American 
____American Indian/Native-American 
____Pacific Islander-American 
Other (Please specify):___________________________ 
3. Which of the following relationship situations best describes you? (Please check 
one) 
____Single, not currently dating 
____Single and currently dating 
____Steady boyfriend 
____Cohabitating or married 
4. How many children do you have? ____None ____1 ____2 ____3 or more 
 
5. Have you ever had sexual intercourse?  ____ YES   ____NO 
 
6. How old were you when you had intercourse for the first time?  
_____Years old  _____I have not yet had sexual intercourse 
 
(If you have not yet had sexual intercourse, you can skip the rest of the questions 
on this questionnaire. If you have had sexual intercourse please proceed) 
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7. Do you regularly have pain with sexual intercourse? ____YES ____NO 
(If your answer is NO to #6, you can skip the rest of the questionnaires. If you 
have pain with intercourse, please proceed) 
8. When did intercourse start to become painful?  
a. _____From the first time  
b. _____After a few months 
c. _____After a year or more 
 
9. For how long have you had consistent pain with intercourse?  
_____Years ______Months  
 
10. How often do you have pain with intercourse (Please check one) 
____Once in a while (less than 10% of the time) 
____Occasionally (about one time out of four – 25% of the time) 
____About half of the time (50% of the time) 
____Very often ( 75% of the time) 
____Almost always or always   
Choose the words that describe your pain but do not select more than one word in a 
group.  
Group 1 
____Flickering  
____Pulsing  
____Quivering 
____Throbbing 
____Beating 
____Pounding 
Group 2 
____Jumping, 
____Flashing 
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____Shooting 
Group 3 
____Pricking 
____Boring 
____Drilling       
____Stabbing 
Group 4 
____Sharp 
____Gritting 
____Lacerating 
Group 5 
____Pinching 
____Pressing 
____Gnawing 
____Cramping 
____Crushing 
Group 6 
____Tugging 
____Pulling 
____Wrenching 
Group 7 
____Hot 
____Burning 
____Scalding 
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____Searing 
Group 8 
____Tingling 
____Itching 
____Smarting 
____Stinging 
Group 9 
____Dull 
____Sore 
 ____Hurting 
____Aching, 
____Heavy 
Group 10  
____Tender 
____Taunt 
____Rasping 
____Splitting 
Choose the words that describe your pain but do not select more than one word in a 
group.  
Group 11 
____Tiring 
____Exhausting 
Group 12 
____Sickening 
____Suffocating 
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Group 13 
____Fearful 
____Frightful 
____Terrifying 
Group 14 
____Punishing 
____Grueling 
____Cruel 
____Vicious 
____Killing 
Group 15   
____Wretched 
____Binding 
Choose the words that describe your pain but do not select more than one word in a 
group.  
Group 16 
____Annoying 
____Troublesome 
____Miserable 
____Intense 
____Unbearable 
Group 17 
____Spreading 
____Radiating 
____Penetrating 
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____Piercing 
Group 18 
____Tight 
____Numb 
____Squeezing 
____Drawing 
____Tearing 
Group 19 
____Cool 
____Cold 
____Freezing 
Group 20 
____Nagging,  
____Nauseating 
____Agonizing 
____Dreadful 
____Torturing 
Group 21 
____No pain 
____Mild 
____Discomforting 
____Distressing 
____Horrible 
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____Excruciating 
11. How distressing is this problem to you? (Please check one) 
____ Not at all  
____ Slightly  
____ Somewhat  
____ Very  
____ Extremely  
 
12. Have you reported the problem to a health professional? ____YES  ____NO 
a. If so, what type of health professional? (Please check one) 
 
____General medical doctor (family doctor) 
____Obstetrician/Gynecologist (OBGYN) 
____Nurse/Physician‟s assistant 
____Psychotherapist/Counsellor/Sex therapist 
____Physical Therapist 
____Other (please specify):_______________________________ 
13. Approximately how many times have you complained to a health professional 
about this problem (if you have spoken multiple times to one doctor, count those 
also)? _____ 
14. Approximately how many different doctors or health professionals have you seen 
about this problem?_____ 
15. Approximately how many different treatments or suggestions made by a doctor or 
health professional have you tried? _____ 
16. What type of treatment have you received? (Please check all that apply) 
 
____Acupuncture 
____Pain killers 
____Anticonvulsants 
____Antidepressants 
____Antianxiety medications 
____Biofeedback 
____Couples therapy/Sex therapy 
____Electrical stimulation 
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____ Reducing contact with irritating substances, i.e., nylon panties, 
soaps, detergents, etc.) 
____Individual Psychotherapy/Counseling 
____Interferon injections 
____Special diets 
____Lubricants 
____Physical therapy 
____Surgery 
____Anaesthetic creams (creams that numb the area) 
____Vaginal dilation 
____Sitz bath 
____Antifungal creams (same as those used for yeast infections) 
____Other creams (e.g. cortisone) 
____Antifungal pills (e.g., Diflucan) 
 
17. If you have consulted a doctor or another type of health professional for this 
problem, please rate how satisfied you have been with the care provided by the 
last health professional you consulted? 
____Not at all satisfied 
____Slightly satisfied 
____Somewhat satisfied 
____Moderately satisfied 
____Very satisfied 
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Somatosensory Amplification Scale (SSAS) 
 
On this questionnaire are groups of statements. Please read each group of statements 
carefully. Then check off the one statement in each group which best describes YOU IN 
GENERAL! 
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1. I can‟t stand smoke, smog, or pollutants in the air. 1 2 3 4 5 
2. I am often aware of various things happening within 
my body. 
1 2 3 4 5 
3. When I bruise myself, it stays noticeable for a long 
time. 
1 2 3 4 5 
4. I sometimes feel the blood flowing in my body. 1 2 3 4 5 
5. Sudden loud noises really bother me.  1 2 3 4 5 
6. I can sometimes hear my pulse or my heartbeat 
throbbing in my ear.  
1 2 3 4 5 
7. I hate to be too hot or too cold.  1 2 3 4 5 
8. I am quick to sense the hunger contractions in my 
stomach. 
1 2 3 4 5 
9. Even something minor, like an insect bite or a 
splinter, really bothers me.  
1 2 3 4 5 
10. I can‟t stand pain.  1 2 3 4 5 
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Health Anxiety Questionnaire (HAQ) 
 
This questionnaire is concerned with people‟s attitudes about their health. Some of the 
questions concern your bodily symptoms and feelings which can mean pains, aches, 
sickness, dizziness, breathing difficulties, tiredness, etc. 
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1. Do you ever worry about your health? 0 1 2 3 
2. Are you ever worried that you may get a serious illness 
in the future? 
0 1 2 3 
3. Does the thought of a serious illness ever scare you? 0 1 2 3 
4. When you notice an unpleasant feeling in your body, do 
you tend to find it difficult to think of anything else? 
0 1 2 3 
5. Do you ever examine your body to find whether there is 
something wrong? 
0 1 2 3 
6. If you have an ache or pain, do you worry that it may be 
caused by a serious illness?  
0 1 2 3 
7. Do you ever find it difficult to keep worries about your 
health out of your mind? 
0 1 2 3 
8. When you notice an unpleasant feeling in your body, do 
you ever worry about it? 
0 1 2 3 
9. When you wake up in the morning do you find you very 
soon begin to worry about your health? 
0 1 2 3 
10. When you hear of a serious illness or death of 
someone you know, does it ever make you more 
concerned about your own health? 
0 1 2 3 
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11. When you read or hear about an illness on TV or 
radio, does it ever make you think you may be suffering 
from that illness? 
0 1 2 3 
12. When you experience unpleasant feelings in your body 
do you tend to ask friends or family about them? 
0 1 2 3 
13. Do you tend to read up about illness and diseases to 
see if you may be suffering from one? 
0 1 2 3 
14. Do you ever feel afraid of news that reminds you of 
death (such as funerals, obituary notices)? 
0 1 2 3 
15. Do you ever feel afraid that you may die soon? 0 1 2 3 
16. Do you ever feel afraid that you may have cancer? 0 1 2 3 
17. Do you ever feel afraid that you may have heart 
disease? 
0 1 2 3 
18. Do you ever feel afraid that you may have any other 
serious illness?   
0 1 2 3 
19. Have your bodily symptoms stopped you from 
working during the past six months or so? 
0 1 2 3 
20. Do your bodily symptoms stop you from concentrating 
on what you are doing? 
0 1 2 3 
21. Do your bodily symptoms stop you from enjoying 
yourself? 
0 1 2 3 
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Pain Catastrophizing Scale (PCS) 
 
Think about past painful experiences and indicate how much you experienced each of the 
following thoughts or feelings.  
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1. I worry all the time about whether the pain will 
end.  
0 1 2 3 4 
2. I feel I can‟t go on. 0 1 2 3 4 
3. It‟s terrible and I think it is never going to get 
any better. 
0 1 2 3 4 
4. It‟s awful and I feel that it overwhelms me.  0 1 2 3 4 
5. I feel I can‟t stand it anymore.  0 1 2 3 4 
6. I become afraid that the pain may get worse. 0 1 2 3 4 
7. I think of other painful experiences.  0 1 2 3 4 
8. I anxiously want the pain to go away. 0 1 2 3 4 
9. I can‟t seem to keep it out of my mind.  0 1 2 3 4 
10. I keep thinking about how much it hurts.  0 1 2 3 4 
11. I keep thinking about how badly I want the 
pain to stop.  
0 1 2 3 4 
12. There is nothing I can do to reduce the 
intensity of the pain. 
0 1 2 3 4 
13. I wonder whether something serious may 
happen.  
0 1 2 3 4 
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Mental Health Inventory (MHI) 
For each question, choose only one answer.  
How much of the time, during the 
past month. 
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1. Has your daily life been full of 
things that were interesting to you? 
 
      
2. Did you feel depressed?  
 
 
      
3. Have you felt loved and wanted? 
 
      
4. Have you been a very nervous 
person? 
 
      
5. Have you been in firm control of 
your behavior, thoughts, emotions, 
and feelings? 
      
6. Have you felt tense or high-
strung? 
 
      
7. Have you felt calm and peaceful? 
 
      
8. Have you felt emotionally stable? 
 
      
9. Have you felt downhearted and 
blue? 
 
      
10. Were you able to relax without 
difficulty? 
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How much of the time, during the 
past month. 
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11. Have you felt restless, fidgety, or 
impatient? 
 
      
12. Have you been moody, or 
brooded about things? 
 
      
13. Have you felt cheerful, light-
hearted? 
 
      
14. Have you been in a low or very 
low spirits? 
 
      
15. Were you a happy person? 
 
 
      
16. Did you feel you had nothing to 
look forward to?  
 
      
17. Have you felt too down in the 
dumps that nothing could cheer you 
up? 
      
18. Have you been anxious or 
worried? 
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Demographic Information  
 
1. How old are you ? ____________ 
 
2. With which of the following groups do you most identify? (Please check one.) 
 
___African American  
      ___ American Indian/Native American 
___Asian American  
___EuroAmerican (Caucasian)  
___Hispanic American  
___Pacific Islander-American 
Other: ___________________________ 
3. Which of the following relationship situations best describes you?  
 (Please check one.) 
 ___Single, not currently dating 
 ___Single and currently dating 
 ___Steady boyfriend 
 ___Cohabitating or married 
4. How many children do you have? ______ 
5. Have you ever had sexual intercourse? 
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___Yes           
___No 
6. How old were you when you had intercourse for the first time?______ 
7. Over the past 4 weeks, how often did you experience discomfort or pain during vaginal 
penetration? 
___ Did not attempt intercourse. 
___ Almost always or always 
___ Most times (more than half the time)  
___ Sometimes (about half the time) 
___ A few times (less than half the time) 
___ Almost never or never 
8. Over the past 4 weeks, how often did you experience discomfort or pain following 
vaginal penetration? 
___ Did not attempt intercourse. 
___ Almost always or always 
___ Most times (more than half the time)  
___ Sometimes (about half the time) 
___ A few times (less than half the time) 
___ Almost never or never 
9. Over the past 4 weeks, how would you rate your level (degree) of discomfort during or 
following vaginal penetration? 
___ Did not attempt intercourse. 
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___ Very high 
___ High 
___ Moderate 
___ Low 
___ Very low or none at all 
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